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INTRODUCTION 
This thesis deals with a number of methodological and 
clinical aspects of essential hypertension in relation to the 
sympathetic nervous system, with special reference to the 
adrenoceptors. For a clear comprehension of the studies 
presented later, some of the clinical backgrounds and the 
methodological principles will briefly be explained in the 
following introductory section. Furthermore, a short outline 
of the thesis will be given. 
HYPERTENSION 
High blood pressure or hypertension affects about 10% of 
the adult population in western countries and is one of the 
major risk factors for cardiovascular morbidity and 
mortality. In less than 10% of the hypertensives a cause can 
be determined -the so-called secondary forms of hypertension. 
In the remaining 90% or more no cause can be found according 
to the present state of knowledge. This vast majority of 
hypertensives is considered to have primary or essential 
hypertension. 
Although for more than 50 years many investigators have 
studied the problem, they have not succeeded in detecting a 
definite pathophysiology for primary hypertension. The 
failure to find the primary anomaly has led some authors to 
speculate that primary hypertension is not a uniform entity, 
but that it consists of a number of different subgroups. 
Others have hypothesized that primary hypertension is 
multifactorial. This means that there is a number of factors 
from different regulatory systems, separately or in 
connection with each other, that can disturb the balance in 
the regulation of the circulation. In the literature the 
latter theory is referred to as the mosaic theory, originally 
brought forward by Page in 1949 (1) and adapted by him in 
1982 (2). Table 1 gives the basic factors or elements of both 
versions of the mosaic, without showing the complex mutual 
interrelations between them. 
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Table 1. The 8 main elements of Page's mosaic theory of 
primary hypertension in 1949 (left) and in 1982 
(right). 
cardiac output haemodynamics 
volume endocrine 
neural neural 
chemical humoral 
elasticity anatomical 
vascular caliber adaptive (intracellular 
electrolytes and autoregu-
lation) 
reactivity genetic (race, stress, 
salt sensitivity etc.) 
viscosity environmental 
(salt, body weight, 
alcohol) 
Both versions of the mosaic include the neural element of 
the nervous system. In fact the central and in particular the 
sympathetic part of the nervous system have been the subject 
of an increasing number of investigations. The central 
nervous system in humans remains relatively inaccessible for 
investigations, so most energy has been spent on the 
peripheral sympathetic nervous system and its possible role 
in the pathogenesis of primary hypertension. 
THE PERIPHERAL SYMPATHETIC NERVOUS SYSTEM AND PRIMARY 
HYPERTENSION 
It has been assumed for a long time that the sympathetic 
nervous system (SNS) may contain the essential abnormality 
responsible for primary hypertension (3). However, assumption 
has not yet been proved for at least two reasons. The first 
reason is that independent investigation of the SNS is 
difficult, since the system interacts with nearly all other 
elements of the mosaic, as illustrated in Figure 1. Thus, 
cause and consequence cannot easily be distinguished. The 
second reason is that the methodology of investigation of the 
SNS is complex. All messages within the SNS are transported 
along the nervous fibres and finally translated into a 
release of the neurotransmitter (usually noradrenaline), 
which is carried into the synaptic cleft of the target organ. 
The neurotransmitter binds to a structure, 
the adrenoceptor. These ADRENOCEPTORS are localized in an 
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effector organ, for instance, the vascular smooth muscle. 
haemodynamic 
k 
genetic 
structural 
endocrine 
(adrenaline) 
environment (stress) 
Na-membrane-
transport 
(renal, vascular wall) 
intracellular Ca ++ 
renin-angiotensin system 
Figure 1. The elements considered to play a possible role in 
the pathogenesis of primary hypertension, in their 
relationship to the sympathetic nervous system 
(SNS) 
Binding of the transmitter to the adrenoceptor starts a 
number of biochemical events, ultimately resulting in a 
haemodynamic effect, for example, contraction or dilatation 
of the vascular smooth muscle, depending upon the type of 
adrenoceptor. 
It is difficult to perform direct measurement of the 
sympathetic nerve activity in large groups of patients. A 
method for determining the concentration or the turnover of 
the transmitter(s) directly within the synaptic cleft is not 
even available for application in humans. Therefore, we have 
to manage with indirect parameters like venous plasma 
catecholamine levels as an index for sympathetic activity. 
Although there have been numerous comparative studies in 
hypertensives and normotensive controls carried out, it is 
still controversial whether or not plasma catecholamines are 
elevated in patients with primary hypertension (4). 
Additional information about the SNS can be obtained by 
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measuring the binding sites or the adrenoceptors themselves. 
ADRENOCEPTORS 
The development of the radioligand binding technique with 
radioactively labeled agonists or antagonists has made it 
possible to study the adrenoceptors at the molecular level. 
Adrenoceptors not only play a crucial role in the 
cardiovascular system but also in a variety of metabolic 
processes. Three of the four subtypes of adrenoceptors are 
linked to the same biochemical effector, the adenylyl cyclase 
system, which generates the second messenger З'Б'-cyclic 
adenosine monophosphate or cAMP. The ßj.- and ß2-adrenoceptors 
stimulate the enzyme, whereas the «z-adrenoceptors inhibit 
the system (5). =!-Adrenoceptors are coupled to processes 
that regulate cellular calcium-ion levels. The receptors ctnd 
the adenylyl cyclase are connected with each other by a 
coupling protein (G), which is regulated by guanosine 
triphosphate (GTP). Two structurally related forms of this 
protein couple either stimulatory (β) or inhibitory (=2) 
receptors with the catalytic moiety. The uncomplexed receptor 
comprises the low affinity state, while the receptor-coupling 
protein complex forms the high affinity state. In general two 
binding states сгш be distinguished when agonists bind to a 
receptor. Antagonists bind only to the uncomplexed receptor. 
Agonists occupy the receptors and induce a stimulatory or 
inhibitory effect on the cAMP production, depending on 
whether it involves a β- or an «z-adrenoceptor. Antagonists 
occupy the receptors and block further signal transduction. 
In Figure 2 a schematic view of the connection of the β- and 
•»^-adrenoceptor with the adenylyl cyclase system is given. 
For reasons of convenience both « 2- and ß-adrenoceptors are 
drawn in connection with the same enzyme system. Whether 
these two receptor subtypes are actually coupled with the 
same cyclase system has not been proved. For a better 
understanding of the system, one has to take into mind that 
the different components of the adenylyl system are not 
permanently coupled, but collide to each other at certain 
times, due to the fluidity of the membrane. 
In humans most studies of adrenoceptors have been 
performed with blood cells. Platelets contain «2-
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adrenoceptors, whereas mononuclear cells have ß2-adreno-
ceptors. 
Figure 2. Schematic view of adrenoceptor signal pathways in 
relation to CAMP. 
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Abbreviations used: H; h; hormone, neurotransmitter or drug 
(agonist or antagonist) 
»z = "z-adrenoceptor GTP= guanosine triphosphate 
β = ß-adrenoceptor GDP= guanosine diphosphate 
Ge = stimulatory G-protein ATP= adenosine triphosphate 
Gi = inhibitory G-protein 
cAMP= З'З'- cyclic adenosine monophosphate 
However, it has yet to be established how accurately changes 
of receptors on blood cells reflect those on vascular 
tissues. 
Adrenoceptors have been studied on blood cells in relation 
to several disorders, such as thyroid disease, congestive 
heart failure, asthma, ischaemic heart diseases, psychiatric 
diseases and essential hypertension (5,6,7). It has been 
shown that physiological phenomena, such as desensitization 
and hypersensitivity are caused by, respectively, a decrease 
(downregulation) and an increase of receptor numbers 
(upregulation). These phenomena have mainly been studied in 
ß-adrenoceptors (5,7). A change in adrenoceptor numbers, and 
defects in effector coupling and regulation mechanisms have 
been stated as being involved in several disorders. However, 
data from clinical studies are often confusing and 
contradictory. The field of radioligand binding studies of 
the adrenoceptors is young and exciting. Many methodological 
factors, such as the choice of the radioligand, tissue 
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preparation, definition of the non-specific binding and 
correlation of the physiological effect with the findings in 
direct binding studies, are still subject of investigation. 
Furthermore, the selection criteria of patients and 
measurements of clinical parameters, such as blood pressure 
have not always been properly defined in clinical studies. 
METHOD FOR DETERMINATION OF THE ADRENOCEPTORS 
In this section the general principle of the method will 
be described. For more detailed information the reader is 
referred to the chapters 1, 2 (ßz-adrenoceptor) and 3 (œ2-
adrenoceptor). In direct binding studies tissue homogenates 
or cell suspensions are incubated with increasing 
concentrations of radioactively labeled agonists or 
antagonists, called radioligands. After the incubation the 
bound radioligand is separated from the free radioligand by 
filtration or centrifugation. By plotting bound against free 
radioligand concentrations a binding curve can be 
constructed. In practice, the total radioligand binding is 
measured. This consists of both specific and non-specific 
binding. To determine specific receptor binding, the total 
binding has to be corrected for non-specific binding. Non-
specific binding is measured as radioligand binding in the 
presence of an excess of non-labeled or cold ligand. By 
subtracting the latter binding from the total binding, a 
curve representing the specific binding can be calculated. An 
example is shown in Figure 3. From the binding curves two 
parameters can be derived - the receptor density (further in 
this thesis abbreviated as B„,^x or R0) and the affinity of 
the radioligand for the receptor (Κα). If the ratio specific 
bound/free radioligand concentration is plotted against 
specific bound radioligand concentration, a straight line is 
obtained (Scatchard plot) (8). Figure 4 shows such a plot. 
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Figure 3. An example of a simulated binding curve, showing 
that the specific binding is a subtraction of the 
non-specific binding from the total binding. The 
affinity corresponds with the free radioligand 
concentrations (abscissa) at a 50% receptor 
occupancy (ordinate) 
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Figure 4. scatchard plot of the simulated specific binding 
data of Figure 3 
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The intercept on the abscissa represents the receptor 
density, whereas the affinity can be calculated from the 
slope of the line as indicated in the figure. However, in all 
our studies we have always used the affinity constant and the 
receptor density, as estimated in a non-linear fit of the 
binding curve. The Scatchard plot was used for quality 
control and to detect whether additional binding sites were 
present. For further details and theoretical background we 
refer to the literature (5,6,7,9). 
OUTLINE OF THE THESIS 
This thesis consists of a methodological part (chapters 
1-3) and a clinical part (chapters 4-11). 
In the methodological section special attention is given 
to the cell preparation used for the adrenoceptor measure-
ments and to the definition of the non-specific binding. In 
particular, the determination of ß2-adrenoceptors on 
lymphocytes was evaluated both in intact and in broken cells 
(chapter 1). Furthermore, the kinetics of high and low 
concentrations of the radioligand :l2Slodocyanopindolol have 
been studied (chapter 2). With regard to the measurement of 
the «z-adrenoceptor on platelets with 3Hrauwolscine as 
radioligand, we describe the method that we have adopted from 
the laboratory of Brodde in Essen (FRG) and only report some 
quality tests (chapter 3). 
In the clinical part the baseline characteristics of the 
β2- and «2-adrenoceptors have been measured in a group of 
healthy normotensive volunteers and compared with those 
measured in a group of subjects with primary hypertension. 
The influence of a number of other variables, such as age, 
sex, Quetelet's index, have been taken into account (chapter 
4). Besides differences in the number and affinity of the 
adrenoceptors at rest, abnormalities concerning these 
properties in hypertensives may only emerge when a 
provocation test is done. For the sympathetic nervous system 
a number of these so-called "stress-tests" are known (10). In 
small groups of normo- and hypertensive subjects we have 
tested the following stresses: mental arithmetic (chapters 5 
and 6), handgrip isometric exercise (chapter 7) and dynamic 
bicycle exercise (chapters 8 and 9). 
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Previously we acquired experience with a large number of 
patients with complaints of triphasic discoloration of hands 
and feet due to peripheral vasospasm. This clinical picture 
is called the primary Raynaud's phenomenon. When we observed 
these patients in conjunction with the literature, the 
question arose whether this phenomenon might be caused by a 
disturbance in the sympathetic nervous system, especially an 
increase in the vasoconstrictive «2- and/or a decrease in the 
vasodilatory ßz-adrenoceptor number (chapter 10). 
Finally the regulation of the adrenoceptors could be studied 
in a small group of adrenalectomized females (all had 
previously suffered from Cushing's disease). Since mental 
arithmetic stress caused an acute upregulation of the ßz 
adrenoceptors in volunteers, the role of the adrenal medulla 
in this upregulation could be studied (chapter 11). 
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CHAPTER 1 
COMPLICATIONS OF ( - ) ^23lODOCYANOPINDOLOL BINDING TO HUMAN 
MONONUCLEAR CELLS 

Archives internationales de Pharmacod)namie et de Thérapie 
Vol. 290 -No. 2- December 1987 
Complications of (-)125l-lodocyanopindolol 
Binding to Human Mononuclear Cells 
S. J. G R A A F S M A , P. J. F . S N I J D E R S , 
J. F . R O D R I G U E S D E M I R A N D A A N D T H . T H I E N 
Departments of Pharmacology and Internal Medicine, 
Division of General Internal Medicine, University of Nijmegen, 
The Netherlands 
Abstract—(-)l25I-Iodocyanopindolol (l25ICYP) binding to intact 
and ultrasonically treated human mononuclear cells (MNC) was 
studied. Specific binding of 125ICYP defined as the difference in 
binding in the presence and absence of 2 μΜ ( ± )-propranolol 
displayed in intact cells a dissociation constant (Kd) of 
11.8±2.7pM and a ^-adrenoceptor number (Rt) of 2371 ±154 
sites/cell. This specific binding, however, still had a complex 
character. In broken cells a homogeneous class of binding sites with 
a Kd-value of 6.7+1.0 pM and a Rt-value of 883 + 89 sites/cell 
was found. When in intact cells nonspecific binding was determined 
with CGP-12177, a hydrophilic ^-adrenoceptor antagonist, a 
homogeneous class of binding sites was found with a Kd of 
7.0 ± 0.3 pM and a Rt of 1645 + 95 sites/cell. Inhibition curves with 
( + )-, ( — )-, ( + )-propranolol, timolol and CGP-12177, obtained 
with ultrasonically treated cells were monophasic. In intact cells 
propranolol and timolol not only displaced 125ICYP from its specific 
sites, but in an almost monophasic way also from nonspecific 
binding sites. CGP-12177, however, showed a clear plateau. It is 
concluded that in broken MNC a loss of binding sites may occur, 
whereas in intact cells additional binding interferes with the correct 
determination of specific 125ICYP binding. The latter can be reduced 
to a minimum by using hydrophylic ligands such as CGP-12177 to 
measure nonspecific binding. 
Introduction 
Mononuclear cells (MNC) from human peripheral blood are often 
employed to monitor changes in ^-adrenoceptor characteristics in relation 
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to several disorders, in spite of the fact that it is not yet clear how well 
defects in receptor characteristics in target tissues are mirrored in receptors 
on these cells. 
Meurs et al (1982) as well as Landmann et al. (1983) compared 
( —l'H-dihydroalprenolol ^HDHA) binding in crude membrane 
preparations of MNC with binding to intact viable cells. Both groups 
measured lower /?-adrenoccplor binding sites in broken cells than in intact 
cells With respect to the affinities Landmann et al. (1983) found similar 
values in both cell preparations, whereas Meurs et al. (1982) measured 
lower affinity in the membrane preparation, and therefore, concluded that 
the use of membranes might give erroneous interpretation of binding 
results With the introduction of '^I-Iodocyanopindolol (i:;5ICYP) a more 
appropriate radioligand for the measurement of low receptor densities has 
become available (Engel et ai, 1981 ). Nevertheless, the affinities and recep-
tor densities in intact MNC, as found by several authors in clinical studies 
with i:sICYP, still differ considerably (Halper et al, 1984; Krawietz étal., 
1985, O'Hara and Brodde, 1984) 
The advantage of the use of broken cells is that they can be pooled and 
stored and experiments can be repeated. However, incorrect values for 
adrenoceptor densities and affinities may be found, due to disruption and 
storage (Landmann et al, 1983). 
Studies on intact cells are complicated by a high proportion of uptake of 
hgand into the cell (Laduron, 1984) which can easily be mistaken for 
receptor binding. Different experimental conditions have been used, like 
hypotonic treatment and inclusion of phentolamine or chloroquine, to 
circumvent this problem (Paletta et ai, 1982; Meurs et al., 1982, O'Hara 
and Brodde, 1984; Marinem et al, 1983). Recently Staehehn and Hertel 
(1983) introduced a hydrophilic ^-adrenoceptor ligand CGP-1217?^ In 
intact C6-glioma cells they demonstrated that CGP-12177 probably binds 
exclusively to cell surface receptors. The advantage of using hydrophilic 
agents instead of the above mentioned procedures to circumvent uptake is 
that no interference with physiological cell processes will take place. 
Although recent studies indicate an increased number of ^-adrenoceptors 
in MNC in patients with essential hypertension (Brodde et ai, 1984; 
Fitzgerald et ai, 1983; Middeke et ai, 1983) others did not confirm those 
results (Feldman et ai, 1984; Kafka étal, 1979). This discrepancy may be 
due to the above mentioned problems Therefore, we performed a study of 
l2,ICYP binding to intact MNC and tried to find out the optimal con-
ditions to measure receptor density in intact cells, using propranolol and 
CGP-12177 to determine nonspecific binding. We compared these results 
with those found in ultrasonically treated cells. 
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Methods 
( —)125I-Iodocyanopindolol (l25ICYP) was purchased from NEN Europe 
(±2200Ci/mmol) or from Amersham International (± 1800Ci/mmol); 
( —)- and ( + )-propranolol were obtained from ICI; timolol from Merck 
Sharp and Dohme; CGP-12177 was generously supplied by Dr. 
M. Staehelin from Ciba Geigy; ( + )-propranolol from Sigma Chemical Co. 
All other reagents were of analytical grade. 
Blood was taken from healthy volunteers by venipuncture. M NC were 
isolated from heparinized blood (lithium heparin 14.3 U.S.P. units/ml) by 
the method of Böyum (1968). Fresh whole blood was diluted with an equal 
volume of phosphate buffered saline (PBS), pH = 7.4, containing 2.7 mM 
KCl, 7.7 mM Na2HP04 , 1.5 mM KH 2P0 4 and 150 mM NaCl and layered 
on Ficoll-Paque (Pharmacia Fine Chemicals) in a proportion 5:2 in 
polypropylene (Falcon) tubes. Tubes were centrifuged at 800 χ g for 15 min 
at room temperature. The MNC band was carefully aspirated, and washed 
3 times with PBS at 4° С After the last washing step cells were resuspen-
ded in Dulbecco's buffer, pH=7.4, containing 0.9 mM CaClj, 0.5 mM 
MgCl2, 1.5 mM ΚΗ 2 Ρθ4, 6.5 mM N a 2 H P 0 4 , 2.6 mM KCl, 5.1 mM 
glucose and 150mM NaCl. Bovine serum albumin (0.1 %) was added to 
prevent adhesion of cells. For some experiments a buffy coat 
anticoagulated with sodiumcitrate (2.63 %) was obtained from the local 
blood bank and treated in the same way as mentioned above. Cell viability 
was checked by the trypan blue exclusion test. 
Broken MNC were prepared by ultrasonication at an amplitude of 
6 microns, 3 times during 3 sec with an ultrasonifier (M.S.E.) immediately 
after isolation or after storing at - 20° С The broken cells could be stored 
for 2 weeks without effects on binding parameters. For the binding studies 
with intact cells, cells were immediately used after isolation. Particle bound 
radioactivity was measured as follows: 500 μΐ conical polypropylene 
centrifuge tubes received in this order: 50 μΐ 125ICYP in Dulbecco's buffer 
(for binding experiments 2-150 pM or for inhibition experiments about 
20 pM), 50 μΐ Dulbecco's buffer with or without competing ligand, and 
320 μΐ of a suspension of intact cells (0.8 1.12.106) or membrane suspension 
(from 0.8-1.12.106 cells). The tubes were incubated at 37° С for 60 min in a 
water bath, gently shaken during 5 sec every 15 min and then centrifuged at 
18,000xg for 15 min in a Heraeus Hämofuge. Aliquote (250/Л) of the 
supernatants were taken for assessing free concentrations of radioligand 
(the remaining supernatant was removed by aspiration). The tips of the 
centrifuge tubes containing the pellets were cut off, to measure bound 
radioligand. The samples were counted in a Nuclear Enterprise 1612 
Gamma counter at an efficiency of about 75 % (SD < 0.025). 
The binding and inhibition parameters were calculated by subjecting the 
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data to a nonlinear, least squares curve fitting procedure using the Gauss 
Newton algorithm (Rodrigues de Miranda étal, 1985). Two kinds of 
models were used in the analysis of the data In model A, total binding was 
corrected for nonspecific binding determined m the presence of 2 μΜ 
( ± )-propranolol or 3 μΜ CGP-12177. The resulting specific binding was 
fitted with a model with one class of binding sites. In model B, total 
binding was analyzed in terms of one class of binding sites plus a non­
specific binding term Inhibition curves were analyzed according to one and 
a two binding site model Statistical criteria All values are given ± S E. 
Preference was given to a model with more parameters, when a significant 
diminution in the residual sum of squares (X2) was obtained (F-test) 
Wilcoxons signed rank test was used in those expenments where paired 
observations were compared A P-value<005 was considered to be 
significant 
Results 
Figure 1 shows a representative example of 125ICYP binding to intact 
and broken cells from the same blood sample The specific part of the 
binding was saturable in the case of broken cells, and a Scatchard represen-
bound , 2 5ICYP 
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Binding of '25ICYP to human mononuclear cells in intact (a) and broken cell preparations 
(b) of the same blood sample Binding parameters intact cells Kd = 101 pM, 
Rt = 1926 sites/cell, broken cells Kd = 2 8 pM, Rt = 638 sites/cell Inset Scatchard plot of the 
specific part of binding Nonspecific binding was defined as the radioactivity measured in the 
presence of 2 μΜ ( + )-propranolol 
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TABLE I 
Comparison of nsICYP binding parameters of intact and broken cells 
Kd (pM) 
Rl (sites/cell) 
Intact Cells ( 
model A 
11.8 ±2.7 
2371 ±154 
n = l l ) 
model В 
7.0 ±1.1 
1632 ±144 
Broken Cells ( 
model A 
6.7 ± 1.0 
883 ± 89 
n = 13) 
model В 
5.9 ±0.6 
819 ±90 
tation (insert) pointed to a homogeneous population of binding sites. 
Binding to intact cells showed a more complex appearance, and could not 
adequatedly be described by one binding site model. For this reason 
analysis was performed with a model presuming an additional partition 
term, to determine nonspecific binding (model B). 
bound 1 2 5 ICYP ( fmol / I O 5 cells) 
0 2 5 
0 2 0 -
015 
0104 
0 0 5 
- 6 - 4 - 2 
log cone inhibitor ( M ) 
FIG. 2 
Inhibition of 125ICYP by ( ± )- and ( + ^ propranolol in intact and broken cell preparations. 
Intact cells: closed circles: ( ± )-propranolol Ki1=0.29nM, open circles: ( + ^propranolol 
Ki1 = 31.2nM; ultrasonically treated cells: closed squares: ( ± ^ propranolol Ki = 0.35nM, 
open squares ( + )-propranolol Ki = 35 nM. Inhibition of total binding was analyzed presum­
ing one type of binding site, in case of ultrasonically treated cells, whereas in case of intact 
cells a two binding site model was used. Free '"ICYP concentration was approximately 
20 pM. 
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In Table I, Kd- and Rt-values of 125ICYP binding in the presence or 
absence of ( ± )-propranolol to intact and broken cells, calculated as the 
mean of resp. 11 and 13 experiments are summarized. Binding parameters 
of broken cells did not vary within experimental error, when nonspecific 
binding was measured using either model A or B. However, in intact cells 
in most cases, statistical significant better fits were obtained (F-test 
ρ < 0.05) with model B. The use of model В was accompanied with a 
decrease in Rt of 33.1 % + 5.8 %. 
TABLE II 
inhibition constants (Ki-values) of antagonists for ß-adrenoceptors on intact 
and broken mononuclear cells 
^-Adrenoceptor antagonist 
( - )-Propranolol 
( + )-Propranolol 
( + )-Propranolol 
Timolol 
CGP-12177 
Intact Cells 
Κι,ίηΜ) 
006 
0 20 
0 29 
0 27 
31.2 
130 
08 
0 4 * 
017 
Broken Cells 
Ki (nM) 
021 
0 50 
053 
035 
40 
65 
0.33 
031 
Inhibition of total l25ICYP-binding was analyzed according to a model with one class of 
binding sites for broken cells and a model with two classes of binding sites for intact cells 
except for CGP-12177 where in experiment (*) the model presuming one class of binding sites 
gave an adequate (it. 
The stereoselectivity of the binding sites was investigated by inhibition of 
125ICYP binding at a free concentration of about 20 pM, by ( + )-, ( - ) -
and ( ± )-propranolol (Fig. 2). As can be seen in Table II, inhibition 
appeared to be stereoselective for both cell preparations, with similar 
inhibition constants. The values are given as the result of individual 
experiments. Curves obtained with ultrasonically treated cells were 
monophasic for all agents used. In intact cells, however, a more complex 
pattern was seen, and additional binding sites had to be assumed to 
describe the inhibition of 125ICYP binding. The characteristics of the 
additional binding sites could not be determined accurately as only part of 
125ICYP bound to these sites was displaced in our experiments. The 
calculated dissociation constants for these sites (data not shown) have no 
direct physical meaning and served merely to correct the lower part of the 
curve describing the inhibition of 125ICYP to the /^-adrenergic receptors. 
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To examine the effect of lipophilicity of the unlabeled ligand on deter­
mination of the specific binding to intact cells, 125ICYP binding was perfor­
med in the presence of either ( + )-propranolol or CGP-12177 to estimate 
nonspecific binding. In 6 paired determinations in which the binding curves 
were analyzed according to model A, Kd decreased from 9.2 ± 0.6 to 
7.0±0.3pM (p<0.05), and Rt from 2068 ±136 to 1645 ±95 sites/cell 
(p<0.05) (n = 6), when CGP-12177 was used instead of propranolol. The 
effect of lipophilicity was further investigated by inhibition of l25ICYP 
binding by timolol and CGP-12177 in intact and broken cells (Table II). 
Although timolol is a more hydrophilic agent than propranolol, it 
displaced 125ICYP from its additional binding sites. 
When CGP-12177 was used as a competing agent a monophasic dis­
placement curve was obtained with a plateau between 3.10-8 and 10 " 6 M. 
At higher concentration however CGP-12177 also displaced 125ICYP 
binding from additional sites. 
Discussion 
Specific 125ICYP binding to ultrasonically treated MNC appeared to be 
saturable, of high affinity and stereospecific. 
Binding to intact cells, although being of high affinity and stereoselective, 
had a more complex appearance. Besides being composed of specific 
saturable binding and nonspecific nonsaturable binding, defined as the 
125ICYP binding in the presence of 2 μΜ ( ± )-propranolol, there was a 3rd 
additional binding component. Additional binding to intact cells could be 
determined by analyzing the total binding curve with a fitmodel with an 
additional partition term or could be circumvented by the use of a 
hydrophilic ligand like CGP-12177 to define nonspecific binding. On the 
basis of its hydrophilicity, it is to be expected that CGP-12177 cannot enter 
the cell. It should only displace 125ICYP from binding sites on the outer 
surface of the MNC (Staehelin and Hertel, 1983). The additional binding 
sites thus seem to be located inside the cell being internalized receptors (De 
Blasi et ai, 1985), or sites involved in uptake processes. 
Specific saturable binding to intact MNC, determined by analysis of the 
total binding with one class of binding sites plus a nonspecific binding term 
or by defining nonspecific binding with 3 μΜ CGP-12177, was of high 
affinity with a Kd-value identical within experimental error to Kd-values 
determined on broken cells (Table I). Adrenoceptor density, however, 
appeared to be twice as high on intact cells. A possible explanation for this 
discrepancy may be a loss of receptors during ultrasonic treatment 
(Landmann et al., 1983). The presence of additional binding sites on intact 
cells could be confirmed by the inhibition of 125ICYP binding by 
^-adrenoceptor antagonists. Propranolol not only displaced 125ICYP from 
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its specific binding sites but also from the nonspecific binding sites (Fig. 2). 
From this curve it becomes clear that nonspecific binding to intact cells 
cannot unambiguously be defined with propranolol as no clear plateau can 
be measured above 10"7 M propranolol. Also timolol displaced 125ICYP 
from nonspecific or additional binding sites on intact cells. Contrary to 
propranolol, CGP-12177 showed a clear plateau in the inhibition curve 
between ЗЛО"8 and 10 _ 6 M. However, at higher concentrations it dis­
placed 125ICYP from additional binding sites in spite of its hydrophilicity. 
As a plateau in the inhibition curve forms a prerequisite for a ligand to be 
suitable to define nonspecific binding, it is obvious that preference should 
be given to CGP-12177 over propranolol to define nonspecific binding in 
intact MNC. In binding experiments 125ICYP concentrations up to 150 pM 
were applied. Assuming a parallel shift of the inhibition curve over 
approximately one log unit at these higher 125ICYP concentrations, a 
CGP-12177 concentration between ЗЛО-7 and ЗЛО"6 M will be suitable to 
define nonspecific binding. 
Speculations can be made whether the additional binding sites are 
related to internalized adrenoceptors or to entirely different processes such 
as trapping of radioligand into lysosomes or into other compartments in 
the cell (Laduron, 1984). 
Additional binding sites have been demonstrated earlier in membranes 
from bovine lung parenchyma (Nahorski and Richardson, 1979) and 
cultured Hela and Chang liver cells (Rademaker et al., 1985) and can lead 
to incorrect estimations of specific binding. De Blasi et al. (1985) 
demonstrated in in vitro experiments a down regulation of ^-adrenoceptors 
in MNC to 33 % of the original receptor density, after a pre-incubation of 
20 min with isoproterenol. Recently, we have demonstrated that an 
up-regulation of ^-adrenoceptors of about 23 % can already take place 
after a mental stress during 5 min (Graafsma et ai, 1987). Changes in 
binding parameters of this order of magnitude could easily pass unnoticed, 
when interference of receptor binding with high affinity nonreceptor 
binding occurs. 
We conclude that considerable differences in receptor characteristics may 
be found in /f-adrenoceptor studies in MNC, depending upon the choice of 
ligands, cell preparations or incubation buffers. The conflicting data in 
adrenoceptor binding studies in patients as reported by various groups, 
may partly be caused by these methodological factors (Graafsma et ai, 
1986; Mann et ai, 1985; Halper et ai, 1984). 
In our opinion preference should be given to intact cells in ^-adrenocep­
tor binding studies to MNC, because the physiological circumstances are 
best maintained and no ultrasonification induced loss of receptors occurs. 
The use of CGP-12177 to determine nonspecific binding at a concentration 
of approximately 1 μΜ reduces interference of additional binding to a 
minimum. 
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ABSTRACT 
In association experiments of (-)^"lodocyanopindolol 
(12SICYP) with human mononuclear cells (MNC) at 70 pM and a 
temperature of 370C equilibrium was reached within 30 min. 
However, when the same experiments were performed at a 
concentration of 4 pM 125ІС¥Р, equilibrium was only reached 
after 3 hours. The consequences of incomplete equilibrium for 
the interpretation of binding experiments under the incorrect 
assumption that equilibrium has been reached, was investi­
gated at equilibration times of one, two and three hours. The 
dissociation constant, Κ
α
, decreased from 7.4 + 0.2 pM after 
one hour to 2.5 + 0.4 pM after three hours of incubation 
while the receptor density, R0, decreased from 970 + 170 to 
713 + 58 sites/cell. Analysis of computer simulated binding 
curves confirmed the decrease in K
a
 and R0 at prolonged 
incubations. We conclude that in ;L2SICYP binding in intact 
MNC one hour of incubation is not sufficient to obtain 
equilibrium at the lower concentrations. This leads to an 
overestimation of K
a
- and to a lesser extent of R0-values. 
Extending the incubation time to three hours on the other 
hand may lead to a loss of cells and therefore to am 
underestimation of R0. 
INTRODUCTION 
At the moment (-)i2Slodocyanopindolol (iasICYP) with a 
specific activity of about 2000 Ci/mmole (1) is the most 
commonly used radioligand in beta-adrenoceptor binding 
studies. The high specific radioactivity and the high 
affinity to the beta-adrenoceptors makes X25ICYP very 
suitable for binding studies in small tissue samples or to 
measure low receptor densities (1-4). 
XZSICYP binding characteristics have been studied 
extensively in different tissues (1-8). However, kinetic 
experiments with г"1С¥Р have only been performed at free 
radioligand concentrations of 30 pM or higher (7). From these 
kinetic studies, the conclusion has been drawn, that in 
direct binding studies one hour of incubation is sufficient 
to obtain equilibrium. The equations which are used to 
calculate the binding parameters are based upon the assump­
tion that equilibrium has been reached. At lower free 
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radioligand concentrations this condition may not have been 
fulfilled, after an incubation period of one hour. Inproper 
use of the equations then could lead to a wrong estimation of 
receptor density and affinity constants. 
We performed kinetic experiments of ;L2SICYP to intact MNC at 
about 4 and 70 pM and demonstrated by computer simulation and 
binding experiments the consequences of inproper use of 
equilibrium equations in situations that equilibrium has not 
been reached completely. 
MATERIALS AND METHODS 
(-) 1-zsIodocyanopindolol (:lzsICYP) was purchased from NEN 
Europe (+ 2200 Ci/mmol) or from Amersham International (+ 
1800 Ci/mmol); CGP-12177 was generously supplied by Dr. M. 
Staehelin from Ciba Geigy. All other reagents were of 
analytical grade. Blood was taken from healthy volunteers by 
venipuncture. Mononuclear cells (MNC) were isolated from 
blood anticoagulated with sodium citrate (0.105 M) by the 
method of Böyum (9). Fresh whole blood was diluted with an 
equal volume of phosphate buffered saline (PBS), pH =7.4, 
containing 2.7 mM KCl, 7.7 mM Na2 HP04, 1.5 mM KHZ P04 and 
150 mM NaCl, and layered on Ficoll-Paque (Pharmacia Fine 
Chemicals, Sweden) in a proportion 5:2 in Sarstedt tubes (25 
ml). Tubes were centrifugea at 800 χ g for 15 min at room 
temperature. The MNC were harvested in Falcon tubes and 
washed three times with PBS buffer at 4°C. After the last 
washing step cells were resuspended in the incubation buffer, 
pH = 7.20, containing 10 mM Tris, 154 mM NaCl, 0.55 mM 
ascorbic acid and 0.1% bovine serum albumine, to prevent 
adhesion of cells. The cells were counted with a Coulter 
counter (Coulter Electronics, Holland). In some cases a buffy 
coat was obtained from the local Blood Bank and treated in 
the same way as mentioned above. Binding assays were 
routinely carried out in new disposable polypropylene tubes 
(Otan, Holland). Aliquote of the MNC (320 μΐ, approximately 
106 cells) were incubated with 50 μΐ of various 
concentrations of 125ІСУР, ranging from 2-150 pM and 50 μΐ 
buffer solution with or without CGP-12177 in a shaking 
waterbath at 370C. Incubation was terminated by the addition 
of 4 ml ice chilled buffer (pH = 7.4) containing: 10 mM Tris 
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and 154 mM NaCl, followed by rapid filtration over Whatman 
GF/C glass fibre filters. Filters were washed three times 
with 4 ml ice chilled-buffer and the bound radioactivity of 
the wet filters was determined in a Nuclear Enterprise 1612 
Gamma Counter at an efficiency of about 78%. Non-specific 
binding of ^"ICYP was defined as radioactivity bound in the 
presence of 1 μΜ CGP-12177. Specific binding amounted to at 
least 60% of the total binding at the highest 12í4CYP 
concentration. In the kinetic experiments, MNC were incubated 
with 4 or 70 pM ^"ICYP, with or without 1 μΜ CGP-12177. At 
certain time intervals samples in duplicate were taken and 
specific binding measured as described above. In the 
dissociation experiments, CGP-12177 in a final concentration 
of 1 μΜ was added to the reaction mixture after 60 min of 
incubation and at different time intervals samples in 
duplicate were taken to measure specific binding. Total 
binding never exceeded 20% of 1 2 5ICYP added. The association 
rate constants were estimated graphically. 
Data Analysis 
Receptor density (R^ ,) and affinity constants (Κα) with their 
standard error (SE) were calculated by subjecting the data to 
a non-linear, least squares curve fitting procedure, using 
the Gauss-Newton algorithm (10). Bimolecular reaction 
kinetics is given by eq.l. 
2.3 RDeq (RDt + HD««, - A) 
ko^.t = log (i) 
С (HD»«, + С) (RDt - Ηϋ.4) 
where A = R 0 + D 0 + К.,; В = Ro.D0; С = A
2
 - 4B 
RD t and R D e 4 are the concentration of specifically bound 
1 2 5ICYP after an incubation time of t min and at equilibrium 
(3 hrs) respectively, ко,, = association rate constant; 0
ο
 = 
initial ligand concentration; R«, = total receptor concen­
tration. 
in the first minutes dissociation is negligible and the 
simplified eq. 2 can be used to analyse the association 
reaction. By plotting the right part of eq. 2 as a function 
of time a straight line with slope k 0„ is obtained. 
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2.3 R 0 (D0 - RD-t) 
3c0n.t = (log ) (2) 
(D0 - R 0) 0 0 (R0 - RD t) 
Dissociation of the ligand receptor complex obeys eq. 3 and a 
plot of the log bound concentration of 1 2 5ΙΟΥΡ versus time 
after addition of an excess of cold ligand yields Jc^ ,* 
in = - k^f.t (3) 
RD 
where t=0 refers to the time of addition of excess of cold 
ligand i.e. start of the dissociation and t=t to the time 
elapsed since this moment; ti^ir is the dissociation rate 
constant. 
In the kinetic experiments all points represent the 
average of duplicate measurements. Where mentioned, values 
are given + SE. 
In the simulations, the concentrations of 1 Ζ 5ΙΟΥΡ bound 
after one or three hours of incubation at a concentration 
ranging from 2-150 pM were calculated using equation (1) and 
averaged kon-, Κ
α
-, and Ro-values from several kinetic and 
equilibrium studies previously performed at an incubation 
time of 3 hours. Subsequently the simulated data were 
analysed by the curve fitting routine mentioned before, 
yielding binding parameters with SE from simulated 
experiments. 
RESULTS 
In Figure 1 time dependent association of 1 2 5ІСУР to MNC 
at 4 and 70 pM are shown. At a concentration of 70 pM 
equilibrium was reached within 30 min. Binding at 4 pM 
however needed 150 to 180 min to reach equilibrium. 
The association rate constants calculated for both 
concentrations were similar and amounted (2.9+0.4)- IO7 
M-isec-1 (n=6) and (3.3+0.2) -107 M^sec- 1 (n=7) at 4 and 70 
pM respectively. Dissociation of i 2 5ICYP from intact MNC 
occurred with a k 0 « of (8.4+2.2)-IQ-^sec"
1
 (n=3). From the 
dissociation and association rate constants a K^-value of 
about 2.7 pM was calculated. 
From the kinetic experiments it becomes clear that one 
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hour of incubation is not sufficient to reach equilibrium at 
the lower concentrations of 1 2 5ІС Р. To estimate the 
consequences of the deviation from equilibrium for the 
interpretation of the experimental data, bound concentrations 
were calculated as a function of the free concentration at 
incubation times of one and three hours using eq. 1 with K
e
 = 
3 pM, R 0 = 0.17 fmol/100.000 cells and k0„= 2.5-10
v
 M"1 
sec
-
*. 
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Figure 1. Association kinetics of X25ICYP binding to MNC. 
Ш С (106 cells) were incubated with X25ICYP at 
37°C in the presence or absence of 1 μΜ 
CGP-12177; at all indicated time points samples 
in duplicate were taken and specific binding was 
determined as described in methods. When no error 
bars are given, the results of the determinations 
in duplicate are within 2%. At the right: 
Graphical determination of the association rate 
constant according to eq. 2 in methods. 
The two series of theoretical data points at 1 and 3 hrs 
were analysed with our computer fit program (fig 2A). Fitted 
K
a
-values were 11.1+0.8 pM at 1 hr and 4.0+0.1 pM at 3 hrs 
incubation. Fitted receptor densities amounted to 1137+42 
sites/cell at 1 hr and 1029+12 sites/cell at 3 hrs 
incubation. For reasons of comparison binding experiments 
were performed with incubation times of 1 and 3 hrs yielding 
Κα-values of 7.7+0.4 and 3.2+0.4 pM and R 0 values of 1054+34 
30 
and 891+53 sites/cell after l and 3 hr incubation 
respectively (fig 2B). Table ι summarizes the results of 
similar experiments performed at incubation times of 1,2 and 
3 hrs. 
bound '"ICYP fmol/105cells 
A 
. ^ 
bound/free " 5 ICYP 
О 05 л 
SO 100 150 
lree l 2 5ICYP ( рм ) 
Figure 2A. 
Figure 2B. 
020 
bound '"ICYP 
Upper panel: computer fit of theoretical points 
of ±ZSICYP binding to MNC, calculated with eg. 1, 
with K^ = 3 pM, R0 =0.17 fmoles/10
5
 cells and 
kon = 2.5-ΙΟ7 Μ-χ sec-1 at 1 hr (closed circles) 
and 3 hrs (open circles) of incubation. Lower 
panel gives the corresponding Scatchard plot. 
Computer fit of experimental points of 125ІСУР 
binding to MNC after l hr (closed circles) and 3 
hours (open circles) of incubation. 
Table 1. The effect of different 
binding parameters 
incubation periods on 
Exp. no 
1 
2 
3 
4 
5 
6 
7 
one 
K« 
7.7 
10.0 
13.2 
13.9 
6.9 
7.2 
7.9 
hour 
Ro 
1054 
1863 
1824 
1144 
566 
879 
1379 
Incubation times 
two 
K«, 
4.8 
5.8 
7.4 
5.5 
3.1 
3.4 
2.9 
hours 
R 0 
1041 
1656 
1511 
969 
530 
837 
969 
three 
K
a 
3.2 
-
-
-
3.0 
1.7 
2.1 
hours 
R 0 
891 
-
-
-
632 
620 
710 
Mean+SE* 7.4+0.2 970+170 3.6+0.4 844+113 
Mean+SE— 9.5+1.1 1240+179 4.1+0.8 1073+113 
-n=4 --n=7 
2.5+0.4 713+58 
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DISCUSSION 
MNC from human peripheral blood are often used to monitor 
changes in beta-adrenoceptor characteristics in several 
disorders, with 12SICYP as the most commonly used 
radioligand. However binding parameters as reported in 
the literature differ considerably (7,8,11,12). The 
differences may be caused by differences in circumstances 
among which blood samples are taken, or methodological 
factors (11). 
A prerequisite for a proper determination of K
a
- and 
Ro-values in direct binding studies ijs that equilibrium in 
the incubation mixture has been reached. The use of 
radioligands with a high affinity creates the disadvantage 
that longer incubation periods are necessary to fulfil this 
criterium. 
Our time dependent experiments clearly demonstrate that 
whereas at the higher X2SICYP concentrations equilibrium is 
reached within about 30 min, at the lower concentrations an 
incubation up to 3 hrs is necessary. Association constants 
were similar at both concentrations (k0„ approximately 
3.0.10"7 M-^-sec-1), which is conformable to the results of 
O'Hara and Brodde (7). Others found similar results in 
different tissues such as guinea-pig left ventricle membranes 
(2), guinea-pig lung membranes (13), rat kidney membranes 
(14), rabbit lung membranes (15) and rat brain (5). As far as 
we know, time dependent experiments of X2!5ICYP beneath 30 pM 
have not been published. 
The consequences of deviation from equilibrium for Κ
α
-
and R0-values, as determined by computer analysis of 
theoretical points, can obviously be seen in the simulated 
experiments (Figure 2a), where one hour of incubation 
resulted in an overestimation of К
л
 of 175%. Surprisingly not 
only a difference in affinity but also an overestimation of 
R 0 of 10% was found. As can be seen in Table l, extending of 
the incubation period from 1 to 3 hours indeed results in 
higher affinities under experimental conditions. The receptor 
densities decrease too, although in most of the experiments 
to a higher extent as can be expected from the simulated 
experiments. Probably other factors such as decrease in 
viability of the cells play a role when the incubation time 
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is prolonged. In some experiments we did find a decrease in 
number of cells after an incubation longer than one hour 
(data not shown). 
In conclusion we would recommend concentrations of 
J25ICYP of 30 pM or higher for a proper measurement of Re,- an 
incubation time of one hour is than sufficient. For the 
correct determination of K
a
,
 125
ІСУР concentrations in the 
K
a
-range are needed and the incubation time should be 
extended. Providing that a loss of cells during incubation 
occurs equally at all concentrations, this should not affect 
the slope of the binding curve, and as a consequence not the 
affinity constant. 
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CHAPTER 3 
•=2-ADREN0CEPTORS ON INTACT AND BROKEN HUMAN PLATELETS 
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HISTORY 
In 1898, Langley first proposed the term 'autonomic 
nervous system', which included both the orthosympathetic and 
parasympathetic divisions (1). The original concept of 
receptor sites with which neurotransmitters or drugs reacted 
to produce their effect was introduced independently by 
Langley (1) and Ehrlich (2). 
The existence of different types of adrenoceptors was 
first introduced by Ahlquist (3), who found that the 
responses to catecholamines in a variety of tissues were 
mediated through two distinct types of receptors, which he 
termed <=- and p-adrenergic receptors. For «-adrenergic 
receptors, adrenaline was more potent than noradrenaline, 
which was in turn more potent than isoprenaline. «-
Adrenoceptors classically mediate catecholamine effects such 
as smooth muscle contraction. In contrast, smooth muscle 
relaxation is induced by ß-adrenoceptors. Isoprenaline is 
more potent than either adrenaline or noradrenaline for ß-
adrenoceptors. In 1967, Lands et al.(4) provided evidence 
that there were two subtypes of ß-adrenoceptors, termed ßj. 
and ß2. «-Adrenoceptors could also be divided into two 
subtypes. This was preceded by the discovery that 
noradrenaline inhibits its own presynaptic release (5). 
Presynaptic autoregulatory «-adrenoceptors differ in their 
pharmacologic properties from postsynaptic «-adrenoceptors 
mediating typical «-adrenergic effects. A wide variety of 
drugs has been found with different potencies for either 
presynaptic or postsynaptic «-receptors. This selectivity led 
to the suggestion that two subtypes of «-adrenoceptors should 
be distinguished: "presynaptic" and "postsynaptic" «-
receptors (5). However, nowadays it seems preferable to adopt 
a nomenclature analogous to that used for ß-adrenoceptors: 
"«ι" and "« 2
n
 adrenoceptors (6). «j.-Adrenoceptor s include 
typical postsynaptic «-receptors mediating smooth muscle 
contraction. «2-Adrenoceptors not only include all known 
presynaptic autoregulatory «-receptors, but also some less 
typical post- or extrasynaptic receptors existing on, for 
example, human platelets. At present, prazosin (=i-
antagonist) and yohimbine («2-antagonist) are commonly used 
to distinguish pharmacologically between «l- and « z-
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adrenoceptors. Prazosin is much more potent than yohimbine at 
<=j.-adrenoceptors, whereas yohimbine is generally more potent 
at œz-adrenoceptors. 
For a long time the characteristics of the adrenoceptors 
could only be studied by contraction/relaxation experiments, 
or in the case of platelets, by aggregation studies. With the 
development of the technique of radioligand binding during 
the last 15 years, using radioactively labeled hormones or 
drugs, adrenoceptors can be studied more directly. With this 
method of direct binding, information can be obtained about 
the affinity of several drugs for the receptor, the receptor 
density, and the receptor-effector mechanism. Although 
radioligand binding studies require rather simple techniques, 
many pitfalls have been described in the literature, that may 
lead to incorrect estimates of both the drug affinity for the 
receptor and the receptor density. The questions that should 
be answered affirmatively for adrenoceptor radioligand assays 
have been summarized by MotulsXy et al. (7) and are given in 
Table 1. 
Table 1. Questions that should be answered affirmatively for 
adrenoceptor radioligand assays. 
1. Is specific binding saturable (i.e, is there a finite 
number of receptors)? 
2. Does specific binding occur as rapidly and reversibly as 
the response to the unlabeled ligand? 
3. Do unlabeled drugs compete stereo-selectively for 
specific binding sites and in the rank of order of 
potency predicted by pharmacologic experiments? 
4. Does specific binding increase as a linear function of 
increasing tissue concentration? 
5. Do independent methods of deriving the dissociation 
constant of the radioligand agree? 
6. Does the radioligand remain unmetabolized during the 
experiment? 
7. Has non-specific binding been defined appropriately? 
Identification of =2-adrenoceptors on human platelets through 
radioligand binding techniques was first accomplished by 
binding of the non-selective radioligands 3Hdihydro-
ergocryptine (3HDHE) and 3Hphentolamine to platelet 
membranes. Neither of these differentiates between «i- and 
«z-receptors. Furthermore, 3HDHE binds to other types of 
receptors in some tissues as well (8,9). The «^-selective 
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ligand 3Hyohimbine binds with higher selectivity, lower non-
specific binding, and adequate reproducibility. These 
differences are most apparent in studies with intact cells 
(8,10). Therefore, direct binding studies with =2-
adrenoceptors are at present preferably performed with 
3Hyohinibine 
<=2-ADRENOCEPTORS ON HUMAN PLATELETS 
Binding studies with intact cells as well as membranes 
with different radioligands have clearly shown that a 
homogeneous class of œ2-adrenoceptors exists in humans. Table 
2 shows that the receptor densities, reported by different 
authors agree fairly well. 
Table 2. *2-Adrenoceptor density (B™« in sites/cell in intact cells 
and in fmol/mg protein in broken cells) and affinity (Κα in 
nM) of various radioligands in human platelets from healthy 
normotensive volunteers, as reported in the literature 
(n=nuniber, nm=not mentioned). 
Radioligand 
3Hdihydroergocryptine 
3Hdihydroergocryptine 
3HdihydroergocrYptine 
3Hclonidine 
3Hphentolamine 
3Hyohimbine 
3Hyohimbine 
3Hyohiinbine 
3Hyohinibine 
3Hyohinibine 
3Hrauwolscine 
3Hrauwolscine 
3Hrauwolscine 
η 
4 
nm 
7 
7 
7 
5 
41 
15 
10 
34 
7 
44 
7 
broken 
В™« 
183 
130 
337 
64 
165 
182 
191 
221 
241 
cells 
Κα 
1-3 
3-10 
6.6 
25 
12 
1.3 
1.7 
2.0 
1.8 
intact 
Brmuc 
220 
215 
300 
300 
319 
ceils 
Κα 
3.1 
4.1 
2.7 
4.6 
2.1 
References 
this 
this 
11 
12 
14 
14 
13 
10 
15 
16 
17 
8 
8 
thesis 
thesis 
This is the case for intact cells as well as membrane 
preparations. Studies with «^-adrenoceptors in humans -in 
particular when it concerns large groups of subjects- have to 
be restricted to blood cells. Schlicker et al. (18) have 
found that «z-adrenoceptors of the rabbit pulmonary artery 
correlated well with human platelet »z-adrenoceptors, with 
respect to the affinities of several BE 2254 congeners («-
adrenoceptor antagonist) for the receptor. Also similar 
characteristics of 3Hrauwolscine binding to human cerebral 
cortex and human platelets have been measured (19). Exactly 
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how accurately properties of receptors on blood cells reflect 
those on internal tissues still has to be established. 
With the intention of studying »^-adrenoceptors on 
platelets in essential hypertensive patients, we started 
direct radioligand binding studies according to the method of 
Brodde et al. (17) with some modifications. Rauwolscine is an 
»-stereoisomer of yohimbine, which has been reported to have 
an equal to somewhat higher affinity for =2-adrenoceptors 
than yohimbine (8,17,20). Therefore, we have chosen for 
3Hrauwolscine (3Hrauw) as the radioligand in «z-adrenoceptor 
binding studies on platelets. In order to find out whether 
our binding experiments fulfilled all criteria of receptor 
studies, some quality tests were performed which are 
reported in the following sections. 
3HRAUWOLSCINE BINDING TO INTACT AND BROKEN HUMAN PLATELETS 
a. Materials and Methods 
3H-methyl-rauwolscine (72-74 Ci/mmol;3Hrauw) was purchased 
from the Radiochemical Centre Amersham UK; yohimbine, 
prazosin, phentolamine, (-)-adrenaline- and (+)-adrenaline-
bitartrate were generously supplied by Boehringer Ingelheim, 
Pfizer, Ciba-Geigy and Winthrop respectively. Clonidine was 
purchased from Boehringer Ingelheim. All other reagents were 
of analytical grade. 
The main part of the experiments was performed with 
buffycoats, anticoagulated with sodiumcitrate (0.105M), from 
the local blood bank. For further preparation of platelets 
the buffycoat was diluted with an equal volume of phosphate 
buffered saline (PBS), pH=7.4, containing 2.7 mM KCl, 7.7 mM 
Na2HPOA, 1.5 mM ΚΗ2Ρ0Λ and 150 mM NaCl, and centrifugea at 
300.g for 10 min at room temperature. Platelet rich plasma 
was removed and the remaining cell suspension again diluted 
with 2 volumes of PBS and the above mentioned procedure 
repeated. So far, preparation of membranes and intact cell 
suspensions were identical. In the case of intact platelets, 
cells were washed 3 times with PBS and centrifugea at 1200.g 
for 10 min at room temperature. The intact cells were finally 
suspended in PBS. Platelets were counted with a Sysmex 
platelet counter PL-110. Preparation of platelet membranes 
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was performed according to the method of Brodde et al. (17). 
Platelet rich plasma was centrifugea at 17,000.g for 15 min 
at 4eC, the supernatant discarded and the pellets were washed 
in 50 mM Tris-HCl, pH=7.35, containing 120 mM NaCl and 20 mM 
EDTA, recentrifuged, suspended in ice-cold "lysing buffer" (5 
mM Tris-HCl, 5 mM EDTA, pH=7.5) and homogenized by the use of 
an Ultra-Turrax (Jahnke & Kunkel) for 10 sec. The homogenate 
was centrifuged at 30,000.g for 15 min at 40C, the pellets 
were washed once with ice-cold incubation buffer (50 mM Tris-
HCl, 0.5 mM EDTA, pH=7.5) centrifuged again at 30,000.g for 
15 min at 40c and resuspended in the incubation buffer. 
Protein concentrations were determined with bovine serum 
albumin used as the standard (21). Binding assays were 
carried out as follows: 150 μΐ membrane suspension (170-150 
цд of protein) or cell suspension (1-8.10е cells/ml) were 
incubated with various concentrations of 3Hrauw (ranging from 
0.2-15 nM) at 25*^ for 30 min in a final volume of 250 μΐ in 
a shaking water bath. Incubation was terminated by adding 4 
ml ice-chilled incubation buffer, followed by rapid 
filtration over Whatman GF/C glass fibre filters. Filters 
were washed three times with 4 ml ice-chilled buffer and the 
bound radioactivity of the wet filters was determined in a 
Philips PW 4700 liquid scintillation analyzer, at an 
efficiency of about 50%, after addition of 10 ml Agualuma as 
scintillation fluid. Non-specific binding of 3Hrauw was 
defined as radioactivity bound in the presence of 10-5M 
phentolamine. Specific binding amounted to at least 70% of 
the total binding at the highest 3Hrauw concentration. Adre­
noceptor density (В,««»:) and antagonist affinity (Κα) were 
calculated by subjecting the data to a non-linear, least 
squares curve fitting procedure using the Gauss-Newton al­
gorithm. 
b. Direct binding studies in intact and broken cells. 
Figure 1 shows a representative example of 3Hrauw binding 
to intact and broken platelets from the same blood sample. 
The specific part of the binding was saturable, and a 
Scatchard representation pointed to a homogeneous population 
of binding sites. In intact cells (n=7) the average value of 
Κα was 1.92+0.37 nM and for Β„« 0.53+0.04 fmol/106 cells 
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(=319+24 sites/cell). For membranes (n=44) K
a
 was 1.81+0.11 
nM and В™« 241+17 fmol/mg protein. In Table 3 the results of 
3Hrauw binding to intact as well as membrane fractions from 
the same samples are shown. 
bound 'Hrauw (rnol/10* cells 
B/F 
IS0-( 
bound 'Hrauw fmol/mg 
BIF • 
Figure 1. Binding of 3Hrauwolscine (3Hrauw) to human 
platelets in intact (left) and broken (right) cell 
preparations of the same blood sample. Binding 
parameters: intact cells: affinity =2.20 nM; 
density = 0.68 fmol/10e cells (=409 sites/cell); 
broken cells: affinity = 2.00 nM; density = 464 
fmol/mg. Inset: Scatchard plot. 
Table 3. 3Hrauwolscine affinity (Κ
Λ
) and specific binding 
(Broax) to membrane fractions of human platelets and 
to intact cells from the same blood sample. 
Experiment 1 and 2 were performed in duplicate. 
intact cells membrames 
experiment к*, Вт««; Κα 
number (nM) (sites/cell) (nM) 
В
т < >
зс 
(fmol/mg protein) 
la 
lb 
2a 
2Ь 
1.8 
2.2 
3.0 
3.1 
1.2 
235 
409 
349 
379 
241 
2.2 
2.0 
3.1 
3.4 
1.2 
257 
464 
336 
312 
592 
mean (n=3) 2.1+0.9 309+63 2.2+1.0 426+145 
When 1 mg protein corresponds with approximately 9.10a 
platelets, the receptor density found in membranes, as shown 
in Table 3, can be calculated at 285 sites/cell, being almost 
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similar to the 309 sites/cell in intact cells. Figure 1 shows 
that the proportion specific/non-specific binding was more 
favourable in membrane suspensions than in intact cells. 
Membranes, in contrast to intact cells, can be stored. 
Therefore further experiments were performed with membrane 
suspensions. 
c. Reproducibility 
From the literature it is known that there is a large 
range in inter-individual receptor density. Less is known 
about the intra-assay variation for adrenoceptor affinity and 
density or the effect of storing at low temperatures. We 
performed some pilot experiments to test the intra-assay 
variation under different circumstances. The results are 
summarized in Table 4. 
Table 4. 3Hrauwolscine affinity (Kä) and specific binding 
(Bmax) to human platelet membranes; intra-assay 
variation (sample 1) and variation after storing at 
-20 or -80oC (sample 2 and 3) 
storing 
temperature 
(°C) 
-20 
-80 
-20 
days of 
0 
0 
0 
0 
0 
16 
20 
51 
6 
37 
0 
1 
27 
storing 
sample 1 
sample 2 
sample 3 
K* 
(nM) 
1.4 
1.9 
1.5 
4.1 
1.5 
1.2 
1.2 
0.8 
1.2 
1.2 
1.0 
0.8 
3.8 
Bmaix 
(fmol/mg) 
256 
249 
258 
278 
243 
141 
268 
70 
254 
208 
145 
108 
232 
From these data we conclude that storing at low temperatures 
does not lead to a uniform reduction of receptor density or 
change in affinity. In our experiments, we never stored 
membrane suspensions for longer than 5 days. 
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d. 3Hrauw binding at different tissue concentrations. 
Binding experiments with cell concentrations ranging from 108 
to Ю-* cells/ml and membrane suspensions ranging from 0.5 to 
1.5 mg/ml resulted in a linear function between receptor 
density and tissue concentration for both preparations. 
e. Inhibition experiments. 
For assessment of the ability of «-adrenoceptor agonists and 
antagonists to inhibit specific 3Hrauw binding, membrane 
suspensions were incubated with 10 nM 3Hrauw and 20 different 
concentrations of the competing agents for 30 min at 25 "С 
and specific binding was determined as described above. In 
case of agonist displacement, ascorbic acid in a final 
concentration of 10-SM was added to the incubation buffer. 
Various «-adrenergic agents were tested on their ability to 
inhibit specific 3Hrauw binding in platelet membranes. 
Inhibition of 3Hrauw binding occurred with the order of 
potency: yohimbine > phentolamine > Clonidine > (-)adrenaline 
> (+) adrenaline > prazosin, which is the expected one for 
«2-adrenoceptors. Table 5 summarizes K* values of the 
inhibition curves of the investigated agents. 
Table 5. Inhibition constants (Ki) of specific 3Hrauwolscine 
displacement by «-adrenergic agents. Individual 
values, or mean + SD of η experiments, indicated in 
brackets. In case of phentolamine two binding sites 
could be discriminated, therefore also two 
inhibition constants are given. 
Inhibitor K±l (nM) K.i.2 (nM) 
yohimbine 0.6 4 
phentolamine (3) 6.1 + 2.6 845 + 1192 
Clonidine 31.7 
Clonidine 23.2 
(-)-adrenaline (3) 451 + 220 
(+)-adrenaline 4641 
(+)-adrenaline 4995 
prazosin 24580 
Phentolamine, although being an «-antagonist, displaced 
3Hrauw according to a two binding sites model. All drugs 
investigated displaced specific 3Hrauw binding completely. 
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f. Kinetic studies. 
In a kinetic experiment, membranes were incubated with 8 
nM -''Hrauw, with or without 10-SM phentolamine. At certain 
time intervals samples were taken in triplicate and specific 
binding was measured as described above. In the dissociation 
experiment, phentolamine was added in a final concentration 
of ΙΟ-5 M to the reaction mixture after 45 min of incubation 
and at different time intervals samples in triplicate were 
taken to measure specific binding. Total binding never 
exceeded 20% of 3Hrauw added. The rate constants for the 
association and dissociation reactions were estimated 
graphically. Kinetics of 3Hrauw binding to human platelet 
membranes showed a rapid binding of 3Hrauw to platelet 
membranes with a ti/z of about 2 min. The second order rate 
constant for the association reaction, kx amounted to 0.024 
nM-1 min_i. Binding reached equilibrium after about 15 min 
and lasted for at least 120 min. Phentolamine displaced 
3Hrauw rapidly from the binding sites. The dissociation 
reaction followed first order kinetics with a ti/z of 2 min. 
The rate constant for the dissociation reaction, к
г
 was 
calculated to be 0.076 min-^. Thus, the equilibrium 
dissociation constant K
a
 for 3Hrauw binding determined from 
the ratio k
z
/ki was 3.2 nM and agreed quite well with the Κα 
value of 2.07 nM as found in a simultaneously performed 
direct binding experiment. Our results are in agreement with 
those of other authors, who found similar K* values in 
kinetic and equilibrium studies, using 3Hyohiinbine. Motulsky 
et al. (22) reported a kinetically derived K
a
 of 0.4 nM for 
intact cells, whereas this value from equilibrium studies 
amounted to 2.7 nM. Brodde et al. (17), using the same 
radioligand, reported values of 1.59 and 4 nM in platelet 
membranes in the kinetic and direct binding experiments 
respectively. 
INTERPRETATION OF RADIOLIGAND BINDING TO «=2-ADRENOCEPTORS ON 
PLATELETS 
Our results indicate that 3Hrauw binding to human 
platelets is saturable, of high affinity (K
a
 in the nanomolar 
range), rapid and reversible. The K
a
 value determined in 
kinetic studies is similar to the K,, value obtained by 
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equilibrium studies. The binding is stereospecific, as is 
shown by the potency of binding inhibition by (-)-adrenaline, 
being 10 times greater than by its (+)-isomer. Furthermore, 
an order of potency in inhibiting 3Hrauw binding by «-
adrenergic agents was found, which is the expected one for 
»^-adrenoceptors. However, agonist inhibition was best 
described according to a one binding site model, whereas a 
two binding site model was the expected one. A number of 
modulators have been described which cam alter the binding 
characteristics of ^-adrenoceptors (23). So, monovalent and 
divalent cations, e.g. Na- and Mg2-, can influence the 
proportion of agonist affinity states (24). Some authors have 
reported that for the demonstration of =z-adrenoceptor high 
affinity sites, divalent cations in the incubation buffer are 
a prerequisite (25). Jones et al. (26) have demonstrated that 
3Hyohimbine binding on human platelets in the presence of 
Mg2-·" resulted in a decreased antagonist affinity as well as a 
decreased receptor density. Therefore, we did not use any 
mono- or divalent ions in the incubation buffer in the 
membranes. Phentolamine displaced 3Hrauw binding according to 
a two binding site model. We do not have a proper explanation 
for this finding. As displacement curves obtained with 
phentolamine reached similar levels as with other agents 
(yohimbine), this finding has no consequences for the 
measurement of affinity constamts or receptor densities. 
PHYSIOLOGICAL AND PHARMACOLOGICAL CHANGES IN «¡.-ADRENOCEPTORS 
ON HUMAN PLATELETS 
Most authors have reported that there is no correlation 
between age and the number or affinity of «2-adrenoceptors on 
platelets (27,28). Brodde (29) found a negative correlation 
between «2-adrenoceptor density and age, while the antagonist 
affinity did not change. Higher receptor densities in females 
than in males have been measured by Jones et al. (28). The 
elevated receptor density in females was accompainied by 
alterations during the menstrual cycle, with higher densities 
at the beginning and the end of the menstrual cycle. These 
findings were conform those of Brodde (29). 
Pharmacological effects on platelet «-adrenoceptors in 
humans have been studied by several authors. It has been 
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reported that incubation of platelets with adrenaline for a 
period of time led to a decreased Œ2-adrenoceptor number 
associated with impaired platelet aggregation (30). Jones et 
al. (31) found that 60-120 min infusions of catecholamines in 
vivo produced attenuation of platelet aggregation and cAMP 
production in vitro, without affecting »¡.-adrenoceptor 
density or affinity. They concluded that acute infusions of 
«z-adrenoceptor agonists may alter the coupling of the 
platelet =2-adrenoceptor to adenylate cyclase, but not the 
receptor density. Egan et al. (32) reported that guanadrel, 
which inhibits noradrenaline storage and release from the 
sympathetic nerve terminal, induced an increased platelet 
-•'Hyohimbine binding in hypertensive patients, without 
affecting physiologic responses to ^ -agonists. 
It has been reported that the number of <=2-adrenoceptors 
on platelets is higher in patients with orthostatic hypoten-
sion than in normal subjects (33). 
Data about <*2-adrenoceptors on platelets in relation to 
essential hypertension are not uniform. Most authors have 
shown that there are no differences in «z-adrenoceptor 
density and antagonist affinity between normotensives and 
hypertensives (34-37). However, increased (38) as well as 
decreased (39) numbers of "^-adrenoceptors on platelets of 
hypertensive patients have been mentioned, whereas Kafka et 
al. (40) demonstrated only elevated «z-adrenoceptor density 
in female hypertensives. 
CONCLUSIONS 
The results of the studies of the characteristics of 
radioligand binding to «z-adrenoceptors on humain platelets, 
in relation to several physiologic and pathophysiologic 
entities, are not uniform in the literature. This may be 
caused by methodological factors such as the choice of the 
radioligand, cell preparations, incubation buffers or 
definition of the non-specific binding. Furthermore, the 
patient groups should be selected carefully and the 
conditions of blood sampling standardized. When all these 
factors have been taken into account, «..-adrenoceptors on 
human platelets may be a promising tool for studying possible 
disorders at the receptor level in relation to those 
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is suspected. 
Receptor density in intact cells as well as membrane 
fractions in our experiments corresponded quite well with 
those found by others (Table 2). The affinity of 3Hrauw to 
=
z
-adrenoceptors was in the same order of magnitude as that 
of 3Hyohimbine, a stereoisomer of rauwolscine. For measuring 
<=2-adrenoceptor density and antagonist affinity on platelets 
our methods seem to be suitable. 
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CHAPTER 4 
ADRENOCEPTORS СМЯ BLOOD CELLS IN PATIENTS WITH ESSENTIAL 
HYPERTENSION AND RELATED VARIABLES 
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ABSTRACT 
The properties of platelet œ2-adrenoceptors and of 
lymphocyte ß^-adrenoceptors were determined in 6 6 patients 
with essential hypertension and 67 normotensive control 
subjects, under baseline conditions. Simultaniously we 
searched for relationships between adrenoceptor charac-
teristics on one side and blood pressure, heart rate, 
Quetelet's index, plasma catecholamines, plasma renin 
activity (PRA) and urinary sodium excretion on the other 
side, «ζ- and ß2-Adrenoceptor density as well as antagonist 
affinity to both receptor subtypes did not differ between 
both groups. There were no differences in the baseline values 
for plasma adrenaline, noradrenaline, PRA or sodium excretion 
between the normotensives and hypertensives. No differences 
in adrenoceptor densities or antagonist affinities between 
males and females in either of the groups were observed. The 
following significant correlations between the adrenoceptor 
densities and the other parameters were found: In all 
subjects together, a positive correlation between ß2-
adrenoceptor density and both systolic blood pressure 
(r=0.22;p<0.05) and plasma adrenaline (r=0.21;p<0.05) was 
found. In the separate groups there was a positive cor-
relation between the «^-adrenoceptor density and age in the 
hypertensive patients (r=0.30;p<0.05), whereas this cor-
relation was negative in the normotensives (r=-0.38;p<0.01). 
In the hypertensives, but not in the normotensives a positive 
correlation was found between «^-adrenoceptor density and 
heart rate (r=0.36;p<0.05). Furthermore, there was a positive 
correlation between the «z-adrenoceptor density and PRA in 
the normotensives (r=0.40 ;p<0.05), but no such correlation in 
the hypertensives. In the normotensives, there was a positive 
correlation between ß2-adrenoceptor density and age 
(r=0.32;p<0.01), systolic blood pressure (r=0.36;p<0.01), 
plasma adrenaline (r=0.30;p<0.05) and Quetelet's index 
(r=0.38;p<0.01). It is concluded, that there are no 
differences in adrenoceptor characteristics between essential 
hypertensive patients and normotensive subjects. No very 
relevant correlations emerged, when the relations between the 
adrenoceptor densities and heart rate, blood pressure and 
plasma catecholamines and PRA were studied. 
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INTRODUCTION 
The sympathetic nervous system modulates cardiac output 
and peripheral vascular resistance, which are determinants of 
arterial blood pressure. An abnormality in the sympathetic 
nervous system might contribute to the development or main-
tenance of essential hypertension (1). Most studies of the 
sympathetic nervous system in essential hypertensives have 
been based on measurements of plasma or tissue catecholamine 
concentrations and on observations of the effects of altering 
the sympathetic status by physiological or pharmacological 
means, such as stress tests or infusions of catecholamines. 
Although nvimerous comparative studies in hypertensives and 
normotensive controls have been done, it is still a matter of 
controversy whether or not plasma catecholamines are elevated 
in patients with essential hypertension (2). 
Recently, methods have become available to measure the 
recognition sites for the neurotransmitters and hormones on 
cells and tissues', the adrenoceptors, through which the sym-
pathetic nervous system exerts its effects. Human platelets 
contain «2- and lymphocytes pz-adrenoceptors, which can be 
quantitatively determined by binding with radioligands (3). 
Adrenoceptors on blood cells in relation to essential 
hypertension have been studied by several groups. However, as 
is so often the case, in a new, rapidly evolving field, the 
results are contradictory and confusing. Most authors have 
only given attention to receptor density and affinity, 
sometimes completed with measurements of plasma catecho-
lamines. Only a few have studied adrenoceptors in relation to 
other major blood pressure regulating systems. For instance, 
Wood et al. (4) have shown that the density of ßz-adreno-
ceptors on lymphocytes is correlated with the urinary sodium 
excretion. 
Several factors might play a role in the inconsistencies 
found in those studies where the relation between the adreno-
ceptor characteristics on blood cells and essential hyper-
tension were investigated. In some of the studies the patient 
groups were rather small. Conditions of blood pressure 
measurements and blood sampling were not always properly 
defined. Sometimes insufficient care was taken with the 
selection of the control groups: often they were recruited 
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from medical personnel, who are usually young and familiar 
with the situation and experience this as less stressful. 
Furthermore, methodological factors, such as the choice of 
radioligand, redistribution of receptors or ligand trapping 
may have influenced the measurements (5). Upregulation of ß2-
adrenoceptors on lymphocytes can take place very quickly, as 
we have recently demonstrated in a group of normotensive 
volunteers (6). 
In a group of 66 patients with essential hypertension and 
67 normotensive controls we have measured adrenoceptor cha-
racteristics on blood cells under well defined baseline con-
ditions. At the same time, plasma catecholamines and the 
sodium excretion were measured. To study the relation with 
the renin angiotensin system also blood samples for plasma 
renin activity were taken. 
METHODS 
66 Patients with essential hypertension according to the 
criteria of the Joint National Committee (7) were selected 
from the outpatient clinic and were without medication for at 
least four weeks. 67 Healthy normotensive subjects served as 
a control group. The majority of them were recruited by means 
of a newspaper announcement and were not familiar with the 
investigative procedures. The characteristics of the 
normotensive (NT) and the hypertensive (HT) subjects are 
shown in Table 1. The reported blood pressures (BP) in this 
table were recorded with a sphygmomanometer and are the 
average of the measurements recorded during 3 successive 
visits at the outpatient clinic, each consisting of two 
readings after a rest period of at least 10 min in supine 
position in the case of HT, whereas in NT the average value 
is given of 3 measurements, taken on the day of the test. 
Body mass index or Quetelet's index was calculated by 
dividing body weight by height square. All subjects gave 
their informed consent. The study was approved by the local 
ethical committee. 
The measurements were carried out in the morning. The 
subjects were asked to abstain for at least 12 h from 
beverages containing caffeine or alcohol, from smoking for 24 
h and from eating for 8 h before the test. All subjects 
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remained supine. A cánula was inserted in an antecubital 
vein. Blood pressure (BP) was measured with the Hawksley 
Random Zero sphygmomanometer. Mean arterial pressure (MAP) 
was calculated as the sum of the diastolic and one-third of 
the pulse pressure. After 15 min of rest, BP and heart rate 
(HR) were measured 3 times, with 2 min intervals, then 
followed by blood sampling. In the blood samples the 
following parameters were measured: Plasma adrenaline (AD) 
and noradrenaline (NA) were determined as described pre-
viously (8,9). Plasma renin activity (PRA) was measured by a 
radioimmunoassay (10). Sodium excretion in the urine per 24 
hours was measured from the day before. Alpha2- and beta^-
adrenoceptor density and antagonist affinity were measured on 
platelets and lymphocytes respectively in the following way: 
After centri fugation of the blood (300.g for 15 min at room 
temperature) , platelet-rich plasma was removed and membrane 
suspensions prepared as described by Brodde et al. (11) The 
remaining cell suspension was diluted with an equal volume of 
phosphate-buffered saline. Lymphocytes were isolated as 
described by Böyum (12). Alpha2-adrenoceptor characteristics 
on platelet membranes were measured by the binding of 
3Hrauwolscine in the presence or absence of IO-3 M phento-
lamine after an incubation of 30 min at 25° С (11). Beta-
adrenoceptor characteristics on lymphocytes were measured as 
described earlier (13). (-)123Іоаосуапоріпао1о1 binding to 
intact lymphocytes was measured in the presence or absence of 
10-β M CGP-12177 after an incubation of 1 hour at 37° С 
Adrenoceptor density (B^ a.^ ) and affinity (K
e
) were calculated 
by subjecting the data to a non-linear, least squares curve 
fitting procedure using the Gauss-Newton algorithm. Statisti­
cal comparisons were made with Student's t-test or Wilcoxon's 
rank sum test. Correlation coefficients were calculated ac­
cording to the Pearson correlation or the non-parametric 
Spearman's rank correlation test. A p-value < 0.05 (two-
sided) was considered to be statistically significant. 
It has to be noted that in a substantial number of ex­
periments we did not succeed in drawing enough blood in time 
to perform all determinations in each subject. This explains 
the differences in the numbers. Moreover, in the hypertensive 
group, BP on the day of blood sampling had not always been 
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measured in the same way as in the normotensive controls. 
Therefore, in HT comparisons have been made with BP measure­
ments obtained on the day of blood sampling (n=34) as well as 
those measured at the outpatient clinic (n=66) 
RESULTS 
In Table 1 the characteristics of both groups are given. 
Both groups did not differ with respect to age and gender. As 
expected, systolic (SBP) and diastolic (DBF) blood pressure 
were higher in HT than in NT. HR and the Quetelet's index 
were also significantly higher in HT than in NT. 
Table 1. Characteristics of the normotensive (NT) and hyper­
tensive (HT) subjects. Mean + SD are given. 
number 
male/female 
age (years) 
Quetelet's index (kg/m2) 
supine blood pressure 
systolic (mmHg) 
diastolic (mmHg) 
heart rate (beats/min) 
NT 
67 
33/34 
44.3 + 13.5 
23.3 + 2.3 
117 + 16 
75 ± 10 
65 + 9 
* 
* 
* 
* 
HT 
66 
37/29 
45.3 + 9.9 
27.3 + 4.8 
159 + 24 
98 + 11 
71 + 10 
* ρ < 0.0001 
Table 2 summarizes the results of all the measurements in 
the hypertensives (HT) and normotensives (NT). For HT 2 
columns are given, one representing those measurements for 
which also BP measurements on the day of blood sampling were 
available and one consisting of all HT patients. AD, NA and 
PRA were not different between HT and NT. 
Similar values of œ2- and ß2-adrenoceptor densities and 
antagonist affinities for the receptors were seen in both 
groups. 
In Table 3 the Bmllx and К
л
 values in males and females of 
both groups are shown. No differences in adrenoceptor cha­
racteristics between both sexes were seen in the two groups, 
although in HT there was a tendency of a higher «z-B,,,«^  in 
males than in females (p=0.07). 
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Table 2. Baseline values of haemodynamic and humoral 
variables and adrenoceptor characteristics in 
normotensives (NT) and hypertensives (HT). In case 
of HT two columns are given. One refers to all 
parameters in relation to BP as measured on the day 
of blood sampling ^», the other refers to all 
parameters in relation to the average BP values as 
measured at the outpatient clinic 2 > 
SBP 
DBP 
«z-Ka 
«z-B,,,^ 
β2-κα ß 2-B m M 
AD 
NA 
PRA 
η 
67 
67 
51 
52 
67 
67 
66 
66 
48 
117 
75 
1.8 
171 
7.7 
1052 
0.16 
1.53 
0.77 
NT 1' 
+ 16 
+ 10 
+ 0.6 
+ 81 
+ 1.9 
+ 295 
+ 0.10 
+ 1.09 
+ 0.52 
η 
66 
66 
51 
51 
58 
58 
56 
56 
17 
154 
100 
1.9 
183 
7.8 
1070 
0.15 
1.42 
0.94 
HT2> 
+ 28 
+ 12 
+ 1.3 
+ 74 
+ 2.6 
+ 513 
+ 0.09 
+ 0.55 
+ 0.61 
η 
34 
34 
25 
25 
31 
31 
25 
25 
12 
Η Τ
Χ ! 
165 + 
105 + 
2.1 + 
201 + 
7.1 + 
1146 + 
0.16 + 
1.57 + 
0.99 + 
29 
12 
1.7 
87 
2.5 
641 
0.10 
0.66 
0.68 
Abbreviations and units are as follows: systolic (SBP) and 
diastolic (DBP) blood pressure in mmHg; «z-adrenoceptor 
density («z-B,,,,»^ ) in fmol/mg and antagonist affinity (Κ
Ζ
-Κ
Λ
) 
in nM; ß2-adrenoceptor density (ßz-Bms„) in sites/cell and 
antagonist affinity (ßz-K^) in pM; plasma adrenaline (AD) in 
nM; plasma noradrenaline (NA) in nM; plasma renin activity 
(PRA) in пМ/1/h. All values are mean + SD. For each variable, 
the number (n) of the observations is given. 
Table 3. œz- and ßz-adrenoceptor density (B^«) and affinity (K^ ) in 
normotensive (NT) and hypertensive (HT) subjects, subdivided 
according to gender, η is number of measurements. All values 
are expressed as mean + SD. 
NT HT 
η male η female η male η female 
«z-adreno-
ceptors 
Ka (nM) 24 1.86+0.64 27 1.81+0.58 29 1.91+0.27 22 1.76+1.00 
Β™,« (fmol/mg) 24 175+83 28 167+81 29 202+80 22 160+59 
02-adreno-
ceptors 
Ka (pM) 33 8.0+1.8 34 7.4+1.9 33 7.8+3.0 25 7.8+2.0 
B^„ 33 1098+279 34 1007+307 33 1070+450 25 1069+596 
(sites/cell) 
To study the relations between the adrenoceptor densities 
and the other variables mentioned in Table 1 and 2, we 
searched for possible correlations. The results of these 
calculations are summarized in Table 4. In the total group, a 
positive correlation between β2-Β„„ and SBP as measured on 
the day of the experiments (n=97)(r=0.22;p<0.05) and AD 
Table 4. Correlations of the *2-adrenoceptcr number (=2), the ßz-adrenoceptor number (ßz) and the βζ/αι ratio (ßa/«^) at one 
side and Quetelet's index, haemodynamic parameters, plasma catecholamines or renin activity on the other side, in 
the total group and in the hypertensives and nonnotensives separately. Numbers between brackets. 
Total group Hypertensives Nonnotensives 
ßa вг/=г "г Pz β*/"* Œ 2 β? β*/"* 
age -0.07 0.17 0.16 0.30* 0.01 -0.16 -0.38** 0.32** 0.49** 
(103) (125) (99) (51) (58) (47) (52) (67) (52) 
Quetelet's index ^ 
systolic blcod pressure *> 
diastolic blood pressure a' 
M A P >•> 
heart rate *> 
adrenaline 2 ) 
noradrenaline 2 ) 
plasma renin activity *' 
0.03 
(101) 
<-0.01 
(77) 
< 0.01 
(77) 
0.02 
(76) 
0.08 
(86) 
0.15 
(93) 
-0.09 
(93) 
0.24 
(54) 
0.16 
(122) 
0.22* 
(97) 
0.17 
(97) 
0.19 
(96) 
-0.05 
(106) 
0.21* 
(114) 
0.10 
(114) 
-0.15 
(63) 
0.03 
(97) 
0.06 
(77) 
0.03 
(77) 
0.03 
(76) 
-0.15 
(82) 
0.03 
(89) 
0.11 
(89) 
-0.36** 
(53) 
0.03 
(50) 
-0.02 
(25) 
-0.38 
(25) 
-0.25 
(25) 
0.36* 
(41) 
0.29 
(42) 
<0.01 
(42) 
<-0.01 
(14) 
0.04 
(56) 
0.29 
(31) 
0.40 
(31) 
0.35 
(30) 
-0.01 
(47) 
0.07 
(48) 
-0.09 
(48) 
-0.43 
(15) 
<0.01 
(46) 
0.17 
(25) 
0.43 
(25) 
0.34 
(25) 
-0.24 
(37) 
-0.06 
(38) 
0.05 
(38) 
-0.20 
(13) 
-0.07 
(51) 
-0.20 
(52) 
-0.12 
(52) 
-0.15 
(52) 
0.01 
(52) 
0.04 
(51) 
-0.15 
(51) 
0.40* 
(40) 
0.38** 
(66) 
0.36** 
(66) 
0.24 
(66) 
0.31 
(66) 
-0.04 
(66) 
0.30* 
(66) 
0.23 
(66) 
-0.05 
(48) 
0.22 
(51) 
0.29 
(52) 
0.18 
(52) 
0.22 
(52) 
<-0.01 
(52) 
0.09 
(51) 
0.20 
(51) 
-0.43** 
(40) 
1 1
 MAP! mean arterial pressure, the sum of the diastolic and one-third of the pulse pressure 
z
' for the units, see the text u, 
statistics: * p<0.05, **p<0.01 CO 
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(r=0.21;p<0.05) was found, whereas a negative one was seen 
between the ratio of ßz^z-B™«,^ and PRA. Both groups were 
also studied independently. These results are also shown in 
Table 4. In HT, a positive correlation between œ 2-B m« and 
age (r=0.30;p<0.05) as well as HR (r=0.36;p<0.05) was ob-
served. In NT, «ζ-Β,η^ ,,: correlated negatively with age (r=-
0.38;p<0.01) and positively with PRA (r=0.40;p<0.05). There 
was a positive correlation between ß2-Bmal><: and age 
(r=0.32;p<0.01), Quetelet's index (r=0.38;p<0.01) and SBP 
(r=0.36;p<0.01). The ratio βζ/^-Β^,^ correlated positively 
with age (r=0.49;p<0.01) and negatively with PRA 
(r=0.43;p<0.01). 
DISCUSSION 
In this study we have demonstrated that <=
z
- and βζ-
adrenoceptor densities and antagonist affinities of human 
platelets and lymphocytes, respectively, in HT do not differ 
from those found in NT. A review article about adrenoceptors 
and hypertension in rats has recently been published by 
Rosendorff et al. (14). The conclusion of the authors were, 
that, although differences in adrenoceptor characteristics 
between several types of hypertensive rats and control 
animals could be observed, no uniform anomaly emerged. 
In humans, where studies of adrenoceptors mainly have been 
performed on blood cells, most authors reported that there 
are no differences in «^ z-adrenoceptor density and antagonist 
affinity on platelets between NT and HT (15-18). However, 
increased (19) as well as decreased (20) numbers of «
z
-
adrenoceptors on platelets of hypertensive patients were 
demonstrated, whereas Kafka et al. (21) observed only 
elevated «2-adrenoceptor density in female hypertensives. In 
this study both in NT and HT, we did not find differences in 
adrenoceptor characteristics between both sexes. Thus, in 
contrast to Kafka et al. (21), we found no sex difference in 
HT, but if anything, the ««z-adrenoceptor density was higher 
in males than in females. 
With respect to the number of ßz-adrenoceptors on 
circulating lymphocytes, data are not uniform; elevated ßz-
adrenoceptor density was found (22-24), whereas others found 
no differences between NT and HT (25,26). Landmann et al. 
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(27) measured similar ß2-adrenoceptor numbers on lymphocytes 
in HT and NT when l2=Iodocyanopindolol was used as radio-
ligand, but higher numbers in HT in the case of determination 
with 3Hdihydroalprenolol. 
In the total group and in NT, but not in HT, a positive 
correlation was found between SBP and р 2-В т в ж. In NT a 
positive correlation was also observed between ß2-B„„< and 
MAP, although there was no statistical significance. The 
latter findings were also reported by Brodde et al. (19). 
However, their correlation coefficient (r=0.65;p<0.001;n=80) 
was much higher than ours. In the same study they also 
reported a positive correlation between "z-B,,,^  and MAP 
(r=0.59;p<0.001;n=80). In this study, we could not confirm 
this finding. 
In NT a negative correlation between age and "^-Β,η« was 
found. These results are in accordance with those reported by 
Brodde et al. (28), but in contrast with the findings of 
Motulsky et al. (17), who found no correlation between age 
and the number of «^-adrenoceptors on intact platelets. A 
positive correlation between ß2-adrenoceptor numbers and age 
was seen in NT. In the literature most authors (28-31) did 
not report any age-related changes in ß2-adrenoceptor numbers 
on lymphocytes, whereas Schocken and Roth (32) found a de-
creasing ßz-adrenoceptor density at increased age. Studies on 
age and ß^/^z-adrenoceptor ratios have not been reported. We 
found a positive correlation in NT, but no correlation in HT. 
There were no differences in adrenoceptor characteristics 
between males and females in our study, although in HT <*
г
-
B™« tended to be higher in males than in females. In the 
literature elevated "z-B^^ values in females have been 
reported (28,33), but those findings were related to the 
course of the menstrual cycle. We have not collected 
information about the menstrual cycle in our study. 
Wood et al. (4) have that in normotensives ßz-adreno-
ceptors on lymphocytes are increased during a high sodium 
diet. Dietary sodium restriction causes intravascular volume 
reduction and an increase in circulating catecholamines. The 
converse occurs during increased sodium intake. The alte-
rations of catecholamine levels may induce a subsequent up-
or downregulation of the ß2-adrenoceptors. Moreover, it has 
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been shown that a low sodium diet corrects the defect in 
lymphocyte ß2-adrenoceptor responsiveness in HT, as measured 
by cAMP accumulation (34). In a previous study we found a 
positive correlation between the percentage increase of p2-
adrenoceptors on lymphocytes after handgrip isometric 
exercise and the sodium excretion (35). Furthermore, Ashida 
et al. (15) demonstrated that HT, who were salt responders 
with respect to a lowering of the BP after a low salt diet, 
had an increase in platelet ^z-adrenoceptor number in the low 
sodium period. In the non-responders no such changes were 
seen. All these findings point to a role of dietary sodium in 
the regulation of the Œ2- and 3z-adrenoceptor numbers. In 
this study we could not observe a direct relationship between 
the sodium excretion and *2- or β2-Β„Α3<ί. This may have been 
caused by the fact that none of the subjects had a high or 
low sodium diet. Furthermore we have not tested the subjects 
for salt sensitivity. 
No differences in plasma AD and NA were seen between both 
groups. There was a positive correlation between Зг-В,,,«« and 
AD. Because adrenoceptor agonists are known to induce a down-
regulation of ßz-adrenoceptors, a negative correlation had 
been expected. This finding of ours, together with previous 
studies where we demonstrated a positive correlation between 
the percentage increase of AD and ßz-Bm»^ increase after 
isotonic bicycle exercise (chapter 9) and an absence of the 
increase of pz-B™,»^  in adrenalectomized females after mental 
arithmetic (36), point to a pivotal role of AD in the 
regulation of the p2-adrenoceptor density. 
PRA did not differ between HT and NT. PRA was positively 
correlated with «2-Β„„ and negatively with the βζ/^ζ-Β™« 
ratio in NT, whereas no such correlations were seen in HT. 
However, it has to be noted that in the latter group the 
number of observations was rather small. With respect to 
these findings the recently reported findings of Michel et 
al. (37) are of interest. They found a negative correlation 
between PRA and «z-B™« on platelets of children of hyper­
tensive parents and no such correlation in children of 
normotensive parents. Their results as well as ours point to 
a relation between the p2-adrenoceptors and PRA and deserve 
further investigations in relation to essential hypertension. 
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We conclude that the =2- and ß2-adrenoceptor density and 
antagonist affinity on blood cells in patients with essential 
hypertension are not different from the values found in 
normotensive healthy volunteers. There was no difference in 
adrenoceptor properties between males and females in both NT 
and HT. When looking for possible relationships between «z-
or p2-adrenoceptor numbers (or the p2/œ2 ratio) on one side 
and haemodynamic and humoral factors or age at the other 
side, a number of significant correlations was found. 
However, these correlations were not very relevant in a 
clinical sense, since they were all below 0.5, thus ac-
counting for maximal 25 % of the variance observed in the 
adrenoceptor numbers. 
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CHAPTER 5 
ADRENOCEPTOR DENSITY ON HUMAN BLOOD CELLS AND PLASMA 
CATECHOLAMINES AFTER MENTAL ARITHMETIC IN NORMOTENSIVE 
VOLUNTEERS 
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Adrenoceptor Density on Human Blood Cells and Plasma 
Catecholamines After Mental Arithmetic in Normotensive 
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Summary We investigated the effect of mental anthmetn. 
(MA) on plasma Ldtccholamines β adrenoceptors on monomi 
clear cells and α adrenoceptors on platelets A standard MA 
test was performed in 14 normotensive male volunteer» (age 
20-28 years) β Adrenoceptor density was determined by 
(-) l 1 ^IJiodocyanopmdolol (ICYP) binding and α adrenocep­
tor density by pHjrauwolscine binding After MA plasma 
adrenaline increased from 0 08 ± 0 02 (mean ± SE) io 0 14 
± 0 02 пЛ/ immediately after the test while plasma noradrena 
Recent studies have demonstrated that β adrenoceptor 
density on lymphocytes increases acutely during physical 
exercise ( 1-1) whereas others have reported that chroni­
cally increased catecholamines cause a downregulation 
and a concomitant decrease in β adrenoceptor density 
(4) 
Mental stress is common in daily life and causes an 
increase in heart rate blood pressure and plasma adrena 
line (5) but so Гаг (he effect on adrenoceptor density 
has not been studied Therefore we examined in normo 
tensive volunteers the influence of mental arithmetic 
(MA) on α and β-adrenoceptor density in platelets and 
lymphocytes, respectively and on plasma catechol 
amines 
M F T H O D S 
Fourteen male normotensive subjects (aged 20-28 years) 
were studied They were asked to abstain from drinking coffee 
or alcoholic beverages from 1 2 P M the day before the test 
and noi io smoke during 12 h preceding the lest Investigations 
dlwa>s started at 9 00 л м The subjects were supine throughout 
the test During the initial rest period of 30 mm an antccubital 
vein m the left arm was cannulatcd for blood sampling Blood 
pressure (BP) was measured with the Artcrmsonde Mean arte 
nal pressure (MAP) was calculated as the sum of the diastolic 
line rose from 0 79 ± 0 OR to 0 97 ± 0 11 nM 0 Adrenoceptor 
density increased from 679 ± 57 before to 835 •+ 88 ICYP 
binding sites/ctll after MA (p < 0 01) α Adrenoceptor density 
in nine subjects did not change nor did the affinity to the α 
and β adrenoceptors after MA We conclude that u pre KU lat ion 
of β adrenoceptors can take place very quickly after ihis form 
of mental stress Key Words Mental arithmetic—Adrcnoccp 
tor density —Catecholamines 
and one third of the pulse pressure Heart rate (HR) v. as calcu 
latcd from the electrocardiogram After the period of rest 
BP and HR were recorded three times and averaged and blood 
anticoagulatcd with 0 105 M sodium curate was sampled for 
measurement of (he α and β adrenoceptor density and for 
plasma adrenaline (A) and noradrenaline (NA) MA was per 
formed by asking the volunteer to subtract repeatedly 17 from 
a four digit number as quickly as possible for 5 mm while a 
metronome speeded up the subject (5) BP and HR were re 
corded during the final 45 s Samples for NA and A were 
taken immediately after termination of the test followed by 
sampling for adrenoceptor measurements Catecholamines were 
measured by a recent 1\ improved radioenzymatic assay (6) 
After centnfugation of the blood (300 g for 15 mm at room 
temperature) for adrenoceptor measurements platelet rich 
plasma was removed and membrane suspensions prepared as 
described by Brodde et al (7) The remaining cell suspen 
sion was diluted with an equal volume of phosphate buffered 
saline Lymphocytes were isolated as described by О Нага 
and Brodde (8) The adrenoceptor density (R ) and affinity 
(Kd) were determined by radioligand binding assays (7 8) us 
mg [1H]rauwolscinc for a. adrenoceptor and (-) l P , l ] iodocy 
anopindolol (ICYP) for β adrenoceptor measurements Incu 
bation time was 30 mm at 250C for platelet membranes and 
60 mm at 37aC for lymphocytes Specific binding was de 
fined as total binding minus radioactivity measured in the 
presence of 1 μΜ (±> CGP 12177 m the ease of the β ad 
rcnoeeptor and 10 μΜ phentolamine in the case of the o ad 
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TABLE 1. MAP HR plasma tarecholamtnes anda and β adrenoceptor 
ι haracteristics on platelet membranes and intact lymphocytes before and 
after MA respectively 
Adrenjlinc (nM) 
Noradrcnalmc (nM) 
a AdreiKKepors 
K a ( n M l 
R, (fmol mg) 
β Adrenoceptors 
K j l p M ) 
R, (biœs/ccll) 
MAP (mm Hg) 
HR (beai!, mm) 
η 
14 
11 
9 
14 
14 
14 
Before MA 
0 08 ± 0 02 
0 79 2:008 
2 84 ± 0 39 
339 * 29 
6 8 І . 0 3 
679 ± 57 
81 ± 2 
63 ± 2 
After MA 
0 14 + 0 02 
0 97 ± 0 11 
3 2 2 - 0 5 1 
338 ± 37 
6 5 ± 0 3 
835 ± 88 
97 ± 2 
70 ι 2 
ρ Value 
< 0 01 
0 0 l < p < 0 0 5 
NS 
NS 
NS 
< 0 0 l 
< 0 01 
< 0 01 
π Numbtr of measurements IQ affinity R, receptor density NS not significant 
rcnoccptor determination R1 and Ки values were calculated 
by subjecting the data to a nonlinear least squares fitting pro 
cedute using the Gauss-Newton algorithm The results are 
expressed as means + ShM Statistical significance was esti 
mated by Wiltoxon s signed rank test A ρ value <0 05 was con-
bidcred signiltcant 
RESULTS 
MA caused significant increases in HR (ρ < 0 Ol) 
and BP (ρ < 0 Ol) (Table 1) Plasma adrenaline levels 
rose signifìcantly (ρ < 0 01), with an average increase 
of 113% ± 33% after 5 mm Plasma noradrenaline 
showed a signiltcant but less pronounced increase, with 
ameanof21%±7%(0 0 1 < p < 0 05) α-Adrenoceptor 
density varied widely in nine subjects, at rest as well 
as after MA, with R, values ranging from 197 to 459 
before and 218 to 483 fmol [3H]rauwolscme bound/mg 
protein after the test Kd values before and after MA 
ranged from 1 7 to 5 2 and I 8 to 6 1 nM respectively 
No differences in either R, or Kj values before and after 
the test were seen 
ß-Adrenoceptor density vaned considerably between 
individual subjects, with values ranging from 325 to 
1264 ICYP binding sites/cell before and 355 to 1535 
ICYP binding sites/cell after the test, while K,, values 
varied from 5 7 to 9 4 before and 5 4 to 9 3 ρΛί after 
the test 
In contrast to the α-adrenoceptor density, ß-adrenoeep-
tor density increased by 22% ± 7% (p < 0 01) during 
MA (Fig I), without changes in Kd values 
DISCUSSION 
TTie marked increase in plasma adrenaline and smaller 
increase in noradrenaline after mental stress found in 
this study conforms with earlier observations of mainly 
elevated plasma adrenaline levels after mental stress and 
a predominant increase in noradrenaline after physical 
stress (9) However, contradictory reports have been pub-
lished concerning plasma NA after mental stress (5,9) 
Our results point to an activation of prejunctional ß-
adrenoceptors to facilitate NA release via stimulation 
by A of adrenal-medullary ongin 
1500-
• 1250-
o 1000· 
J-
V 750· 
500-
before M A after M A 
FIG 1. ß-Adrenoceptor density on lymphocytes before and after 
MA 
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We could not observe a significant change in specific 
[3H]rauwoIscine binding in platelet membranes after MA 
Reports on the effect of adrenoceptor agonists on a-
adrenoceptor binding characteristics in platelets are con­
troversial Reduction (10) as well as no changes (11) in 
receptor numbers have been reported The increase in 
β adrenoceptor density after MA is in agreement with 
reports concerning increased lymphocyte β adrenoceptor 
density after physical exercise or infusions of adrenocep­
tor agonists (1-4) 
β Adrenoceptor density on lymphocytes as reported 
in the literature vary widely This variation might be 
caused by differences in assay methods (Ref 12 see 
also S J Graafsma et al , unpublished observations), 
as well as several physiological stimuli such as upnght 
or supine position, and penod of resting before blood 
sampling 
The stimulus in our study consisted of mental stress, 
and wc demonstrated a change in β adrenoceptor density 
already taking place after 5 mm It is unlikely that such 
a fast increase represents new receptor synthesis Our 
data support the suggestion of Stmtmatter et al (13), 
who hypothesized an atute uncovering of receptor sites 
that may not have been accessible to the radioligand 
before 
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SUMMARY 
The effect of Mental Arithmetic (MA) on <*2- and ß2-
adrenoceptors on platelets and lymphocytes respectively and 
on plasma catecholamines was studied in normotensive (NT) and 
essential hypertensive (HT) subjects. There were no 
significant differences in responses of blood pressure, 
forearm blood flow and heart rate to MA between the two 
groups. Baseline values and changes in adrenaline and 
noradrenaline levels during MA were similar in NT and HT. <*z-
Adrenoceptor density and antagonist affinity did not differ 
between NT and HT and were not influenced by MA. Baseline 
values of ß2-adrenoceptor density did also not differ between 
NT and HT and increased similarly after MA in both groups. 
Antagonist affinity to the ß2-aärenoceptors under baseline 
conditions was lower in HT, and did not change during MA in 
either group. Our results indicate that there are no 
differences in «2- and ß2-adrenoceptor densities both at 
baseline conditions and after mental stress between NT and 
HT. 
INTRODUCTION 
Alterations in the sympathetic nervous system may play a 
role in the pathogenesis of essential hypertension (1). Since 
direct measurement of sympathetic nerve activity is difficult 
to perform in large groups of patients, venous plasma 
catecholamine levels have been taken as an index for 
sympathetic activity. Although numerous comparative studies 
in hypertensives and normotensive controls have been done, it 
is still a matter of controversy whether or not plasma 
catecholamines are elevated in patients with essential 
hypertension (2). Moreover Hjemdahl has criticised the 
validity of venous plasma catecholamine samples for 
measurement of sympatho-adrenal activity (3). 
Because of the above mentioned problems, attention has 
been given to other parts of the sympathetic nervous system. 
Nowadays methods for determination of the adrenoceptors, the 
effectors of the sympathetic nervous system, are available. 
Human platelets contain alpha2- and lymphocytes beta2-
adrenoceptors, which can be quantitatively determined by 
binding with radioligands (4). 
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Recent studies have demonstrated that the regulation of 
adrenoceptors is indeed dynamic (5,6). Brodde et al. (5) have 
found that in patients with essential hypertension the ß2-
adrenoceptor density on lymphocytes is elevated, together 
with an impaired upregulation of the receptors after 
exercise. In a number of studies differences in haemodynamic 
responses and changes in catecholamines to different forms of 
stress between normotensives and hypertensives have been 
reported (1,7-9). The mental arithmetic test (MA) induces 
significant increases in plasma catecholamines (8). In a 
small group of young male normotensives we have found that a 
five minute ΜΆ test caused already a statistically 
significant increase in beta2-adrenoceptor density of 23 %, 
together with a rise of plasma adrenaline of 75 % (10). There 
are no data about the effect of other stress tests than 
bicycle exercise on adrenoceptors in essential hypertension. 
Consequently we studied the MA-induced changes in both Œz-
and ß2-adrenoceptors and in haemodynamics and plasma 
catecholamines in a group of essential hypertensives and in 
an age and sex matched group of normotensive healthy 
volunteers. 
METHODS 
Twenty patients with essential hypertension according to 
the criteria of the Joint National Committee (11) were 
recruited from the outpatient clinic, and were without 
medication for at least four weeks. Twenty healthy 
normotensive subjects served as a control group. They were 
recruited by means of a newspaper announcement and were not 
familiar with the investigative procedures. The 
characteristics of the normotensive (NT) and the hypertensive 
(HT) subjects are shown in Table 1. 
The reported blood pressures (BP) in this table were recorded 
with a sphygmomanometer and are the average of measurements 
recorded at 3 successive visits at the outpatient department, 
after a rest period of at least 10 min in supine position, in 
the case of HT, whereas in NT the average value of 3 
measurements, taken on the day of the test is given. Body 
mass index or Quetelet's index was calculated by dividing 
body weight by height square. All subjects gave their 
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20 
11/9 
42.6 + 7.5 
23.0 + 2.4 
114 + 12 
73 + 10 
63 + 8 
12.5 + 4.6 
** 
** 
** 
* 
11. 
20 
8/12 
46.0 +6.7 
29.4 ± 5.4 
152 + 22 
94 + 9 
7 2 + 9 
,4 + 4.9 
informed consent. The study was approved by the hospital 
ethical committee. 
Table 1. Characteristics of the normotensive (NT) and 
hypertensive (HT) subjects (mean + SD) 
NT HT 
number 
male/female 
age (years) 
Quetelet's index(kg/m2) 
supine blood pressure 
systolic (mmHg) 
diastolic (mmHg) 
heart rate (bpm) 
24 hour sodium excretion 
(mmol/mmol creatinine) 
* ρ < 0.01 
** ρ < 0.0001 
The tests were carried out in the morning. The subjects 
were asked to abstain for at least 12 h from beverages 
containing caffeine or alcohol, from smoking for 24 h and 
from eating for 8 h before the test. All subjects remained 
supine throughout the experiment. A cánula was inserted in an 
antecubital vein in the left arm. Blood pressure (BP) was 
measured with the Arteriosonde 1225. Mean arterial pressure 
(MAP) was calculated as the sum of the diastolic and one-
third of the pulse pressure. Heart rate (HR) was calculated 
from the electrocardiogram. Forearm blood flow (FBF) was 
measured by mercury strain gauge venous occlusion 
plethysmography (12) at the left arm. After 30 min of rest, 
BP, HR and FBF were measured. A blood sample for 
determination of plasma catecholamines (13) and of 
adrenoceptor characteristics was taken. MA was performed 
according to a standard procedure for 5 min. (14). During MA, 
BP and HR were recorded 3 times, in the first, third and the 
last min of the test, whereas FBF was measured in the second 
and the fourth min. A blood sample for plasma catecholamines 
was taken in the last 15 seconds of the test, followed by 
sampling for receptor measurements. It has to be noted that 
occasionally we did not succeed in drawing enough blood to 
perform all determinations; this explains the differences in 
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the numbers in the tables. Alpha2- and beta2-adrenoceptors 
were measured on platelets and lymphocytes respectively in 
the following way: After centrifugation of the blood (300.g 
for 15 min at room temperature), platelet-rich plasma was 
removed and membrane suspensions prepared as described by 
Brodde et al. (15) The remaining cell suspension was diluted 
with an equal volume of phosphate-buffered saline. 
Lymphocytes were isolated as described by Böyum (16). Alpha2-
adrenoceptor characteristics on platelet membranes were 
measured by the binding of 3H-rauwolscine in the presence or 
absence of 10"s M phentolamine after an incubation of 30 min 
at 25° с (15). Beta-adrenoceptor characteristics of lympho­
cytes were measured as described earlier (17). (-)г25Іоао-
cyanopindolol (:L2SICYP) binding to intact lymphocytes was 
measured in the presence or absence of 10^* M CGP-12177 after 
an incubation of 1 hour at 37° C. Adrenoceptor density (В™«) 
and antagonist affinity (Κ
β
) were calculated by subjecting 
the data to a non-linear, least squares curve fitting proce­
dure using the Gauss-Newton algorithm. The results are ex­
pressed as means + SE, unless indicated otherwise, statisti­
cal comparisons between paired observations were made with 
Student's t-test or wilcoxon's rank sum test, correlation 
coefficients were calculated according to the Pearson 
correlation or the non-parametric Spearman's rank correlation 
test. A p-value < 0.05 (two-sided) was considered to be 
statistically significant. 
RESULTS 
The course of BP, HR and FBF during MA was similar in NT 
and HT, although for BP and HR at a substantial lower level 
in NT (Figure 1, Table 2). 
Plasma adrenaline (AD) and noradrenaline (NA) at rest did 
not differ between the two groups (Table 3). AD rose 
significantly in NT (73%; p<0.001) ) as well as in HT (75%; 
p<0.001). NA showed a less pronounced increase of 20% in NT 
(p<0.05) and 30 % in HT (p<0.01)/ the difference between the 
two groups being not significant. 
«z-Adrenoceptor density varied widely at rest and after 
MA. At rest Bm«Ä ranged from 100 to 276 fmol/mg in NT and 
from 83 to 441 fmol/mg in HT. 
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Figure 1. The course of blood pressure (BP), heart rate (HR) 
and forearm blood flow (FBF) before and during 
mental arithmetic (MA) in the normotensive and 
hypertensive groups. 
Table 2. Baseline values and proportional changes during 
mental arithmetic(MA) in systolic blood 
pressure(SBP), diastolic blood pressure(DBF), heart 
rate(HR), and forearm blood flow(FBF) in 
hypertensives(HT) and normotensives(NT). Mean + SE 
are given 
SBP 
(mmHg) 
DBP 
(mmHg) 
HR 
(bpm) 
FBF 
ml/100ml/min 
baseline 
NT 
110 + 
76 + 
63 + 
3.1 + 
3 
2 
2 
0. 5 
values 
HT 
145 + 5 
94 + 2 
68 + 2 
3.1 + 0.5 
changes during MA (%) 
NT 
15 + 
12 + 
12 + 
49 + 
2*** 
2*** 
3*** 
14** 
HT 
11 + 
15 + 
7 + 
47 + 
2*** 
3*** 
2*** 
20* 
* ρ < 0.05 
** ρ < 0.01 
*** ρ < 0.001 
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Table 3. Mental arithmetic induced changes in adrenaline (AD), 
noradrenaline (ΝΑ), =2- and ßz-adrenoceptor density 
(Bm^J and antagonist affinity (K^ ) in normotensive (NT) 
and hypertensive (HT) subjects. All values + SE 
NT HT 
η before MA after ΜΑ η before MA after MA 
AD (ПМ) 20 0.16+0.03 *** 0.25+0.04 20 0.15+0.03 *** 0.25+0.03 
NA (ПМ) 19 1.32+0.07 * 1.52+0.12 20 1.31+0.12 ** 1.61+0.12 
«^-adreno­
ceptors 
Κα (nM) 9 1.58+0.14 1.57+0.11 19 1.58+0.15 1.59+0.15 
Bnuoc 
(fmol/mg) 9 186+23 
ß2-adreno-
ceptors 
Ka (pM) 20 6.7+0.4 
BniAX 
(sites/cell) 931+56 ** 1080+68 
183+19 19 199+20 208+17 
6.7+0.4 20 8.8+0.6 8.8+0.6 
958+77 ** 1166+70 
* ρ < 0.05 ** ρ < 0.01 *** ρ < 0.001 
1 2 5 I C Y P BINDING SITES/CELL 
1 9 0 0 — noTmot»n%\w«% hyper tensivas 
(n = 2 0 ) (n=18) 
1 7 0 0 -
b«fore after before after 
Figure 2. β2-Adrenoceptor density on lymphocytes before and 
after mental arithmetic (MA) in the normotensive 
and hypertensive groups 
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After MA these values ranged from 108 to 253 fmol/mg in NT 
and from 100 to 407 fmol/mg in HT (Table 3). No differences 
in Вт»,, and Ko values of the ^ z-adrenoceptors in both groups 
before as well as after the test were seen. 
ß2-Adrenoceptor density did not differ between NT and HT; 
neither at rest, nor after MA (fig 2). BI„^X increased by 18 + 
5% in NT (p<0.01) and by 27 + 7% in HT (p<0.01). The K^ of 
the ß2-adrenoceptors was higher in HT than in NT (p<0.01) and 
MA had no influence on the К
л
 of both groups. 
No correlations between the Quetelet index on one side 
and baseline ßz-adrenoceptor density, the proportionally 
change in ßz-adrenoceptor density or β
ζ
-Κ
β
 on the other side 
were found. There was also no correlation between baseline 
MAP and baseline ßz-Bn,»« or β
ζ
-Κ
Λ
 values. 
DISCUSSION 
As previously demonstrated in NT male volunteers (10), our 
results indicate that MA induces a similar increase of ßa-
adrenoceptor density in HT subjects, whereas the antagonist 
affinity constants to both receptor subtypes and the œzz-
adrenoceptor density remain unchanged in both groups. The 
increase in ß2-adrenoceptor withstood isolation of 
lymphocytes and the receptor assay. The temperature of 37 
° in 123ΙΟΥΡ binding was maintained because we had discovered 
in previous studies that 1 hour of incubation at body 
temperature was not enough to obtain equilibrium at the lower 
1ZS1CYP concentrations (17). The K^ value of the β
ζ
-
adrenoceptors was slightly but significantly higher in the HT 
than in the NT. No differences in baseline œ2- as well as ßz-
adrenoceptor densities were seen between the two groups. 
Recently the role of adrenergic receptors in hypertension 
has been reviewed in this journal (18). From this review 
article, the conclusion can be drawn, that there are indeed 
some changes in the number, or affinity of adrenergic 
receptors in rats, but that there are important differences 
between adrenoceptor patterns in genetic forms of 
hypertension (such as SHR) and those in renovascular and 
DOCA-Na* types. In SHR, increased renal β- and œz-
adrenoceptors may respectively, enhance renin release, and 
cause sodium and water retention. ß-Adrenoceptors other than 
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in the kidney are downregulated in response to the 
sympathetic hyperactivity. In DOCA-Na- hypertensive rats 
vascular «χ- and «z-adrenoceptors were increased, whereas 
renal «^-adrenoceptors were decreased, leading to an 
increased renin release. 
In man studies of adrenoceptors by direct binding in 
relation to essential hypertension have mainly been performed 
in blood cells. The outcome of these studies are rather 
conflicting, partly due to methodological problems. So in a 
previous study (19) we have reported that Pz-adrenoceptor 
density is lower in broken than in intact lymphocytes. This 
can be caused by receptor loss during membrane preparation. 
However, two other important processes in intact cells may 
play a role. Firstly, agonist-induced internalization of 
adrenoceptors may occur. This internalization of ß-receptors 
has extensively been studied, using hydrophilic and 
lipophilic ligands (20). Secondly, uptake of the radioligand 
by high affinity non-specific sites, or trapping of the 
radioligand may lead to incorrect receptor density 
determinations (19,21). To circumvent the latter and since we 
were only interested in cell surface receptors, we used a 
hydrophylic agent CGP-12177 to define non-specific binding of 
the intact lymphocytes for the ß2-adrenoceptor binding 
studies (21). 
Most authors reported that there are no differences in =2-
adrenoceptor density and antagonist affinity between NT and 
HT (22-25). However, increased (26) as well as decreased (27) 
numbers of =2-adrenoceptors on platelets of hypertensive 
patients have been demonstrated, whereas Kafka et al. (28) 
demonstrated only elevated «2-adrenoceptor density in female 
hypertensives. Ashida et al. (22) found similar Œ 2-
adrenoceptor densities under baseline conditions in HT and 
NT, but an increased number of o:2-aärenoceptors in HT, who 
were salt responders in the high sodium period, whereas it 
did not change in salt non-responders. This was accompanied 
with a decreased adrenaline induced platelet aggregation in 
non-responders. It has been demonstrated (23) that platelets 
from hypertensive subjects exhibit a defect in the ability of 
physiological concentrations of agonists to desensitize the 
"•^-adrenoceptor. Furthermore Erne et al. (29) showed that 
83 
platelets in HT exhibit greater adenylate cyclase responses, 
whereas Continsouza-Blanc et al. (27) found that in HT on 
platelets only the high-affinity ^-adrenoceptor site was 
detectable. All these findings are in favour of a defect, if 
present, rather at the post receptor level than in the =2-
adrenoceptor itself. 
With respect to the number of p2-adrenoceptors on 
circulating lymphocytes, data are also not uniform; elevated 
ß2-adrenoceptor density was found (5,30,31), whereas others 
detected no changes (32,33). Brodde et al. (5) has shown that 
the number of ß2-adrenoceptors on circulating lymphocytes at 
rest was increased and that the upregulation after dynamic 
exercise was impaired. On the other hand Landmann et al. (34) 
measured similar ßz-adrenoceptor densities on lymphocytes in 
HT and NT when ;L2SICYP was used as radioligand, but higher 
density in HT in case of 3H-dihydroalprenolol. Feldman et 
al. (33) demonstrated normal ßz-B™,,^  values on lymphocytes in 
HT, but a reduction of the proportion of ß2-receptors binding 
agonists with a high affinity. 
The antagonist affinity (K,,) of :l2SICYP binding on 
lymphocytes was higher in HT. Changes in antagonist affinity 
does not ultimately implicate changes in agonist affinity, 
but is probable. However alteration in agonist affinity 
points to a defect in the receptor-effector coupling, which 
may be unnoticed when only the cintagonist affinity is 
measured. Up till now differences in antagonist affinity 
have not yet been reported in the literature in relation to 
essential hypertension. Theoretically a reduced affinity to 
ß2-adrenoceptors may lead to a condition of increased 
vasoconstriction, a situation which is considered to be the 
hallmark of essential hypertension. However, since in this 
study the baseline FBF values in HT and NT were very similar, 
and since no differences in the haemodynamic and humoral 
changes between the two groups could be detected, the 
functional significance of this finding remains questionable. 
Caution has to be taken with the interpretation of the 
increase in ß2-receptor density. Strittmatter et al. (35) 
demonstrated in rat reticulocyte membranes a mechanism by 
which phospholipid methylation uncovers hidden ß-adrenergic 
receptors. Stimulation of ß-adrenergic receptors proved to 
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increase the methylation of phospholipids. By this route 
adrenergic agonists may be able to induce upregulation of 
the adrenoceptors. On the other hand the acute changes of ß2-
receptor density may reflect a change in lymphocyte 
population during the period of stress. Several authors have 
shown that ß2-adrenergic receptors are different in 
subpopulations of human circulating lymphocytes (36-38). 
Moreover Landman et al. (39) recently demonstrated that 
exercise induces an increase in ß2-adrenoceptor numbers per 
cell on lymphocytes and, at the same time, an alteration in 
the distribution of lymphocyte subsets in blood. 
Just like the measurement of catecholamines and blood 
pressure, direct binding studies of adrenoceptors in 
essential hypertension do not lead to uniform results. This 
may be caused by the fact that patients with essential 
hypertension are not a homogeneous population. Furthermore 
methodological factors like choice of radioligand, 
interference of internalized receptors or ligand trapping can 
influence the measurements. Special care has to be given to 
the selection of the control groups: often these subjects 
are recruited from laboratory personnel, who are familiar 
with the situation and experience the test less stressful. 
Attention should be given to subgroups for instance young 
patients. Furthermore possible defects might be located at 
the post receptor level. Studies of the high/low affinity 
state of the receptor or the receptor-cyclase coupling 
protein, which stimulates the adenylate cyclase to induce the 
production of cyclic-AMP might give more information. 
We conclude that in essential hypertension the 
adrenoceptor densities on blood cells are not altered, and 
that they are influenced by MA in a similar way. 
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ABSTRACT 
The effect of handgrip isometric exercise on plasma 
catecholamines, œ2-adrenoceptors on platelets and ß2_ 
adrenoceptors on lymphocytes was studied in normotensive 
and essential hypertensive subjects. 
Whereas systolic blood pressure increases were similar in 
normo- and hypertensives, diastolic blood pressure and heart 
rate increased more in the former group. 
Baseline values and changes in plasma adrenaline and 
noradrenaline did not differ between both groups. 
No differences were seen in «z-adrenoceptor density and 
antagonist affinity between normo- and hypertensive subjects 
before as well as after the test. 
Handgrip isometric exercise induced a similar increase in 
p2-adrenoceptors on lymphocytes of 22 + 7 and 13 + 5% in 
normotensives and hypertensives respectively. Antagonist 
affinity to the p2-adrenoceptors under baseline conditions 
was somewhat lower in hypertensives (8.1 + 0.4 pM) than in 
normotensives (6.5 + 0.5 pM) and this difference persisted 
during the test. 
Our results indicate that there are no differences in «2-
and ß2-adrenoceptor densities both at baseline conditions 
and after handgrip isometric exercise between normo- and 
essential hypertensive subjects. Small differences in 
affinity to the ß2-adrenoceptors were found which require 
further investigation. 
INTRODUCTION 
Since methods for determination of the adrenoceptors 
became available (1) and it appeared that the regulation of 
adrenoceptors was far more dynamic than previously thought 
(2), several investigators have studied the relation between 
adrenoceptors and essential hypertension. 
Some authors have reported that under baseline conditions 
ß2-adrenoceptors on circulating lymphocytes in hypertensives 
are increased (3,4). Brodde et al. found that the 
upregulation after dynamic exercise of ß2-adrenoceptors was 
impaired (5). Mental stress induces a similar increase in ß2-
adrenoceptors in hypertensives and normotensives, whereas œ2-
adrenoceptors remain unchanged (6). Mental stress induces a 
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strong and instantaneous increase of the systolic and 
diastolic blood pressure, heart rate and cardiac output and 
is predominantly accompanied by an increase of peripheral 
venous plasma adrenaline, whereas the peripheral venous 
plasma noradrenaline does not change appreciably (7). In 
contrast to mental stress, handgrip isometric exercise 
induces a gradual increase in systolic and diastolic blood 
pressure and heart rate. In this response the role of 
withdrawal of the parasympathetic activity is more important 
than an increment of sympathetic activity (8). Humoral 
factors like catecholamines seem to play a minor role, since 
the haemodynamic response to exercise disappears immediately 
after cessation of exercise, whereas the humoral changes take 
some time to occur. 
Different adrenergic stimuli elicit a differential 
sympathetic discharge to peripheral organs (9). Because of 
the divergent pathways in generating effects on the 
sympathetic nervous system, different stress tests may not 
elicit similar responses at the receptor level. Therefore we 
studied the influence of handgrip isometric exercise on »a-
and ßz-adrenoceptors on platelets and lymphocytes 
respectively in patients with essential hypertension and 
normotensive subjects. 
METHODS 
Thirteen patients with essential hypertension according 
to the criteria of the Joint National Committee (10) were 
recruited from the outpatient clinic, and were without 
medication for at least four weeks. Ten healthy normotensive 
subjects served as a control group. They were recruited by 
means of a newspaper announcement and were not familiar with 
the investigative procedures. The characteristics of the 
normotensive (NT) and the hypertensive (HT) subjects are 
shown in Table 1. The reported blood pressures (BP) in this 
table were recorded with a sphygmomanometer and are the 
average of measurements recorded at 3 successive visits at 
the outpatient clinic, after a rest period of at least 10 
min in supine position, in the case of HT, whereas in NT the 
average value of 3 measurements, taken on the day of the 
test is given. 
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Table 1. Characteristics of the normotensive (NT) and 
hypertensive (HT) subjects. Mean + SD are given. 
number 
male/female 
age (years) 
Quetelet's index(kg/m2) 
supine blood pressure 
systolic (mmHg) 
diastolic (mmHg) 
heart rate (bpm) 
24 hour sodium excretion 
(mmol/mmol creatinine) 
NT 
10 
5/5 
42.6 + 9.1 
23.3 + 2.9 
113 + 8 
73 + 6 
63 + 7 
18.8 + 5.0 
** 
** 
* 
* 
HT 
13 
7/6 
39.1 + 10.4 
24.1 + 3.0 
151 + 14 
95 + 6 
72 + 12 
12.0 + 2.8 
* ρ < 0.01 
** ρ < 0.0001 
Body mass index or Quetelet's index was calculated by 
dividing body weight by height square. All subjects gave 
their informed consent. The study was approved by the local 
ethical committee. The tests were carried out in the morning. 
The subjects were asked to abstain for at least 12 hrs from 
beverages containing caffeine or alcohol, from smoking for 24 
hrs and from eating for 8 h before the test. 24 Hours sodium 
excretion was measured by flame photometry. All subjects 
remained supine throughout the experiment. A cannula was 
inserted in an antecubital vein in the arm. Blood pressure 
(BP) was measured with the Arteriosonde 1225. Mean arterial 
pressure (MAP) was calculated as the sum of the diastolic and 
one-third of the pulse pressure. Heart rate (HR) was 
calculated from the electrocardiogram. After 30 min of rest, 
BP and HR were measured. A blood sample for determination of 
plasma catecholamines (li) and of adrenoceptor 
characteristics was taken. 
Handgrip isometric exercise (HG) was performed with a 
calibrated strain gauge handgrip dynamometer as previously 
described (12). In brief: the subject squeezed with the 
dominant hand with a force of 30 % of the maximal voluntary 
strength during 3 min. BP and HR were recorded every min of 
the test. A blood sample for plasma catecholamines was taken 
in the last 15 seconds of the test, followed by sampling for 
receptor measurements. It has to be noted that occasionally 
we did not succeed drawing enough blood within time to 
perform all determinations; this explains the differences in 
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the numbers in the tables. 
Alpha2- and beta2-adrenoceptors were measured on 
platelets and lymphocytes respectively in the following way: 
After centrifugation of the blood (300.g for 15 min at room 
temperature), platelet-rich plasma was removed and membrane 
suspensions prepared as described by Brodde et al. (13) The 
remaining cell suspension was diluted with an equal volume of 
phosphate-buffered saline. Lymphocytes were isolated as 
described by Böyum (14). Alphaz-adrenoceptor characteristics 
on platelet membranes were measured by the binding of 3H-
rauwolscine in the presence or absence of 10-5 M phentolaroine 
after an incubation of 30 min at 25° С (13). Beta-
adrenoceptor characteristics on lymphocytes were measured as 
described earlier (15). (-)125Іоаосуапоріпао1о1 (і:г=ІСУР) 
binding to intact lymphocytes was measured in the presence or 
absence of ΙΟ-6 M CGP-12177 after an incubation of 1 hour at 
37° C. Adrenoceptor density (B™««) and antagonist affinity 
(Κα) were calculated by subjecting the data to a non-linear, 
least squares curve fitting procedure using the Gauss-Newton 
algorithm. The results are expressed as means + SE, unless 
indicated otherwise. Statistical comparisons between paired 
observations were made with Student's t-test or Wilcoxon's 
rank sum test. Correlation coefficients were calculated 
according to the Pearson correlation or the non-parametric 
Spearman's rank correlation test. A p-value < 0.05 (two-
sided) was considered to be statistically significant. 
RESULTS 
Figure 1 and Table 2 display the course of BP and HR, 
before and during HG. As expected BP increased to a higher 
level in HT than in NT. Some differences in haemodynamic 
reactivity between the two groups were seen. After 1 min, 
there was a significant increase in systolic blood pressure 
(SBP) in HT. Diastolic blood pressure (DBP) rose more in NT 
(37 ± 5%) than in HT (18 + 3%) during the test (p<0.01), 
reaching similar values in both groups after 3 min. Baseline 
HR rate was higher in HT. The percentage increase in HR 
during the test was stronger in NT (29+6 versus 12 + 
5%;p<0.05). 
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Figure l. The course of systolic and diastolic blood pressure 
(BP) and heart rate (HR) before and during handgrip 
exercise in the normotensive and hypertensive 
groups. Mean values + SE are given. 
Table 2. Systolic blood pressure(SBP), diastolic blood 
pressure(DBP) and heart rate(HR), before and after 
handgrip exercise in normotensives(NT) and 
hypertensives(HT). Mean + SE are given. 
NT (n=10) HT (n=13) 
before HG after HG before HG after HG 
SBP 
(iranHg) 
DBP 
(mmHg) 
HR 
(bpm) 
1 1 2 + 3 * * * 1 4 0 + 6 
7 8 + 2 * * 1 0 7 + 5 
6 3 + 2 * * 8 0 + 3 
1 4 1 + 6 * * * 1 6 4 + 8 
9 7 + 2 * * 1 1 5 + 3 
7 2 + 3 * 8 0 + 3 
* ρ < 0 . 0 5 
* * ρ < 0 . 0 1 
* * * ρ < 0 . 0 0 1 
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Differences in HR and BP responses between HT and NT after HG 
did also not change significantly when absolute increases 
were taken into consideration. 
Plasma adrenaline (AD) and noradrenaline (ΝΛ) at rest did 
not differ between the two groups (Table 3). AD rose 
significantly in NT (131 + 40%), as well as in HT (103 + 
36%). NA showed a less pronounced increase of 39 + 13% in NT 
and 32 + 8% in HT. The changes in catecholamines were not 
significantly different between the two groups. 
Table 3. Handgrip (HG) induced changes in adrenaline (AD), 
noradrenaline (ΝΑ), =2-and p2 -adrenoceptor density (Β™^) 
and affinity (Ka) in normotensive (NT) and hypertensive (HT) 
subjects. Values are expressed as mean + SE 
NT HT 
before HG after HG η before HG after HG 
AD (nM) 
NA (ПМ) 
Œ
z-adreno-
ceptors 
Ka (nM) 
Вт.» (fmol/mg) 
ßz-adreno-
ceptors 
Ka (i*l) 
Вщах 
(sites/cell) 
io 
10 
10 
10 
0.18+0.04 
1.51+0.21 
1.94+0.40 
145+20 
6.5+0.5 
998+88 
* 0.38+0.09 
* 1.92+0.18 
1.67+0.26 
157+14 
6.5+0.4 
* 1192+83 
11 
11 
11 
11 
12 
12 
0.16+0.03 * 0.37+0.14 
1.40+0.14 ** 1.79+0.15 
2.01+0.27 
160+11 
8.1+0.4 
1013+93 
2.03+0.29 
147+14 
8.8+0.6 
* 1154+123 
* ρ < 0.01 ** ρ < 0.001 
Œ
2-Aârenoceptor density at rest (Table 3) ranged from 79 
to 265 fmol/mg in NT. Similar values ranging from 103 to 213 
fmol/mg were found in HT. Κβ values to the adrenoceptors 
were in the same order of magnitude in both groups. No 
changes in the =2-adrenoceptor characteristics after 3 min 
HG were seen. 
ß2-Adrenoceptor density at baseline conditions was within 
the same range in NT and HT. The percentage increase of B ™ « 
amounted to 22 + 7% in NT and 13 + 5% in HT and did not 
differ between the two groups (Table 3, Figure 2). 
The Kd of the 32-adrenoceptors was higher in HT than in NT 
(p<0.05) and HG had no influence on the K^ in both groups. No 
correlation between Ka of the β ¡.-adrenoceptors and HR, 
systolic blood pressure, diastolic blood pressure, AD or NA 
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were found. No correlation between ß-adrenoceptor density and 
HR, SBP, AD, NA or age were found. In NT there was a 
correlation between the 32-adrenoceptor density and DBF 
(r=0.65;p<0.05) and with MAP (r=0.63;p<0.05), but not with 
SBP. These correlations were no longer significant when both 
groups were taken together. 
'"ICYP binding sites/cell , 
1900 
1700-
1500 
1300 
1100 
900 
700 
500 
1 I I I 
before after before after 
normotensives hypertensives 
(n = 10) (n = 12) 
Figure 2. ßz-Adrenoceptor density on lymphocytes before and 
after handgrip exercise in the normotensive and 
hypertensive groups. Mean values + SE before and 
after the test in each group are indicated by 
dashes. 
Sodium excretion was higher in NT. When both groups were 
taken together, there was a positive correlation between the 
sodium excretion and the percentage increase of the ßz-
adrenoceptors after HG (r=0.57;p<0.05). 
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However, no correlations between these parameters were found 
when the calculations were made for the individual groups. 
DISCUSSION 
Our results indicate that HR and DBP responses to 
isometric handgrip exercise were higher in NT than in HT, 
whereas changes in SBP were not different between the two 
groups. In the literature most authors have reported no 
differences in haemodynamic responses to HG (16-18). 
Handgrip isometric exercise induces a similar increase of 
ßz-adrenoceptor density, in NT and HT subjects. The 
antagonist affinities of both receptor subtypes and the œ2-
adrenoceptor density remain unchanged in both groups. There 
was a slightly higher К
л
 value of the p
z
-adrenoceptors in HT, 
and the difference with NT was statistically significant. 
A positive correlation between MAP and ß2-adrenoceptor 
density in NT, but not in HT was found. In literature a 
positive (4) as well as no correlation (19) between these 
parameters has been reported. 
A positive correlation was also found between the 
percentage increase of ßz-adrenoceptors and sodium excretion, 
but not between the baseline values of the ßz-adrenoceptors 
and the sodium excretion. Wood et al. (20) have demonstrated 
that in normotensives ß-adrenoceptors on lymphocytes are 
increased during a high sodium diet. Dietary sodium 
restriction causes intravascular volume reduction and an 
increase in circulating catecholamines. The converse occurs 
during increased sodium intake. The alterations of 
catecholamine levels induce a subsequent up- or 
downregulation of the ß2-adrenoceptors. The findings of Wood 
et al. as well as ours indicate that there is a relationship 
between dietary salt intake and ß-adrenoceptor regulation. 
Brodde et al. (5) showed that the number of ß2-
adrenoceptors on circulating lymphocytes at rest was 
increased in patients with essential hypertension and that 
the upregulation after dynamic exercise on a bicycle was 
impaired. Bicycle exercise is a mode of dynamic activity 
involving large skeletal muscles. Complex central and 
peripheral circulatory adjustments become operative to 
provide the exercising muscles of sufficient blood. This is 
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accompanied by a considerable increase of plasma adrenaline 
as well as noradrenaline. During the anticipation phase, 
before starting exercise, an increase of central sympathetic 
activity already increases HR, BP and cardiac output (21). 
Mental arithmetic is also a strong stimulus of central 
sympathetic activity, leading to an increase of plasma 
adrenaline and to a small increase or decrease of plasma 
noradrenaline (7). In a previous study we have demonstrated 
that the effect of mental arithmetic on adrenoceptors on 
blood cells is similar in NT and HT (6). The effect of HG on 
adrenoceptor density and antagonist affinity on blood cells 
has not been studied so far. We did not find differences in 
baseline adrenoceptor density nor in responses to HG at the 
adrenoceptor level between NT and HT. This may have been 
caused by the fact that different stress tests do not elicit 
similar effects at the sympathetic system. The samples may 
have been too small to measure possible differences between 
groups. Furthermore patients with essential hypertension are 
not a homogeneous population. Special care has to be given to 
the selection of the control groups: often these subjects are 
recruited from laboratory personnel, who are familiar with 
the situation and experience the test less stressful. 
Further special attention has to be given to subgroups for 
instance young patients. The conflicting data concerning 
adrenoceptor characteristics between HT and NT in the 
literature may also be caused by methodological factors such 
as the choice of the radioligand, cell preparations or 
incubation buffers (22). 
Humoral factors like catecholamines are said to play a 
minor role in generating the haemodynamic responses during 
handgrip exercise (6) however, we measured a more than 100% 
increase in plasma adrenaline and 30-40% increase in 
noradrenaline levels after handgrip exercise in both groups. 
These values are similar as those found after mental 
arithmetic in normotensives (2). 
The increase of p2-adrenoceptors on lymphocytes after the 
handgrip test is probably caused by adrenaline. In a recent 
study we demonstrated in adrenalectomized females that the 
upregulation of ßz-adrenoceptors on lymphocytes after mental 
stress was impaired, which may have been due to the lower 
100 
levels of adrenaline (23). 
We conclude that despite different haemodynamic responses, 
the effects of isometric handgrip exercise on adrenoceptors 
on blood cells is of a similar magnitude as found after 
mental arithmetic. No differences between normotensives and 
essential hypertensives with respect to the effect of 
handgrip exercise on adrenoceptors on blood cells were seen. 
The lower affinity of :l25ICYP to the ß2-adrenoceptors and the 
absence of a correlation between MAP and ß-adrenoceptor 
density in HT may point to a disturbance at the receptor 
level. 
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ABSTRACT 
Short term physical or mental stress induces an increase 
in ß2-adrenoceptor density on lymphocytes. In order to see 
whether these extra receptors are functional, the effect of 
isotonic bicycle exercise on ß2-adrenoceptors on lymphocytes 
and plasma catecholamines was studied in 9 normotensive 
healthy volunteers. Furthermore, we measured cAMP production 
in lymphocytes after stimulation by forskolin (a non-
receptor mediated stimulator of adenylyl cyclase, 3.10-Λ M) 
and isoprenaline (a ß-adrenoceptor agonist, 10-s M). After 
the exercise test ß^-adrenoceptor density increased from 1207 
+ 144 to 1776 ± 152 sites/cell (56 % increase). Baseline cAMP 
levels were 0.39 + 0.13 before and 0.44 + 0.13 pmol/10e cells 
after the test. After stimulation with forskolin, these 
values amounted to 1.19 + 0.24 and 1.14 + 0.21 pmol/10e cells 
before and after exercise,respectively. However, isoprenaline 
induced cAMP accumulation was 1.28 + 0.43 pmol/10e cells 
before and rose to 1.90 ± 0.43 pmol/l0E cells after the test. 
The proportional increase in isoprenaline stimulated cAMP 
synthesis was 68 + 15 % and was in the same order of 
magnitude as the increment of the receptor density. Physical 
exercise induces an upregulation of ßz-adrenoceptors on 
lymphocytes and these adrenoceptors are functional. 
INTRODUCTION 
Since methods for determination of the adrenoceptors by 
radioligands have become available (1), it has been 
demonstrated that the regulation of these receptors is more 
dynamic than was previously presumed. The number of beta7-
adrenoceptors on lymphocytes increases after various short 
stress tests (2-4). In an earlier study of a small group of 
young male normotensives we found that a five-minute mental 
arithmetic (ΜΆ) test already caused a 23 % increase in the 
number of beta^-adrenoceptors, together with a rise of plasma 
adrenaline of 75 % (5). Adrenaline seems to play a role in 
the increment of the ß^-adrenoceptors, since the upregulation 
was impaired in adrenalectomized females (6). 
Measuring cAMP levels in the presence or absence of stimu-
lating agents gives additional information about the ß-
adrenoceptor function. Isoprenaline gives a ß-adrenoceptor 
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mediated increase in cAMP, whereas forskolin, a diterpene 
extracted from the roots of Coleus forskohlii, can stimulate 
adenylyl cyclase in the absence of ρ-adrenoceptor agonists 
(7). 
We investigated the effect of a standardized isotonic 
exercise test at the level of ßz-adrenoceptors in 
lymphocytes, in combination with its effect on cAMP 
production, in order to observe the functionality of these 
ßz-adrenoceptors. 
MATERIALS AND METHODS 
(-) :lZ5Iodocyanopindolol was purchased from the 
Radiochemical Centre Amersham UK (+ 1800 Ci/mmol) and 3HcAMP 
(+ 15 Ci/mmol) from ICN, Irvine, USA ; CGP-12177 was 
generously supplied by Dr M Staehelin from Ciba Geigy 
Switzerland. The cAMP binding protein was isolated from 
bovine adrenal cortex as described by Brown et al. (8); cAMP 
was obtained from Boehringer, Mannheim, FRG, forskolin from 
Calbiochem, La Jolla, USA, isoprenaline from Lansberg bv, 
Uden, The Netherlands. All other reagents were of analytical 
grade. 
Nine healthy normotensive volunteers (5 males, 4 females) 
at the ages of 30 to 53 were studied. A standardized isotonic 
exercise test was carried out in the upright position with an 
electric bicycle ergometer (Lode's Instruments bv, Groningen, 
The Netherlands). To calculate the individual's maximal 
working power, an exercise pretest till exhaustion was 
carried out in each subject on a separate day. Preceding the 
ultimate test, an antecubital vein was cannulated for blood 
sampling. Heart rate was calculated from the ECG. After a 
resting period of at least 10 min in upright position on the 
bicycle, blood samples for measurement of ß2-adrenoceptors, 
CAMP and for plasma adrenaline (AD) and noradrenaline (NA) 
were taken. All subjects exercised continuously for three 
successive periods of 6 min at work loads of 25, 50 and 75% 
of the previously calculated maximal individual work load. In 
the last 30 sec of the final period a blood sample for AD and 
NA was taken, followed by sampling for ß2-adrenoceptors and 
CAMP. Lymphocytes were isolated as described by Böyum (9). 
Beta-adrenoceptor characteristics were measured as 
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described earlier (10). (-K^Iodocyanopindolol binding to 
intact lymphocytes was measured in the presence or absence of 
10-β M CGP-12177 after an incubation period of 1 hour at 37° 
C. p2-Adrenoceptor density (Β„„) and affinity (Кл) were cal­
culated by subjecting the data to a non-linear, least squares 
curve fitting procedure using the Gauss-Newton algorithm. 
cAMP in lymphocytes was measured as follows: Cells 
suspended in a buffer (10 mM Tris, 154 mM NaCl, 0.55 mM 
ascorbic acid, 0.1 mM theophylline and 0.1% bovine serum 
albumin, to prevent adhesion of cells) were incubated for 15 
min with 3.10-5 M forskolin, 10 - s M isoprenaline or buffer. 
Incubation was terminated by placing the samples in a boiling 
water bath for 10 'min. After сentrifugation at 10000.g a 
sample of the supernatant was taken, dried under N 2 and 
stored at -20° С until further assay. The samples were 
incubated with 2 pM 3HcAMP and an appropriate dilution of 
binding protein in 50 mM Tris HCl, 8mM theophylline, 5mM 
EDTA, 1.7inM MgS04.7H20 and 0.93 mg/ml dithiothreitol (pH=7.4) 
for 60 min at 0° C. After incubation a suspension of 1% 
charcoal and 2% bovine serum albumin in 50 mM Tris HCl 
(pH=7.4) was added and the tubes were briefly agitated. The 
samples were centrifuged at 1200.g for 5 min at 4° С. A 
sample of the supernatant (i.e. the bound fraction) was taken 
for the counting of radioactivity. Standard solutions of cAMP 
in the range of 0 - 100 pmol CAMP were treated in the same 
way. Calibration curves were plotted in terms of the 
percentage of the bound radioactivity against the amount of 
standard nucleotide. The CAMP content of the lymphocytes was 
expressed in pmol/10K cells. Intra-assay variation of cAMP 
measurements was less than 10 %. Cyclic GMP concentrations up 
till 100 pM did not interfere appreciably with the cAMP 
assay. Plasma adrenaline and noradrenaline were determined 
radioenzymatically as previously described (11). 
The results are expressed as mean + SE. Statistical com­
parisons between paired observations were made with Student's 
t-test or Wilcoxon's rank sum test. Correlation coefficients 
were calculated according to the Pearson correlation or the 
non-parametric Spearman's rank correlation test. A p-value < 
0.05 (two-sided) was considered to be statistically 
significant. 
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RESULTS 
The results are summarized in Table 1 and Figure 1. The 
bicycle exercise test caused a significant increase of 111 + 
8% in HR. Plasma adrenaline rose significantly with an 
average increase of 346 + 63%. Plasma noradrenaline also 
showed a significant increase of 251 + 39%. 
Table 1. Heart rate, plasma adrenaline and noradrenaline, 
p2-adrenoceptor density (Втах) and affinity (Κα), 
baseline (B) and forskolin (F) or isoprenaline (I) 
induced cAMP accumulation in lymphocytes before and 
after isotonic bicycle exercise (BE). All values 
are mean + SE. 
before BE after BE 
heart rate (bpm) 
adrenaline (nM) 
noradrenaline (nM) 
в
тЛ
х (sites/cell) 
K*, (pM) 
cAMP accumulation 
В (pmol/10e cells) 
F (pmol/106 cells) 
I (pmol/10e cells) 
* ρ < 0.01 
** ρ < 0.001 
ß2-Aarenoceptor density varied considerably before as well 
as after the test between individuals. In all subjects an 
increase in receptor density was observed (Figure 1), with an 
average of 56 + 14%. As can be seen in Table 1 baseline cAMP 
contents in lymphocytes did not differ before and after the 
test. Forskolin induced a 269 + 58% increase in cAMP 
production before the test, which was not significantly 
different from the 212 + 49% found after the test. The 
increase in cAMP production after isoprenaline stimulation 
was 282 + 56% before and 374 + 61% after exercise. The 
difference between increases of cAMP accumulation by 
isoprenaline stimulation before and after the test were 
statistically significant (p<0.01). The percentage increase 
in isoprenaline stimulated cAMP synthesis amounted to 63 + 
15% and was in the same order of magnitude as the increase in 
receptor density. The antagonist affinity constants to the 
ßz-adrenoceptors were not affected by the test. Mean values 
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of 7.9 + 0.5 рм before and 8.7 ±0.9 pM after the bicycle 
exercise were measured. 
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Figure 1. ß2-Adrenoceptor density on lymphocytes before and 
after isotonic bicycle exercise. Individual (open 
circles) and average values + SE (closed 
triangles) are given. 
No correlation was found between baseline receptor density 
and baseline cAMP synthesis neither before nor after 
stimulation by isoprenaline or forskolin. No correlation was 
found between the increase in receptor density and the 
increase of isoprenaline induced cAMP production. An almost 
significant negative correlation was found between baseline 
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ß2-adrenoceptors and the increase in heart rate 
(r=0.60;p=0.088). 
DISCUSSION 
Our finding of a 56% elevation in the number of ß2-adreno-
ceptors on lymphocytes after a bicycle exercise test confirms 
the earlier reports of other investigators (2,3). The con-
comitant higher isoprenaline induced CAMP production 
indicates that the additional ßz-adrenoceptors are 
functional. Brodde et al. (2) demonstrated a higher increase 
(100%) in ß2-adrenoceptors, but their exercise protocol was 
carried out somewhat different from ours. 
Baseline cAMP levels in human lymphocytes, as reported in 
the literature, vary considerably. Conolly et al. (16) 
already stated that cAMP levels in human lymphocytes not only 
showed large inter-, but also large intra-individual 
differences, when samples were taken on different days. In 
Table 2, cAMP levels, measured in human lymphocytes as 
reported in the literature, are shown. 
Table 2. Cyclic AMP levels in pmol/10B lymphocytes before 
and after stimulation with 10-s M isoprenaline 
(unless indicated otherwise) in normal controls and 
assay methods, as reported by several authors. Mean 
values (+SD) or range are given. 
baseline after assay reference 
stimulation 
3.5+0.26 
6.8+3.0 
3.8+3.2 
0.85+0.26 
2.2-34.0 
27.1+18.3 
6.9 
0.39+0.39 
5.5+0.84 
33.0+15 
103.3±12.7 
3.64+0.84 
5.9-227.2 
93.0+23.6* 
52.2+27.7" 
21.6 
1.3+1.3 
protein binding 
protein binding 
isotope dilution 
radioimmunoassay 
protein binding 
radioimmunoassay 
radioimmunoassay 
protein binding 
protein binding 
12 
13 
14 
15 
16 
17 
18 
this 
* ίο-
-1
 M isoprenaline 
** ΙΟ"
7
 M isoprenaline 
Ill 
Compared with the values in this table, our cAMP 
concentrations were in the lower range. The percentage 
increase of intracellular cAMP after isoprenaline shows less 
variation and amounts to a factor 3 to 5. Differences in 
lymphocyte isolation and assay methods may be responsible for 
these variations. Insel et al. (18) reported that lymphocytes 
prepared at 4° С had an isoprenaline stimulated cAMP 
accumulation of about 30-100 pmol/10e cells, whereas at 21° С 
these values were two to ten fold lower. We tried to 
standardize our cAMP assay as much as possible, by measuring 
all samples of one exercise test in the same run and by 
including the standard solutions (9 different concentrations 
in duplicate), whenever a protein binding assay was 
performed. 
To our surprise forskolin and isoprenaline were equally 
potent in stimulating cAMP production under baseline 
conditions, whereas after the test isoprenaline exceeded 
forskolin in this effect. Most studies report a stronger 
effect of forskolin than of isoprenaline on cAMP 
accumulation, although, as far as we know no comparative 
studies of these two agents in human peripheral lymphocytes 
have been reported. Our results indicate that forskolin and 
isoprenaline exert their effects at different sites of the 
adenylyl cyclase complex. We could not demonstrate 
additional effects of isoprenaline and forskolin on cAMP 
accumulation (data not shown). 
Our results are conform those of Brodde et al. (2), who 
also demonstrated that the increase in ßz-adrenoceptor 
numbers after isotonic bicycle exercise was accompanied by a 
comparable increase in isoprenaline evoked cAMP level in 
lymphocytes. The effect of forskolin was not studied by them. 
We conclude that isotonic exercise on a bicycle induces an 
upregulation of ßz-adrenoceptors, without affecting the anta-
gonist affinity, and induces a concomitant similar increase 
in isoprenaline evoked cAMP accumulation, indicating that the 
newly exposed receptors are functional. 
REFERENCES 
1. Motulsky HJ, Insel PA: Adrenergic receptors in man. 
Direct identification, physiologic regulation, and 
clinical alterations. N Engl J Med 1982, 307:18-28. 
112 
2. Brodde OE, Daul A, Wang XL, Michel MC, Galal O: Dynamic 
exercise- induced increase in lymphocyte beta2-adreno-
ceptors: Abnormality in essential hypertension and its 
correction by antihypertensives. Clin Pharmacol Ther 
1987, 41:371-379. 
3. Butler J, Kelly JG, O'Malley K, Pidgeon F: Beta-adreno-
ceptor adaptation to acute exercise. J Physiol (London) 
1983, 344:113-117. 
4. Tohmeh JF, Cryer PE: Biphasic adrenergic modulation of 
beta-adrenergic receptors in man. J Clin Invest 1980, 
65:836-840. 
5. Graafsma SJ, van Tits B, Westerhof В, van Valderen R, 
Lenders JWM, Rodrigues de Miranda JF, Thien Th: Adreno­
ceptor density on human blood cells and plasma catecho­
lamines after mental arithmetic in normotensive 
volunteers. J Cardiovasc Pharmacol 1987, 10 
(suppl.4):S107-S109. 
6. Graafsma SJ, Lenders JW, Peters JH, van Tits LJH, 
Pieters GF, Rodrigues de Miranda JF, Thien Th. Role of 
adrenaline in the short-term upregulation of beta-
adrenoceptors in essential hypertensive and 
adrenalectomized females. J Hypertension 1988, 
6(suppl.4):S578-S580. 
7. Seamon KB, Daly JW. Forskolin, cyclic AMP and cellular 
physiology. Trends Pharmacol Sci 1983, 4:120-123. 
8. Brown BL, Albano JDM, Ekins RP, Sgerzi AM: A simple and 
sensitive saturation assay method for the measurement of 
adenosine 3*5'-cyclic monophosphate. Biochem J 1971, 
121:561-562. 
9. Böyum A: Isolation of mononuclear cells and granulocytes 
from human blood. Scand J Clin Lab Invest 1967, 
97(suppl.): 77-89. 
10. Graafsma SJ, van Tits LJH, Rodrigues de Miranda JF, 
Thien Th: Kinetics of (-(^"lodocyanopindolol binding to 
intact human mononuclear cells. J Recept Res 1988, 
8:773-785. 
11. Hoffmann JJML, Willemsen JJ, Lenders JWM, Benraad ThJ: 
Reduced imprecision of the radioenzymatic assay of 
plasma catecholamines by improving the stability of the 
internal standards. Clin Chim Acta 1986, 156:221-26. 
12. Brodde OE, Daul A, O'Hara N: Beta-adrenoceptor changes 
in human lymphocytes, induced by dynamic exercise. 
Naunyn Schmiedeberg's Arch Pharmacol 1984, 325:190-
192.[Erratum: Naunyn Schmiedeberg's Arch Pharmacol 1985, 
328:326] 
13. Kraft CA, Castleden CM: The effect of aging on ß-adreno-
ceptor-stimulated cyclic AMP formation in human lympho-
cytes. Clin Sci 1981, 60:587-589. 
14. Venter CP, Daya S, Joubert PH, Strydom WJ: Ethnic dif-
ferences in human lymphocytic cyclic AMP production 
after isoprenaline stimulation and propranolol blockade. 
Br J Clin Pharmacol 1985, 19:187-190. 
15. Sager G, Lyberg T, Prydz H, Christoffersen Τ, Jacobsen 
S: Effect of serum on isoproterenol-induced cyclic AMP 
accumulation in human lymphocytes. Acta Pharmacol et 
Toxicol 1985, 57:197-203. 
16. Conolly ME, Greenacre JK: The lymphocyte ß-adrenoceptor 
in normal subjects and patients with bronchial asthma. J 
Clin Invest 1976, 58:1307-1316. 
113 
17. Lima DR, Turner Ρ: Propranolol increases reduced beta-
receptor function in severely anxious patients. Lancet 
1983, ii:1505. 
18. Insel PA, Motulsky HJ, Mahan LC: Regulation of cyclic 
AMP accumulation in lymphoid cells. Proc Soc Exper Biol 
Med 1985, 179:472-478. 

CHAPTER 9 
ISOTONIC EXERCISE AND ADRENOCEPTORS ON BLOOD CELLS IN 
ESSENTIAL HYPERTENSION. 
Sietze J. Graafsma, Ellen Beld, Magda Hectors, Lambertus J. 
van Tits, Joeke Reyenga, Jaap F. Rodrigues de Miranda and 
Theo Thien. 
Department of Medicine, Division of General Internal Medicine 
and Department of Pharmacology, University of Nijmegen, The 
Netherlands 

117 
ABSTRACT 
The effect of isotonic bicycle exercise on «2- and ßz-
adrenoceptors on platelets and lymphocytes respectively and 
on plasma catecholamines was studied in normotensive and 
essential hypertensive patients. No statistically significant 
differences in responses of blood pressure and heart rate to 
the exercise test were found between the two groups. There 
were no differences between normo- and hypertensives in 
maximal heart rate or maximal working power reached. Baseline 
values and changes in adrenaline and noradrenaline levels 
during exercise were similar in both groups. Neither 
adrenoceptor subtype densities nor antagonist affinities 
differed between the groups studied at baseline. Whereas <*z-
adrenoceptor density did not change during exercise in the 
normo- and the hypertensives, ßz-adrenoceptor density 
increased with similar percentages in both groups. A positive 
correlation was found between the percentage increase of 
adrenaline and the percentage increase of the ß2-adrenoceptor 
numbers. No such correlation was found with the relative 
increase of noradrenaline. It is concluded that bicycle 
isotonic exercise induces similar effects on «=2- and ßz-
adrenoceptor density and antagonist affinity of blood cells 
in essential hypertensives and in healthy normotensives 
control. Adrenaline, in contrast to noradrenaline seems to 
play a role in the acute upregulation of ß2-adrenoceptors 
during exercise. 
INTRODUCTION 
ßz-Adrenoceptors on lymphocytes increase acutely during 
several stress tests, such as isoprenaline infusion and 
bicycle exercise. Chronically elevated catecholamines cause a 
downregulation in ßz-adrenoceptors (1-3). Recently we have 
shown that a mental arithmetic test of 5 min in healthy 
normotensive male volunteers already induced a 23 % increase 
in ß2-adrenoceptor density on lymphocytes, without affecting 
the antagonist affinity. The <=2-adrenoceptor density as well 
as the antagonist affinity on platelets remained unchanged 
during the mental arithmetic test (4). Furthermore, we have 
demonstrated that patients with essential hypertension show 
similar responses of the adrenoceptors on blood cells as 
118 
normotensives with respect to the effect of mental stress 
(5). In a pilot study (chapter 8) we previously found that 
isotonic bicycle exercise induces an increase in ß2-
adrenoceptor density of 58 %, being much larger than the 23 % 
increase after mental stress. 
Brodde et al. (6,7) have found that in patients with 
essential hypertension the ß2-adrenoceptor density on 
lymphocytes is elevated, together with a decreased 
upregulation of the receptors after exercise. These findings 
are in contrast to ours after mental arithmetic, but this may 
have been caused by the differences in adrenergic stimuli, 
which may elicit a differential sympathetic discharge to 
peripheral organs (8). Bicycle exercise is a mode of dynamic 
exercise involving large skeletal muscles. Complex central 
and peripheral circulatory adjustments become operative to 
provide the exercising muscles of sufficient blood. During 
the anticipation phase before starting exercise on a bicycle 
ergometer, an increase of central sympathetic activity 
already increases heart rate (HR), blood pressure (BP) and 
cardiac output (9). Immediately after the onset of exercise, 
central command from cortical areas is probably the most 
important mechanism responsible for vagal withdrawal, 
causing an instantaneous rise of HR. Afferent information 
from muscle chemoreceptors causes an increase in sympathetic 
outflow to the heart and vessels, but this occurs 
considerably later than the vagal withdrawal. 
Because bicycle exercise has a much stronger effect on 
haemodynamic parameters than mental arithmetic and different 
stress tests may not elicit similar responses at the receptor 
level, we studied the influence of dynamic bicycle exercise 
on «z- and ß2-adrenoceptors on platelets and lymphocytes 
respectively, in patients with essential hypertension and for 
comparison in healthy normotensive volunteers. 
METHODS 
Ten patients with essential hypertension (HT) according 
to the criteria of the Joint National Committee (10) were 
selected from the outpatient clinic. All were without 
medication for at least four weeks. Ten healthy normotensive 
subjects (NT) served as a control group. Most of them were 
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recruited by means of a newspaper announcement and were not 
familiar with the investigative procedures. All subjects gave 
their informed consent. The study was approved by the local 
ethical committee. The tests were carried out in the morning. 
The subjects were asked to abstain for at least 12 hrs from 
beverages containing caffeine or alcohol and from smoking for 
24 hrs. 
A standardized isotonic exercise test was carried out in 
the upright position with an electric bicycle ergometer 
(Lode's Instruments bv, Groningen, The Netherlands). To 
calculate the individual's maximal working power, an exercise 
pretest till exhaustion was carried out in each subject on a 
separate day. Previously to the ultimate test, an antecubital 
vein was cannulated for blood sampling. Blood pressure (BP) 
and heart rate (HR) were recorded with an automated exercise 
blood pressure monitor (Critikon 1165). After a period of 
rest of at least 10 min in upright position on the bicycle, 
blood samples for measurement of adrenoceptors and of plasma 
adrenaline (AD) and noradrenaline (NA) were taken. All 
subjects exercised continuously for three 6 min periods at 
work loads of 25, 50 and 75% of the individually determined 
maximal working power. During all tests a pedal rate of 60 
rounds per min was used and during the first min of each 
period the load was gradually increased to the pre-determined 
level. In the last 30 sec of the final period a blood sample 
for AD and NA was taken, followed by sampling for 
adrenoceptors. After the subjects had finished the exercise 
test, they remained in a sitting position for another 60 min. 
Then BP and HR were measured and again blood samples were 
drawn. Occasionally we did not succeed in drawing enough 
blood to perform all determinations; this explains the 
differences in the numbers in the tables. AD and NA were 
determined by a radioenzymatic assay (11). Alpha2- and beta2-
adrenoceptors were measured on platelets and lymphocytes 
respectively in the following way: After centrifugation of 
the blood (300.g for 15 min at room temperature), platelet-
rich plasma was removed and membrane suspensions prepared as 
described by Brodde et al. (12) The remaining cell suspension 
was diluted with an equal volume of phosphate-buffered 
saline. Lymphocytes were isolated as described by Böyum (13). 
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«^-Adrenoceptor characteristics on platelet membranes were 
measured by the binding of 3Hrauwolscine in the presence or 
absence of 10-5 M phentolamine after an incubation of 30 min 
at 25° С (12). ß2-Adrenoceptor characteristics on lymphocytes 
were measured as described earlier (14). Briefly (-) ^ "lodo-
cyanopindolol (ігьІСУР) binding to intact lymphocytes was 
measured in the presence or absence of 10 β M CGP-12177 after 
an incubation of 1 hour at 37° C. Adrenoceptor density (B
me3t) 
and antagonist affinity (K^) were calculated by subjecting 
the data to a non-linear, least squares curve fitting proc­
edure using the Gauss-Newton algorithm. 
Mean arterial pressure (MAP) was calculated as the sum of 
the diastolic and one-third of the pulse pressure. 
The results are expressed as means + SE, unless indicated 
otherwise. Statistical comparisons between paired observa­
tions were made with Student's t-test or Wilcoxon's rank sum 
test. Correlation coefficients were calculated according to 
the Pearson correlation or the non-parametric Spearman's rank 
correlation test. A p-value < 0.05 (two-sided) was considered 
to be statistically significant. 
RESULTS 
Table 1 summarizes the baseline clinical characteristics 
of the two groups studied. The Quetelet's index was higher in 
HT than in NT. 
Table 1. Characteristics of the normotensive (NT) and 
hypertensive (HT) subjects. Mean + SD are given. 
number 
male/female 
age (years) 
Quetelet's index (kg/m2) 
blood pressure sitting 
systolic (mmHg) 
diastolic (mmHg) 
heart rate sitting (bpm) 
maximal reached 
heart rate (bpm) 
maximal reached 
work load (Watt) 
NT 
10 
3/Ì 
37.9 + 
21.9 + 
117 + 
71 + 
85 + 
180 + 
218 + 
I 
10.9 
2.6 
15 
9 
9 
5 
75 
** 
* 
** 
HT 
10 
6/4 
40.4 + 7.8 
27.5 ± 4.3 
146 + 16 
101 + 9 
88 + 9 
179 + 12 
192 + 57 
* ρ < 0.01 ** ρ < 0.001 
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Figure l. The course of blood pressure (BP) and heart rate 
(HR) before and after 3 six minute periods of 
respectively 25%, 50% and 75% of the maximal 
working power and one hour after exercise. 
As can be seen in Figure 1, the increase in BP and HR was 
similar in NT and HT during the first two steps. During the 
third step, both groups differed rather in the rising of BP, 
as compared with baseline values, although the differences 
did not reach statistical significance. For the systolic BP 
these values were 60 + 7 and 46 + 5 % in HT and NT 
respectively, whereas for the diastolic BP increases were 
seen of 33 ± 17 % (NT) and 3 + 8 % (HT). For the M7VP values 
of 45 + 10 % (NT) and 21 + 17 % (HT) were measured. 
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HR at the highest exercise level, was in NT 105 + 7 % and in 
HT 97 + 9 % higher in comparison to baseline values. The 
difference between both groups was not significant. The 
maximal HR reached means that with regard to age the groups 
finished at about 95 % of their real maximum. 
Table 2. Plasma adrenaline (AD), noradrenaline (ΝΑ), adrenoceptor density and antagonist 
affinity before (t=l), immediately after (t=2) and one hour after (t=3) bicycle 
exercise. All values are + SE 
η 
AD 10 
NA 10 
«a-adreno-
cepLors 
Kd (nM) 10 
Bmax 10 
(fmol/mg) 
ßÄ-adreno-
ceptors 
Kd (pM) 9 
Bmax 10 
(sites/cell) 
t-1 
0.23+0.05 
2.89+0.39 
2.05+0.32 
275+44 
9.2+0.7 
1137+136 
nonnotensives 
** 
л 
** 
t=2 
0.87+0.15 
13.61+3.39 
1.84+0.19 
276+40 
9.0+1.0 
1594+103 
t=3 
0.17+0.05 
2.96+0.43 
1 71+0.13 
269+37 
7.5+0.8 
1111+109 
η 
10 
10 
8 
8 
10 
10 
t=l 
0.22+0.03 
2.18+0.15 
2.07+0.44 
174+27 
7.4+0.8 
1207+146 
hypertensives 
* 
* 
** 
t=2 
0.76+0.16 
9.35+1.86 
1.82+0.39 
198+25 
8.9+0.7 
1718+201 
t=3 
0.16+0.02 
1.70+0.10 
2.02+0.36 
205+29 
7.7+0.6 
1078+103 
* p<0.01 
** p<0.001 
Baseline catecholamines did not differ between NT and HT 
(Table 2). The proportional increase of AD was 257 + 62 % in 
NT and 309 + 41 % in HT during exercise. For NA these values 
were 356 + 59 and 323 + 72 % respectively. Although the 
absolute NA values immediately after the exercise were higher 
in NT than in HT (p<0.01), the increments of both 
catecholamines were not significantly different between the 
two groups. 
One hour after the exercise all haemodynamic parameters 
and plasma catecholamines had reached levels that did not 
differ from the pretest values. 
œ2-Adrenoceptor density varied widely between individuals 
and did not change during exercise in both groups. No 
differences in the K«, values for the «z-adrenoceptors were 
seen between NT and HT. In both groups =2-ΚΛ was not affected 
by the test. 
The course of the ß2-adrenoceptor characteristics are 
shown in Figure 2 and in Table 2. 
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Figure 2. Individual ß2-adrenoceptor density on lymphocytes 
before (1), immediately after (2) and one hour 
after exercise (3). The unbroken lines represent 
individual values, whereas the broken lines 
represent the averages. 
Baseline ß2-Bmax was similar in HT and NT. During exercise a 
proportional increase in ß2-adrenoceptors of 48 + 9 % in NT 
and of 44 + 8 % in HT was observed (difference not 
significant). One hour after exercise βζ-Β™,^ in both groups 
had reached values which were not different from those 
measured before the test. The antagonist affinity to the β2-
adrenoceptors did not differ between both groups and did not 
change in NT as well as HT during exercise. 
No correlations between the Quetelet's index and baseline 
ß2-Bm«, or the proportional change in ß2-receptor density 
<^ - normotensives 
A * hypertensives 
3 
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were found. There was also no significant correlation between 
baseline HR, systolic or diastolic BP and baseline ß2-Bm_Ä, 
nor between the relative changes of HR, systolic or 
diastolic BP and the proportional increase of ß2-Bmi«. In the 
NT and HT taken together, a positive correlation was found 
between the percentage increase of AD and the percentage 
increase of the ßz-adrenoceptor numbers (r=0.60; p<0.005; 
Figure 3), whereas no such correlation was found with the 
relative increase of NA. 
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Figure 3. Correlation between the individual percentage 
changes of the β,-adrenoceptor numbers and the 
percentage changes of plasma adrenaline during 
exercise (y = 3.8x + 109;r=0.60;p=<0.005) 
DISCUSSION 
Haemodynamic responses and increments of plasma 
catecholamines and ß2_adrenoceptor density on lymphocytes 
after isotonic bicycle exercise did not differ between HT and 
NT. 
Some authors have reported sympathetic responses during 
exercise in HT that differed from NT (15-17), whereas others 
demonstrated similar effects on BP, HR, AD and NA in both 
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groups (18-20). It should be noted, however, that some 
positive studies in finding higher sympathetic responses to 
bicycle exercise may be flawed, because the same absolute 
work load to NT and HT subjects were given, thus not 
accounting for differences in physical condition. In our 
study the working load was related to the maximal working 
power of each individual subject. 
The effect of isotonic exercise on ßa-adrenoceptors on 
lymphocytes has been studied by several investigators. The 
exercise protocols were not completely comparable with each 
other. Burman et al. (21) reported an increase of ß2-
adrenoceptors of 340 % after exercise. However, this study 
was executed with 5 marathon runners, who exercised until 
exhaustion. Others (2,7,22) have found percentages of p2-
adrenoceptor elevations that were in the same order of 
magnitude as ours, ranging from 56 to 86 %. Studies of «2-
adrenoceptors on platelets in relation to bicycle exercise 
have not yet been reported in the literature. 
Brodde et al. (6,7) have shown that the number of ßz-
adrenoceptors on circulating lymphocytes at rest was 
increased and that the upregulation after dynamic exercise 
was diminished in essential hypertensive patients. Their 
exercise test was also performed somewhat different from 
ours. 
The increase of ß2-adrenoceptors on lymphocytes after the 
bicycle exercise test is probably caused by adrenaline. In a 
recent study we demonstrated that adrenalectomized females 
in contrast to age- and sex-matched normotensives and 
hypertensives did not show an upregulation of (i2-
adrenoceptors on lymphocytes after mental stress. This was 
probably caused by the undetectably low levels of adrenaline 
(23). The finding of a correlation between the increase in AD 
and of the ßz-adrenoceptor number in this study is another 
argument in favour of the role of AD in the acute 
upregulation of ß2-adrenoceptors. 
Some studies have reported that AD levels are elevated in 
patients with essential hypertension (24). Therefore, 
different responses in adrenoceptor reactivity to dynamic 
exercise might have been expected. In this study we found 
that bicycle isometric exercise induces similar effects on 
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=2- and ß2-adrenoceptor density and antagonist affinity of 
blood cells in essential hypertensives and their normotensive 
controls. AD seems to play an important role in the 
upregulation of ßa-adrenoceptors on lymphocytes. 
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ABSTRACT 
«z-Adrenoceptors on platelet membranes and ß2-
adrenoceptors on lymphocytes were studied in 24 patients with 
primary Raynaud's phenomenon (PRP), and 24 age- and sex-
matched controls. In two subgroups, a standardized mental 
arithmetic test (MA) and a finger cooling test (FCT) were 
performed. Whereas baseline systolic blood pressure, heart 
rate and forearm blood flow did not differ between both 
groups, baseline diastolic blood pressure was higher in PRP 
than in the control group (77+7 nunHg in PRP; 74+5 mmHg in 
controls; p<0.05). Baseline skin microcirculation (LDF) was 
decreased in PRP, with 19+15 in PRP and 33+14 arbitrary 
units in controls, respectively (p<0.0l). Baseline 
noradrenaline (NA) with values of 2.00+1.44 and 1.16+0.36 nM 
in PRP and controls respectively, as well as =2-adrenoceptor 
density (œ2-Bmet5t) with values of 301+119 and 210+82 fmol/mg 
in the respective groups were increased in PRP in comparison 
to the controls. Adrenaline, p2-adrenoceptor density as well 
as the antagonist affinity to both receptor subtypes did not 
differ between both groups under baseline conditions. Whereas 
during FCT no differences were seen in responses of the 
variables measured. MA induced an increased LDF in PRP and a 
decreased LDF in the control group. The increase of NA during 
MA was only statistically significant in the control group. 
Our results indicate that in PRP a defect at the «г-
adrenoceptor level may be present. 
INTRODUCTION 
The sympathetic nervous system plays an important role in 
the regulation of cutaneous blood flow (1). Primary Raynaud's 
phenomenon (PRP) is characterized by attacks of vasospastic 
digital ischaemia, usually provoked by exposure to cold or 
emotional stress (2). The pathophysiologic mechanisms 
producing clinical vasospasm in patients with PRP remain 
undefined, despite many suggestions, ranging from altered 
autonomic nervous system function (2,3), to an intrinsic 
vessel wall defect (4). 
Knowledge of human adrenoceptor function has increased 
markedly because of the development of the radioligand direct 
binding studies (5,6). «:2-Adrenoceptors are present on 
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platelets, whereas lymphocytes contain ß^-adrenoceptors. 
Although the precise relationship between adrenoceptors on 
circulating blood cells and those on the vascular wall has 
not been established yet, recent reports of diminished ß-
adrenoceptor density in both circulating lymphocytes and 
cardiac tissue in patients with heart failure (7,8), as well 
as studies in animals (5,6), lend credence to the presumed 
relationship. Increased numbers of <*2-adrenoceptors on 
platelets have been found in patients with PRP (9,10). 
However, in these studies 3Hdihydroergocryptine was used, 
which is nowadays considered to be a less suitable 
radioligand for "=2-adrenoceptor measurements (11). 
The regulation of adrenoceptors is far more dynamic than 
was previously thought. Recently we have shown that, in 
normotensive volunteers, a mental arithmetic test of 5 min 
already induces an increase of ß2-adrenoceptors on 
lymphocytes, without affecting «z-adrenoceptors on platelets 
(12). Adrenaline seems to play a role in the ßz-adrenoceptor 
upregulation, since we demonstrated that this upregulation 
was impaired in adrenalectomized females (13). 
To discover a possible defect at the adrenoceptor level in 
patients with PRP, plasma adrenaline and noradrenaline were 
studied as well as Œ2- and ß2-adrenoceptors on platelets and 
lymphocytes respectively by direct radioligand binding under 
baseline conditions, during mental stress and local cold 
challenge in 24 patients and 24 age- and sex-matched 
controls. 
PATIENTS AND METHODS 
Twenty-four patients with PRP according to the criteria of 
Allen and Brown (14), supplemented by negative clinical, 
biochemical and immunological findings indicative for 
associated diseases, were selected, together with twenty-four 
age- and sex-matched controls without complaints of cold 
hands, peripheral vascular disease or Raynaud's phenomenon. 
All gave informed consent to a protocol approved by the local 
Ethical Committee. Two subgroups were composed, consisting of 
twelve patients and controls each. One group underwent a 
Mental Arithmetic Test (MA), the other a Finger Cooling Test 
(FCT). They were asked to abstain from smoking for 24 hours 
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preceding the investigations and not to drink alcohol or 
drinks containing caffeine from 12 hours prior to the tests. 
The studies were performed with all subjects in the supine 
position in a climate room with a constant ambient 
temperature of 24.2 + 0.3 (SD) centigrade and a humidity of 
53 + 4%. During the acclimatization period of at least 20 
minutes the measurement instruments were attached and a vein 
on the back of the right hand was cannulated for sampling of 
catecholamines and a vein in the fossa cubiti for sampling 
for adrenoceptor measurements. We preferred blood sampling 
for catecholamines from a vein on the back of the hand over a 
vein in the fossa cubiti, since pilot experiments had shown 
that catecholamine levels differed between these two sites 
and we were mainly interested in catecholamine levels in the 
vicinity of the fingers. Plasma adrenaline was higher in 
blood taken from a vein of the hand than from a vein in the 
fossa cubity in PRP and control subjects. Plasma 
noradrenaline in controls was similar in samples from these 
two sites, but in PRP higher in samples from the hand than 
from the fossa cubity (data unpublished HCM Wollersheim). 
Systolic (SBP) and diastolic (DBP) blood pressure were 
measured with an Arteriosonde Roche 1225. Forearm blood flow 
(FBF in ml/100ml/min; Loosco Plethysmograph, Hoekloos) was 
determined by ECG-triggered mercury strain gauge 
plethysmography (15), whereas the venous outflow of the hand 
was occluded by a wrist cuff. After calibration, FBF was 
calculated by the mean of 3 subsequent measurements in each 
period. Heart rate (HR in bpm) was determined by ECG-
monitoring. On the second fingertip of the right hand we 
measured Laser Doppler Flux (16); (LDF in arbitrary units 
(AU); Periflux Pf-ld, Perimed KB, Stockholm, Sweden), by 
determining the area under the curve during the 30 seconds 
around each time point. MA was performed according to a 
standard procedure for five min (17). FCT was performed 
according to the method of Cleophas et al. (18) by immersing 
the gloved right hand in a waterbath of 16° С for 5 min. 
After the acclimatization period 3 baseline values of all 
parameters were measured at 2 minute intervals and averaged. 
These values were compared with the haemodynamic parameters 
as measured during the last min of the test. Before and at 
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the end of the tests, blood samples were taken. Adrenaline 
(AD) and noradrenaline (ΝΆ) were determined as previously 
described (19). Alpha2- and beta^-adrenoceptors were measured 
on platelets and lymphocytes, respectively, in the following 
way: After centrifugation of the blood (300.g for 15 min at 
room temperature), platelet-rich plasma was removed and 
membrane suspensions prepared as described by Brodde et al. 
(20). The remaining cell suspension was diluted with an equal 
volume of phosphate-buffered saline. Lymphocytes were 
isolated as described by Böyum (21). Alpha2-adrenoceptor 
characteristics on platelet membranes were measured by the 
binding of 3Hrauwolscine in the presence or absence of 10~5 M 
phentolamine after an incubation of 30 min at 25° С (20). 
Beta-adrenoceptor characteristics on lymphocytes were 
measured as described earlier (22). (-):L25Ioâocysuiopindolol 
binding to intact lymphocytes was measured in the presence or 
absence of 10-e M CGP-12177 after an incubation of 1 hour at 
37° C. Adrenoceptor density (B,,,«,,«:) and affinity (K«) were 
calculated by subjecting the data to a non-linear, least 
squares curve fitting procedure using the Gauss-Newton al-
gorithm. The results are expressed as means + SE, unless 
indicated otherwise. Statistical comparisons between paired 
observations were made with Student's t-test or Wilcoxon's 
rank sum test. Correlation coefficients were calculated 
according to the Pearson correlation or the non-parametric 
Spearman's rank correlation test. A p-value < 0.05 (two-
sided) was considered to be statistically significant. NS 
means not statistically significant. 
RESULTS 
a. Baseline values 
There were no significant differences between both groups 
with regard to age (30+9 years in PRP, 27 + 6 in controls) 
and sex ratio (female/male = 17/7 in both groups). The 
Quetelet's index (calculated by dividing weight by height 
square), with values of 21.9 + 1.5 kg/m2 in the controls and 
20.5 + 2.3 kg/m2 in PRP, was lower in the latter group 
(p<0.01). In Table 1 blood pressure, HR, plasma catecholamine 
levels and Œ2- and ß2-adrenoceptor characteristics under 
baseline conditions are shown. DBP was higher in PRP than in 
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Table 1. Baseline values of blood pressure, heart r a t e , forearm blood 
flow (FBF), Laser Doppler Flow (LDF), adrenaline (AD), 
noradrenaline (ΝΑ), = 2 - and p 2 -adrenoceptor density (Bm^J 
and a f f in i ty (Κ^) in p a t i e n t s with primary Raynaud's 
phenomenon (PRP) and contro l s . All values are mean + SD 
supine blood 
systolic 
diastolic 
pressure 
(mmHg) 
(mmHg) 
heart rate (bpm) 
FBF (ml/100ml/min) 
LDF (AU) 
AD (ПН) 
NA (ПМ) 
=
z
-adreno-
ceptors 
02-adreno-
ceptors 
Ka (ПМ) 
Β ™ „ (fmol/mg) 
IU [pM 
в
тлх
 (sites/cell) 
PRP (n=24) 
111 + 11 
77 + 7 
69 + 12 
3.0 + 1.7 
19 + 15 
0.17 + 0.11 
2.00 + 1.44 
2.04 + 0.79 
301 + 119 
7.5 + 2.8 
889 + 254 
* 
** 
** 
** 
CONTROLS (n=24) 
110 + 6 
74 + 5 
66 + 7 
3.1 + 2.5 
33 + 14 
0.15 + 0.07 
1.16 + 0.36 
1.79 + 0.51 
210 + 82 
7.0 + 1.3 
883 + 177 
ρ < 0.05 ** ρ < 0.01 
oí - odrenoceptors 
ífmol/mg protein) 
PRP С 
NA 
(nM 
PRP 
LDF 
(AUC) 
PRP 
6 0 0 -
4 0 0 -
2 0 0 -
0 J 
6.0-
4.0-
• ' 
2.0-
0 J 
6 0 
4 0 -
2 0 -
C 
o 
o 
o 
o 
o 
.fc 
Figure 1. I n d i v i d u a l va lues of «^-adrenoceptor numbers, 
plasma n o r a d r e n a l i n e (ΝΆ) and l a s e r doppler flow 
(LDF in area under c u r v e ; AUC) under b a s e l i n e 
c o n d i t i o n s in p a t i e n t s wi th primary Raynaud's 
phenomenon (PRP) and t h e c o n t r o l s (C). The average 
v a l u e s are given by a c l o s e d t r i a n g l e in PRP and by 
an open a s t e r i k s in C. 
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the controls (p<0.05), whereas LDF was lower (p<0.01). The 
other haemodynamic parameters did not differ between the two 
groups. AD was similar in both groups, in contrast to NA, 
which was higher in PRP. In Figure 1 it can be seen that NA 
levels show larger variations in the PRP than in the control 
group. No differences in Β„„ and K^ values of the β2-
adrenoceptors were seen between the patients and their 
controls. The same applied for the Kd values of the «=
z
-
adrenoceptors. «z-B™^ values on platelets from normal 
subjects ranged from 56 to 356 fmol/mg and from 50 to 460 
fmol/mg in PRP. The average œz-Bm<tK; was significantly higher 
in PRP than in the control group (p<0.01). Individual 
baseline levels of ^г-В^аж, NA and LDF are shown in Figure 1. 
Individual high «a-adrenoceptor density did not correspond 
with individual higher or lower NA or LDF values. 
b. Mental Arithmetic 
MA induced similar haemodynamic responses in both normals 
and PRP, except for LDF. p-Values for changes in SBP, DBF and 
HR before and after the test were below 0.001 both in PRP and 
normals. For FBF, these values were below 0.01 and 0.001 in 
PRP and controls respectively (Table 2). LDF increased in 
PRP, although this increase was not statistically 
significant, whereas in the control group a decrease was seen 
(p<0.05). The relative changes in LDF during MA were 
significantly different between the two groups (p<0.05). 
Table 2 also shows the MA induced changes in plasma 
catecholamine levels and adrenoceptor characteristics. In 
both groups AD increased similarly during MA; in controls 
from 0.15 +0.02 to 0.25 + 0.04 nM (p<0.01) and in PRP from 
0.18 + 0.03 to 0.26 + 0.04 nM (p<0.01). An increase in NA 
from 1.27 + 0.12 to 1.64 + 0.17 nM in the control group 
(p<0.01) and from 2.24 + 0.42 to 2.41 + 0.47 nM (NS) in the 
patient group was seen. The percentage changes of both AD and 
NA did not differ between the two groups. The responses of MA 
on the adrenoceptor characteristics were similar in both 
groups. 3-В
твж
 rose from 891 + 84 to 1005 + 95 sites/cell in 
PRP (NS) and from 832 + 47 to 931 ± 56 sites/cell in the 
controls (p<0.05), «-B™«» did not change during MA. 
Table 2. Mental arithmetic induced changes in systolic (SBP), diastolic blood pressure 
(DBP), heart rate (HR), forearm blood flow (FBF), laser doppler flow (LDF), 
adrenaline (AD), noradrenaline (ΝΑ), « 2- and pz -adrenoceptor density (Bmejc) and 
affinity (Id) in patients with primary Raynaud's phenomenon (PRP) and their 
Controls. Also the percentage change is given ( Δ % ) . All values are + SE 
PRP (n= 
before MA 
SBP (mm Hg) 
DBP (mm Hg) 
HR (bpm) 
FBF (ml/100ml 
/min) 
LDF 
AD (nM) 
NA (ПМ) 
115 + 3 
81 + 2 
73 + 4 
3.2+0.5 
18 + 5 
0.18+0.03 
2.24+0.42 
œ2-adrenoceptors 
Κα (ПМ) 
В т « (f то l/mg) 
Pz-adrenoceptc 
К« (рм) 
Вшах 
sites/cell) 
2.09+0.12 
258+34 
irs 
9.5+0.6 
891+84 
= 12) 
after MA 
3 k * * 
*** 
** 
** 
* 
*** 
127+4 
88 + 2 
85 + 4 
4.7+0.6 
31+3 
0.26+0.04 
2.41+0.47 
1.98+0.16 
240+39 
9.4+0.6 
1005+95 
Δ% 
10 + 2 
9 + 1 
19+3 
73 + 25 
36 + 23 
60 + 15 
8 + 6 
-6 + 2 
14+7 
Controls (n= 
before MA 
110+2 
74+2 
67 + 2 
4.4+0.7 
39+4 
0.15+0.02 
1.27+0.12 
1.70+0.08 
203+18 
7.1+0.4 
832+47 
•12) 
after MA 
*** 
*** 
*** 
*** 
* 
** 
** 
* 
124+3 
83+3 
78 + 4 
6.0+0.7 
31 + 4 
0.25+0.04 
1.64+0.17 
1.72+0.08 
211+17 
7.6+0.3 
931+56 
Δ % 
13 + 3 
13 + 3 
15 + 3 
45 + 10 
-18 + 8 
72+17 
38 + 17 
8 + 2 
13+5 
* ρ < 0.05 
** ρ < 0.01 
*** ρ < 0.001 
Table 3. Finger cooled (FCT) induced changes in systolic (SBP), diastolic blood pressure 
(DBP), heart rate (HR), forearm blood flow (FBF), laser doppler flow (LDF), 
adrenaline (AD) , noradrenaline (NA), =2- and ßz -adrenoceptor density (Β„„<) and 
affinity (Ke) in patients with primary Raynaud's phenomenon (PRP) and their 
Controls. Also the percentage change is given ( д % ) . All values + SE 
before FCT 
SBP (mm Hg) 
DBP (mm Hg) 
HR (bpm) 
FBF (ml/100ml 
/min) 
LDF 
AD (nM) 
NA (nM) 
<=2-adrenoceptc 
К« (nM) 
B,,,»^  (fmol/mg) 
107+4 
74+1 
66 + 3 
2.8±0.5 
20 + 3 
0.17+0.04 
1.76+0.42 
1rs 
2.00+0.30 
344+32 
Ρ 2-adrenoceptors 
IU (pM) 
B
m
« 
sites/cell) 
5.5+0.6 
887+64 
PRP 
*** 
* 
(n=12) 
after FCT 
111+1 
75+1 
66+3 
3.1+0.4 
6 + 1 
0.14+0.02 
1.69+0.29 
1.75+0.25 
307+36 
5.7+0.5 
1034+58 
Δ% 
5 + 3 
2+2 
-0.2+1 
5 + 6 
-68 + 4 
-7 + 8 
7±9 
-11+2 
20+6 
Controls 
before FCT 
110+1 
74+1 
65+2 
1.8+0.6 
28+3 
0.16+0.02 
1.05+0.08 
1.86+0.19 
217+29 
6.8+0.4 
935+52 
*** 
** 
(n=12) 
after FCT 
111+2 
74+2 
65+2 
3.2+0.6 
13 + 4 
0.11+0.02 
1.14+0.10 
1.52+0.24 
213+46 
6.8+0.4 
1046+60 
Δ% 
1+1 
0 
0 
3+10 
-59+7 
-18+15 
11+8 
10 + 3 
14+7 
* ρ < 0.05 
** ρ < 0.01 
*** ρ < 0.001 
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The affinities of both receptor subtypes were not affected 
during MA. 
c. Finger Cooling Test 
The effects of FCT on the haemodynamic measurements, 
plasma catecholamines and adrenoceptor characteristics are 
summarized in Table 3. BP, HR, and FBF did not change during 
FCT in both groups. LDF decreased in PRP as well as in the 
control group with similar percentages (p<0.001 for both 
groups). AD was 0.16 +0.02 nM before and 0.11 + 0.02 nM 
after FCT in the controls (p<0.0l), whereas these values were 
0.17 + 0.04 and 0.14 + 0.02 nM respectively in PRP (NS). NA 
amounted to 1.76 + 0.42 before and 1.69 +0.29 nM after FCT 
in PRP (NS). In the control group these levels were 1.05 + 
0.08 and 1.14 + 0.10, respectively (NS). К
л
 and Β
τηΛΧ
 values 
of the adrenoceptors did not differ between the two groups 
before as well as after the test. pz-Bm^x increased in PRP 
(from 887 + 64 to 1034 + 58 sites/cell) as well as in the 
controls (from 935 + 52 to 1046 + 60 sites/cell), but the 
changes only reached statistical significance in the patient 
group (p<0.05). 
When the two groups were taken together a negative 
correlation was found between baseline NA and baseline LDF 
(r=-0.39; p<0.01; n=48). No correlations were found between 
"z-B™««; with baseline LDF or NA. There were no correlations 
between «ζ-Β,,,β.,. values and the haemodynamic changes during 
both tests. 
A ratio composed by the ßz-adrenoceptor density divided by 
the <=2-adrenoceptor density was calculated as theoretical 
index of the balance between vasoconstriction and 
vasodilatation. The baseline value of this ratio was indeed 
significantly higher in controls (5.0 + 0.5) than in PRP (4.0 
+0.8) (p<0.001), indicating a relative enhanced constriction 
in the latter. Furthermore, the changes in the ratio induced 
by both MA and FCT were greater in the PRP group. For MA, the 
ratio increased by 35 + 16 % (p<0.05) in PRP against 9 + 8 % 
(NS) in controls. FCT raised the ratio significantly in both 
groups: in PRP 54 + 25 % (p<0.01) and in controls 48 + 18 % 
(p<0.05). The difference between both groups in the changes 
was not significantly different. 
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DISCUSSION 
In this study we have found that baseline diastolic blood 
pressure, plasma noradrenaline and ^-adrenoceptor density on 
platelets were elevated, whereas the flow in the skin 
microcirculation (LDF) at rest was decreased in PRP. The 
ratio β2/α:2 adrenoceptor numbers was higher in the control 
group, whereas the increase in this ratio tended to be higher 
in PRP. These results all point to an enhanced 
vasoconstriction, probably mediated by the sympathetic 
nervous system, in PRP. A negative correlation was found 
between NA and baseline LDF. Haemodynamic reactivity and 
changes in adrenoceptors during MA and FCT were similar in 
both groups. The divergent changes in LDF during MA between 
PRP and controls, can partly be explained by the fact that 
the potency to induce an increase in LDF is stronger when the 
baseline values are low. 
The results of other investigators regarding NA 
concentrations in Raynaud's phenomenon are somewhat 
controversial. Peacock (23) also found higher baseline venous 
blood levels of NA in PRP than in normals, while others (24) 
found normal arterio-venous concentrations of NA in the 
forearm. In Peacock's study the chromatographic method was 
used to determine the NA concentration, which is nowadays 
judged as unreliable. We used a recently improved 
radioenzymatic assay to determine plasma catecholamine 
concentration (19). Because NA is a locally released 
neurotransmitter, we sampled blood from a vein on the back of 
the hand to obtain information regarding the regional NA 
release from finger skin vessels (25). 
As far as we know, ß^-adrenoceptors have not been studied 
in PRP by direct binding studies. Baseline values of р
г
-
adrenoceptors on lymphocytes did not differ between the two 
groups. The relative increase in ß2-adrenoceptors was not 
different either between PRP and the control group; both 
tests revealed similar responses at the level of the ß2-
adrenoceptor, indicating that this receptor subclass is 
normally regulated in PRP. The decreased baseline fraction 
ß2/=2 adrenoceptor number in PRP and the higher increase of 
this fraction in this group during MA might suggest that, 
whereas at baseline conditions œ2- dominate ß2-adrenoceptors, 
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some kind of compensation mechanism is operational during 
stress. This mechanism might be impaired in PRP. From this 
point of view our data support the suggestions of Vanhoutte 
et al. (26) and Brotzu et al. (27), who stated that Raynaud's 
disease could be due to a relative lack of vasodilatory ß2-
adrenergic sensitivity of the cutaneous vessels. 
Elevated ^z-adrenoceptors on platelets have been found by 
others (9,10). Edwards et al. (9) further noticed in PRP a 
subgroup with a reduced level of «^-adrenoceptors and the 
presence of a receptor blocking substance in the serum. In 
our patient group Œz-adrenoceptor density was normally 
distributed and no subgroups could be discriminated at the 
lower end of the distribution. 
The finding of elevated NA and a:^-BmB,x values, has major 
pathophysiologic implications. A high NA concentration in 
skin vessels is able to induce the white discoloration, 
characteristic of the initial event in a Raynaud's attack 
(28). An elevated NA, together with a higher postsynaptic ^z-
adrenoceptor density, that should have been downregulated, 
could be the basic defect in PRP. We did not find a 
correlation between LDF and «z-adrenoceptors, nor between the 
product of NA and =2-8,,,^ ^ or LDF. Another possibility is 
that the increased «"^ -adrenoceptors are located 
presynaptically. It is their function to decrease NA 
secretion in the synaptic cleft. Somehow this negative 
feedback control should then be disturbed in PRP. Fagius and 
Blumberg (29) have demonstrated by microelectrode recordings 
of skin nerve sympathetic activity that there was no abnormal 
increase of sympathetic outflow to the hand, providing direct 
evidence against a primary sympathetic hyperfunction in PRP 
and Raynaud's original theory (30). Local factors at the 
level of the synaptic cleft seem to be responsible for the 
elevated NA: Either an increased production, a reduced break 
down, a decreased clearance or a diminished re-uptake from 
the synaptic cleft. Furthermore, a disturbed feedback 
mechanism between NA and the presynaptic "^-adrenoceptors 
might be operative. In conclusion, our findings of an 
elevated NA and "z-Bma^ level indicate that there is a defect 
in the regulation of the «a-adrenoceptor numbers in PRP. 
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CHAPTER 11 
ROLE OF ADRENALINE IN THE SHORT-TERM UPREGULATION OF BETA-
ADRENOCEPTORS IN ESSENTIAL HYPERTENSIVE AND ADRENALECTOMIZED 
FEMALES 

Role of adrenaline In the short-term upregulation of 
beta-adrenoceptors in essential hypertensive and 
adrenalectomized females 
Sietze J. Graafsma, Jacques W. Lenders, Jeroen H. Peters, 
Lambertus J. van Tits, Gerlach F. Pieters, 
Jaap F. Rodrigues de Miranda and Theo Thien 
The effect of mental anthmelic on (^-adrenoceptors on lymphocytes, as measured by 
(-)12S1-iodocyanopindolol binding was studied in normotensive and essential hyper-
lensive females To delermme the role of adrenaline mental arithmetic was also carried 
out in bilaterally adrenalectomized females There were no significant differences in 
the blood pressure and heart rate responses to menial arithmetic among the three 
groups Baseline values or changes tn adrenaline levels during mental arithmetic 
were similar in normotensives and hypertensives, whereas levels ol adrenaline 
remained undeteclable throughout the (est in adrenalectomized females Baseline 
values of |iz-adrenoceplors did not differ among the three groups In normotensive and 
hypertensive females the increase m ^-adrenoceptor density was, respectively. 27 and 
20% Baseline values of ß?-adrenoceplors were not related to the percentage changes 
in the receptor densities In adrenalectomized females, in contrast to normotensives 
and hypertensives, there was no change in receptor density These Nndmgs suggest 
that adrenaline plays a role in the short-term upregulation of Эг-adrenoceptors after 
mental arithmetic 
Journal of Hypertension 1988. β (suppl 4) S578-S580 
Keywords: Beta-2-adrenocepIors, upregulation, adrenaline, hypertension, 
adrenalectomized patients. 
Introduction 
Since the sympathetic nervous system may play a role in 
causing primary hypenension (1) different parts of this 
system have been studied by numerous investigators 
Recently methods for determination of the adrenocep­
tors, the effectors of the sympathetic system, became 
available [2) Further, it appeared that the regulation of 
adrenoceptors was far more dynamic than previously 
thought For example, ßz-adrenoceptors on Ivmphoeytes 
increased after a number of short-term manoeuvres, such 
as exercise on a bicycle [3,4] and infusion of ß-adrenergic 
agonists [5] 
In an earlier study m normotensives we found that a 
5-min mental arithmetic test caused a 2$% increase 
in pT-adrenoceptors, together with a rise in plasma 
adrenaline of 75% [6] 
From the Department of Internal Medicine Division of General 
Internal Medicine and Endocrinology and Department of 
Pharmacology University ol Nijmegen, The Netherlands 
Because Brodde et aL [7] suggested that shon-term 
adrenoceptor upregulation after exercise may be im-
paired in patients with primary hypertension, the first 
aim of the present study was to look for upregulation of 
ßz-adrenoeeptors in primary hypenension after mental 
arithmetic The second aim was to determine the effects 
of the rise in adrenaline after upregulation induced by 
mentai arithmetic Therefore, we also studied the effects 
of mental anthmeuc on ßj adrenoceptors in a group of 
adrenalectomi/ed patients 
Methods 
Eight females (48 9 ± 8 6 years) with essential hyper-
tension according to the criteria of the Joint National 
Committee [8] were recruited from the outpatient clinic, 
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and were without meditation for at least 4 weeks Eight 
females (41 ±84 л ears) who had undergone bilateral 
adrenalectomv because of Gushing s disease 1-18 \ears 
before the stud\ were included Fight healthv women 
(41 5 ± И 6 vears) served as a control group All subjects 
gave their informed consent The study was approved by 
the hospital ethical committee All tests were carried out 
in die morning and the subjects were asked to abstain 
for at least 12 h from beverages containing caffeine or 
alcohol from smoking for 24 h and from eating for 
2 h before the test All volunteers remained supine 
throughout the experiment Insertion of a cannula in an 
antecubital vein in the left arm was followed by a 30 mm 
rest period Blood pressure was measured with the 
Artenosonde 1225 Mean arterial pressure was calculated 
as the sum of the diastolic and one third of the pulse 
pressure The heart rate was calculated from the ECO 
After 30 mm of rest blood pressure and heart rate were 
measured in triplicate and averaged A blood sample was 
taken for determination of plasma catecholamines [9] and 
Эг adrenoceptor characteristics Mental arithmetic was 
performed for 5 mm according to a standard procedure 
[10j During the mental arithmetic blood pressure and 
heart rate ъеге recorded three times in the first third 
and the last minute of the test A blood sample for 
plasma catecholamines was taken in the last 15 s of the 
test followed bv sampling for receptor measurements 
Beta adrenoceptor characteristics were measured as de­
scribed earlier (111 С - ) 1 " ! lodocyanopmdolol binding 
to intact Ivmphocytes was measured in the presence 
or absence of 10 mol/1 COP 12P"7 after an incubation 
of 1 h at З^С Beta2 adrenoceptor density ( B ^ J and 
afhnit) (Kd) were calculated by subjecting the data to a 
non linear least squares curve fitting procedure using 
the Gauss-Newron algorithm 
The results are expressed as means ± s e Statistical 
comparisons between paired observations were made 
with Student s t test or Vt ilcoxon s rank sum test 
Correlation coefficients were calculated according to the 
Pearson correlation or the non parametric Spearman s 
rank correlation test Ж 0 05 (two sided) was consid 
ered statistically significant 
Results 
Baseline blood pressure in normotensive subjects 
amounted to 105 ± 3/72 ± 2 mmHg not significantly dit 
ferent from the 118 ± 8/81 ± 6 mmHg in the adrenalec 
tomized subjects both however were significantly lower 
than the 161 ± 10/95 ± 4 mmHg of the hvpertensivcs 
The baseline heart rate did not differ between hyper 
tensives and normotensives Although the heart rate 
was higher in adrenalectomized subjects compared with 
normotensives the difference was not statistically sigmf 
icant Adrenaline levels before mental arithmetic were 
similar in normotensives and hypertensives whereas 
thebe values were undetectable in adrenalectomized 
subjects Noradrenaline levels tended to be higher in 
adrenalectomized subjects than in normotensives and 
hypertensives but the difference was not staustically sig 
nificant Baseline Β ^ was higher in hyjìertensives and 
adrenaleaomi/ed subjects compared with normoten 
bives but here also the difference did not reach 
statistical significance 
Table 1 gives the changes induced bv mental arith 
mem There was a significant increase in mean arterial 
pressure at all time points which was not different 
between the three groups In the normotensives and the 
hypertensives the heart rate increased similarly at all 
time points whereas in the adrenalectomized subjects 
the increase in the heart rate seen after 5 mm of mental 
arithmetic was not statistically significant 
Adrenaline levels rase in normotensives and hyper 
tensives but did not differ between the two groups In 
the adrenalectomized subjects adrenaline remained un 
detectable throughout the test Noradrenaline increased 
shghtlv after mental arithmetic in normotensives and 
hypertensives (difference from baseline not statistically 
significant for either group) but did not change in the 
adrenalectomized subjects after the test B™ increased 
by 27% in normotensives and 20% in the hvperten 
sives (differences between groups not significant) There 
was no increase in Вщ« after mental arithmetic m the 
adrenalectomi/ed subjects Kj values were similar and 
within the experimental error in all three groups before 
Table 1 Mental arithmetic (MA) induced changes in mean arter al pressure (MAP) heart rale adrenaline noradrenaline β adrenoceptor 
density (Β™,) and aft η ty (K,,) in normotensive (Nt) hypertensive (Ht) and adrenalectomized (AE) females 
N1 before MA 
N1 after MA 
HI before MA 
Ht after MA 
AE before MA 
AE afler MA 
MAP 
(mmHg) 
8 3 ± 2 
97 ± 4 
1 I 7 ± 5 
129 ± 5 
94 ± 6 
106 ± 7 
Heart rate 
(beats'm n) 
64 ± 3 
71 ± 6 
6 6 ± 3 
73 ± 3 
73 ± 3 
76 ±4 
Adrenal ne 
(nmoll) 
0 08 ± 0 01 
0 14 ± 0 03 
0 14 + 0 0 5 
0 20 + 0 05 
ND 
ND 
Noradrenal ne 
(ПГТЮІЛ) 
1 11 ± 0 1 3 
1 3 4 ± 0 2 0 
1 30 ± 0 22 
1 52 ± 0 20 
1 65 ± 0 16 
1 62 ± 0 23 
B ™ 
sites/cell 
780 ± 6 8 
9 9 4 ± 9 6 
968 + 110 
1124 ± 125 
887 ± 6 2 
926 ± 72 
K, 
(pmol/l) 
7 0 ± 0 5 
7 3 ± 0 7 
8 7 ± 0 8 
β 2 ± 1 0 
6 9 + 0 5 
6 3 ± 0 5 
ND not delectable below 0 05 nmol/l 
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as well зь after the mental arithmetic No correlation*. 
were found between the percentage changes in the 
heart rate mean arterial pressure, adrenaline and the 
percentage change in Β™ nor between the changes in 
adrenaline and noradrenaline and the change in the 
heart rate or in adrenaline and noradrenaline, and the 
change in mean arterial pressure There was no relation 
between the percentage change in Β,™ and its base­
line values 
Discussion 
Since adrenalet tomized patienus are almost always fe 
males and since sex is an important factor in the 
responbe to stress [121 we decided to studv onl} females 
In the three groups blood pressure and heart rate re 
sponses to the mental arithmetic were similar Recently, 
several groups have demonstrated that in essential hyper 
tensi\es the number of β2 adrenoceptors in circulating 
lymphocytes is increased in comparison with normo 
tensive age matched control subjects [13-15], although 
negative results also ha\e been reported [16 Hj Brodde 
et al [7] found higher baseline values and a smaller in 
сгеале in Kmphocvte ß2 adrenoceptor densitv after 
dynamic exercise in hvpertensives compared Tvith the 
normotensive controls Although Bm„ was higher in 
hypertensive and adrenalectormzed females in our studv, 
the differences did not reach statistical significance owing 
to the small number of females in each group However, 
when the three groups were taken together, no signifi 
cant correlation was found between baseline Β^ ,^ and 
the percentage change in B,^ after mental arithmetic 
A similar increase m B
nUJ( after the mental arithmetic 
was seen in the hvpertensives and the normotensives 
The increased number of receptors in this studv agrees 
well with earlier findings in normal male volunteers [6], 
where we showed that В
т а я
 increased b> about 23% 
after mental arithmetic In the adrenalectomi/ed sub­
jects β adrenoceptor density did not increase during 
mental arithmetic whereas plasma adrenaline remained 
undetectable throughout the test These findings indicate 
that endogenous adrenaline might play a role in the 
short term upregulation of ß-adrenoeeptors in stressful 
situations 
There are at least two reasons for expecting an m 
creased β adrenoceptor density in the adrenalectomi/ed 
females we studied First owing to the lack, of adrenaline, 
an upregulation of β adrenoceptors should be expeaed 
Second all these patients had taken glucocorticoids and 
9 α fluorocortisol Exposure to steroid hormones mav 
lead to an increased β adrenoceptor density enhanced 
coupling and enhanced ademlate qdase acti\it\ [18] 
However our findings in a group of eight females sug 
gest that adrenalectomy docs not lead to a significant 
increase in β; adrenoceptors on lymphoevtes 
From this study we conclude that after mental anth 
metic the short term upregulation of fa adrenoceptors is 
not impaired m essential hvpertenstve females and that 
adrenaline plavs a role in this upregulation 
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SUMMARY 
Although the existence of receptors has been hypothesized 
for about 100 years, they have only been studied directly as 
distinct cellular macromolecules in the past 15 years. The 
development of the technique of radioligand binding has made 
it possible to study receptors more directly. In humans 
direct binding studies have mainly been conducted on blood 
cells. 
This thesis deals with adrenoceptors on human blood cells, 
the structures by which the sympathetic nervous system 
interacts with its target tissues. In the first part 
(chapters 1-3) some fundamental problems and pitfalls of 
direct radioligand binding to =2-adrenoceptors on platelets 
and ß2-aarenoceptors on lymphocytes are discussed. In the 
second part (chapters 4-10) clinical studies are described, 
dealing with measurements of adrenoceptors under baseline 
conditions in essential hypertensives and their age- and sex-
matched controls, and the effect of different stress tests in 
normotensives, essential hypertensives and primary Raynaud's 
patients. In the last chapter the effect of stress in 
adrenalectomized patients is studied in order to elucidate 
the role of adrenaline in the acute upregulation of ß2-
adrenoceptors. 
In chapter 1 (-)125Iodocyanopindolol (12!SICYP) binding to 
intact and to broken lymphocytes is studied. In broken cells 
a loss of binding sites may occur, whereas in intact cells 
additional binding interferes with the correct determination 
of specific radioligand binding. This additional binding can 
be reduced to a minimum by using hydrophylic ligands such as 
CGP-12177 to measure non-specific binding. 
In chapter 2 a study of the kinetics of lrslCYP binding to 
intact lymphocytes is described. Association experiments at a 
concentration of 4 pM 125ICYP demonstrated that equilibrium 
was only reached after 3 hours. However, in the inter-
pretation of the binding experiments it was incorrectly 
assumed that equilibrium would be reached after one hour. 
Incomplete equilibrium gives an underestimate of the affinity 
of about 175 % and an overestimate of the receptor number of 
about 10%. Extending the incubation time to three hours, on 
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the other hand, led to a substantial loss of cells and 
therefore to an underestimate of the receptor number. 
Therefore, an incubation time of one hour is recommended for 
the determination of the ß2-adrenoceptor density with 
123ICYP. 
Chapter 3 contains an overview of the literature on 
studies of the characteristics of radioligand binding to «2-
adrenoceptors on human platelets in relation to several 
physiologic and pathophysiologic entities. A comparison is 
made with our own studies of 3Hrauwolscine binding to human 
platelets. Data in the literature about =2-adrenoceptors in 
several disorders are not uniform. This may be caused by 
methodological factors such as the choice of the radioligand, 
cell preparations, incubation buffers or definition of the 
non-specific binding, as well as the selection of the patient 
groups and the conditions of blood sampling. When all these 
factors are taken into account, "z-adrenoceptors on human 
platelets may be a promising tool for studying possible 
disorders at the receptor level in relation to those 
diseases, where involvement of the sympathetic system is 
suspected. Receptor density in intact cells as well as 
membrane fractions in our experiments correspond quite well 
with those found by others. The affinity of 3Hrauwolscine to 
«¡.-adrenoceptors is in the same order as found with ^yohim-
bine, which is a stereoisomer of rauwolscine. For measuring 
«z-adrenoceptor density and antagonist affinity on platelets 
our methods seem to be suitable. 
In chapter 4 the properties of platelet «z-adrenoceptors 
and lymphocyte ß2-adrenoceptors are discussed, as measured in 
66 patients with essential hypertension and 67 normotensive 
control subjects, under baseline conditions. The results are 
compared with plasma catecholamines, plasma renin activity 
and urine sodium excretion, which were measured at the same 
time. «2- and ß2-Adrenoceptor density as well as antagonist 
affinity to both receptor subtypes did not differ between 
both groups. The most important correlations observed, after 
the relations between all the parameters measured had been 
studied are: In the total group a correlation between p2-
adrenoceptor density with systolic blood pressure and 
adrenaline was found. In the separate groups there was a 
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positive correlation between the «2-adrenoceptor density and 
age in the hypertensive patients, whereas this correlation 
was negative in the normotensives. Furthermore, there was a 
positive correlation between the œ2-adrenoceptor density and 
plasma renin activity in the normotensives, but no such 
correlation in the hypertensives. In the normotensives, a 
positive correlation between the ßz-adrenoceptor density with 
age, Quetelet's index, systolic blood pressure and plasma 
adrenaline is found. 
The effect of mental arithmetic on plasma catecholamine 
and adrenoceptors on blood cells in 14 normotensive young 
male volunteers is described in chapter 5. It is concluded 
that, after mental stress, upregulation of ß2-adrenoceptors 
on lymphocytes can take place very quickly in the absence of 
an effect on the «z-adrenoceptor density on platelets. 
In chapter 6 adrenoceptors on blood cells are studied in 
20 patients with essential hypertension and 20 age- and sex-
matched controls before and after mental arithmetic. There 
were no significant differences between the two groups in 
responses of blood pressure, forearm blood flow and heart 
rate to mental arithmetic. Baseline values and changes in 
adrenaline and noradrenaline levels during mental arithmetic 
were similar in normotensives and hypertensives. «2-
Adrenoceptor density and antagonist affinity did not differ 
between both groups and were not influenced by the stress 
test. Baseline values of ßz-adrenoceptor density did not 
differ either between the hypertensive patients and their 
controls and they increased similarly after the test in both 
groups. Antagonist affinity to the ß2-adrenoceptors under 
baseline conditions was lower in the hypertensives, for which 
we did not find a proper explanation. 
The effect of handgrip isometric exercise on plasma 
catecholamines and adrenoceptors on blood cells in 13 
essential hypertensive patients and 10 age- and sex-matched 
normotensive controls is investigated in chapter 7. Whereas 
systolic blood pressure increases were similar in normo- and 
hypertensives, diastolic blood pressure and heart rate 
increased more in the former than in the latter group. 
Responses similar to those found after mental arithmetic at 
the «z- and ßz- adrenoceptor level were seen after handgrip 
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isometric exercise, showing no differences between normo- and 
essential hypertensive subjects. 
To find out whether the newly exposed ßz-adrenoceptors 
after stress are functional, the effect of isotonic bicycle 
exercise on lymphocyte receptors as well as cAMP production 
is investigated in chapter 8. An increase in 56% of the ß2-
adrenoceptor numbers was seen. Whereas baseline and forskolin 
(a non-receptor mediated stimulator of adenylyl cyclase) 
induced cAMP accumulation were similar before and after 
exercise, isoprenaline stimulated CAMP production increased 
by 68 %, which was in the same order of magnitude as the 
increase of the receptor density. This leads to the 
conclusion that the increased ß2-adrenoceptors induced by the 
bicycle test are indeed functional. 
In chapter 9 the effect of isotonic bicycle exercise is 
investigated. Whereas mental stress and handgrip isometric 
exercise induce a similar increase of (^-adrenoceptors on 
lymphocytes of 14-27 %, the bicycle exercise test elicits a 
much higher increase in 32-adrenoceptors of about 60 %. No 
differences were seen in =:z-adrenoceptor numbers on platelet 
membranes before and after exercise in both groups. 
Normotensives and essential hypertensives did not differ in 
their haemodynamic responses or effects at the plasma 
catecholamine and receptor levels. A positive correlation was 
found between the percentage increase of adrenaline and the 
percentage increase of the f}2-adrenoceptor density on 
lymphocytes after exercise. This indicates that adrenaline 
may play a role in the short-term upregulation of pz-
adrenoceptors. 
In chapter 10 adrenoceptors on blood cells are studied 
in 24 patients with primary Raynaud's phenomenon and 24 age-
and sex-matched controls. In two subgroups a mental stress 
test and a local cold challenge by a finger cooling test were 
performed. Baseline diastolic blood pressure was lower in the 
control group, whereas baseline skin microcirculation was 
lower in the group with a primary Raynaud's phenomenon. 
Baseline plasma noradrenaline and «z-adrenoceptor density 
were elevated in the patient group. Mental arithmetic induced 
an increase in skin microcirculation in the patients, but a 
decrease in the control group. No differences in adrenoceptor 
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reactivity between both groups after either of the tests were 
observed. However, when the ratio β2/=2 adrenoceptor numbers 
was studied after mental stress a significant increase in 
this ratio was only observed in the patient group. It is 
concluded that in primary Raynaud's patients a defect at the 
level of the regulation of the «2-adrenoceptor numbers may be 
present. 
To study the role of adrenaline in the upregulation of β2-
adrenoceptors on lymphocytes after stress, a mental 
arithmetic test was performed in 8 adrenalectomized, 8 
hypertensive and 8 age-matched control females. Adrenaline 
was undetectable before as well as after the test in the 
adrenalectomized patients. Baseline values of β2-
adrenoceptors did not differ between the three groups. In the 
normo- and hypertensive females the increase in ß2-
adrenoreceptor density was 27% and 20%, respectively, after 
mental arithmetic. In contrast to the other two groups there 
was no change in receptor density in the adrenalectomized 
females during the test. These findings once more suggest 
that adrenaline plays a role in the short-term upregulation 
of ß2-adrenoceptors after stress tests. 
GENERAL CONCLUSIONS 
For the measurement of ß2-adrenoceptors on human 
lymphocytes, preference should be given to intact cells 
instead of membrane fractions. :l25Iodocyanopindolol is a 
suitable radioligand with a high specific activity and a high 
affinity to the ß2-adrenoceptor. To prevent interference of 
additional binding or trapping of the radioligand with the 
estimate of the specific binding, the hydrophylic 
radioligand CGP-12177 can be used to determine non-specific 
binding. One hour of incubation in 125Iodocyanopindolol 
binding to lymphocytes is not sufficient to reach equilibrium 
at the lower radioligand concentrations. Whereas this has 
practically no consequences for a proper estimate of the 
receptor density, a considerable underestimateon of the 
antagonist affinity is seen. 3Hrauwolscine can be used to 
measure œ2-adrenoceptor density and antagonist affinity in 
human platelet membranes. However, to study the receptor 
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effector coupling further experiments are required. 
No differences were found in adrenoceptor characteristics 
between essential hypertensive patients and their age- and 
sex-matched controls. Different stress tests provoke similar 
effects at the adrenoceptor level in essential hypertensives 
and their controls. 
In patients with primary Raynaud's phenomenon indications 
were found for a defect at the «^-adrenoceptor level. 
Adrenaline seems to play an important role in the acute 
upregulation of ß2-adrenoceptors on lymphocytes. A question 
that has not yet been resolved is, whether the acute increase 
in ßz-adrenoceptors on lymphocytes reflects a real increase 
in receptor number or whether reflects a change in lymphocyte 
population induced by the period of stress. 
In general it is concluded that adrenoceptor 
characteristics and reactivity do not differ between 
essential hypertensives and their age- and sex-matched 
controls. 
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SAMENVATTING. 
Hoge bloeddruk (hypertensie) komt voor bij ongeveer 10 % 
van de bevolking. In meer dan 90 % van de gevallen is de 
oorzaak van de verhoogde bloeddruk onbekend en spreekt men 
van essentiële of primaire hypertensie. Ondanks vele 
onderzoekingen in de afgelopen decennia verricht, heeft men 
geen enkel orgaan of regelsysteem kunnen aanwijzen waarin de 
oorzaak van essentiële hypertensie gelegen is. Dit heeft er 
toe geleid de pathogenetische grondslag van genoemde 
aandoening niet toe te schrijven aan een enkel orgaan of 
regelsysteem, maar aan verschillende factoren, die 
afzonderlijk of in samenhang aanleiding geven tot verhoogde 
bloeddruk: de zogenaamde mozaïektheorie (Page 1947 en 1982). 
In deze mozaïek theorie neemt het sympathische zenuwstelsel 
een belangrijke plaats in (figuur 1 in de inleiding). 
Bij de bestudering van het sympathische zenuwstelsel doen 
zich twee hoofdproblemen voor. Het eerste betreft de nauwe 
verwevenheid die het sympathische systeem heeft met de andere 
systemen die de bloeddruk reguleren. Hierdoor is het moeilijk 
dit onderdeel afzonderlijk te bestuderen en is het niet goed 
mogelijk om bij gevonden afwijkingen een uitspraak te doen of 
men hier te maken heeft met een oorzaak of een gevolg van 
verhoogde bloeddruk. Een tweede probleem betreft de metingen 
zelf. Aangezien directe metingen aan het sympathische systeem 
bij de mens moeilijk zijn uit te voeren, zijn we aangewezen 
op indirecte parameters zoals het meten van veneuze 
adrenaline- en noradrenalinespiegels. Ofschoon sommige 
studies een verhoogd (nor)adrenaline gehalte in het bloed van 
patiënten met essentiële hypertensie hebben aangetoond, is de 
betekenis van deze bevinding nog omstreden, juist omdat het 
een indirecte maat betreft. Het is namelijk maar de vraag in 
hoeverre bloedspiegels representatief zijn voor hoeveelheden 
die aan de zenuwuiteinden (synaps) vrijkomen. Deze bepalen 
immers de activering van het effectororgaan, bijvoorbeeld de 
gladde spieren in de wand van de bloedvaten. 
De interactie tussen het sympathische systeem en de 
diverse weefsels vindt plaats via eiwitten in het 
plasmamembraan, adrenoceptoren genaamd. Het is mogelijk 
metingen aan deze structuren te verrichten met behulp van 
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radioactief gemerkte hormonen of farmaca, die een hoge 
affiniteit voor deze adrenoceptoren hebben. Receptoren en 
stoffen die hiermee een binding aangaan werken als een slot 
en een sleutel. Stoffen (farmaca) die een receptor kunnen 
bezetten en vervolgens een effect kunnen veroorzaken worden 
agonisten genoemd (sleutel past op het slot en is om te 
draaien). Farmaca die een receptor kunnen bezetten maar geen 
effect veroorzaken worden antagonisten genoemd (sleutel is in 
het slot te steken, maar kan niet omgedraaid worden). Al naar 
gelang de voorkeursvolgorde van bepaalde stoffen om 
receptoren te bezetten worden de receptoren onderverdeeld. We 
onderscheiden =- en ß-adrenoceptoren, afhankelijk van het 
feit of adrenaline (œ) of isoprenaline (p) een hogere 
affiniteit heeft voor de receptor. Een verdere onderverdeling 
in œi-, =2-, βχ- en ß2-adrenoceptoren is mogelijk. 
De techniek van de directe receptor-bindingstudie is vrij 
eenvoudig. Radioactief gemerkte farmaca in opklimmende 
concentraties worden gedurende enige tijd geïncubeerd met 
weefsel- of celsuspensies, waarop de te onderzoeken receptor 
zich bevindt. Omdat de door ons onderzochte receptoren 
onoplosbaar zijn, kan na verloop van tijd de aan de receptor 
gebonden en de nog vrij in oplossing voorkomende radiofarmaca 
door middel van filtratie of centrifugatie van elkaar 
gescheiden en de radioactiviteit gemeten worden. Doordat het 
radiofarmacon ook gebonden wordt aan andere structuren in het 
weefsel dan de receptor (aspecifieke binding), dient hiervoor 
gecorrigeerd te worden. Daarom wordt eveneens de 
radioactiviteit gemeten van de suspensies na incubatie met 
radiofarmaca in aanwezigheid van een overmaat niet-
radioactief farmacon. Op theoretische gronden kan aangenomen 
worden dat de onder deze omstandigheden gemeten gebonden 
radioactiviteit overeenkomt met de aspecifieke binding. Door 
de aspecifieke binding van de totale binding af te trekken, 
wordt de "specifieke" binding verkregen. Door de specifiek 
gebonden en vrije radioactiviteit tegen elkaar uit te zetten, 
wordt een bindingscurve verkregen, waaruit het aantal 
receptoren, en de affiniteit van het radiofarmacon voor de 
receptor berekend kan worden (zie figuur 3 van de inleiding 
als voorbeeld). In werkelijkheid is dit proces minder 
eenvoudig dan hier beschreven, zoals uit de eerste 
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hoofdstukken van dit proefschrift moge blijken. 
Wij stelden ons ten doel te onderzoeken of bij patiënten 
met essentiële hypertensie de eigenschappen van de 
adrenoceptoren anders is dan bij gezonde personen. Metingen 
rechtstreeks in de weefsels, die relevant zijn voor de 
bloeddrukregulatie, zoals het gladde spierweefsel in de 
arteriolenwand, zijn bij de mens niet mogelijk. Daarom zijn 
alleen de adrenoceptoren op bloedcellen bestudeerd. 
Aangenomen wordt dat de eigenschappen van deze receptoren 
representatief zijn voor die van receptoren in de 
bloedvaten, maar dit is niet bewezen. 
Het eerste deel van dit proefschrift (hoofdstuk 1-3) gaat 
over een aantal methodologische problemen bij de bestudering 
van de <»2-adrenoceptor in bloedplaatjes en de ß2-adrenoceptor 
in mononucléaire cellen (in de rest van het proefschrift 
lymfocyten genoemd; dit zijn bepaalde witte bloedcellen). Het 
tweede deel (hoofdstuk 4-10) omvat klinische studies waarin 
de resultaten van metingen aan adrenoceptoren in bloedcellen 
bij de mens worden beschreven. Deze metingen vonden plaats 
onder basale omstandigheden, maar omdat bepaalde afwijkingen 
slechts naar voren treden wanneer het sympathische 
zenuwstelsel moet reageren op veranderingen, zijn er ook 
metingen gedaan na een aantal provocaties of stress tests. 
Dit is gedaan bij patiënten met essentiële hypertensie en bij 
gezonde vrijwilligers met normale bloeddruk, die qua leeftijd 
en geslacht overeenkwamen met de patiëntengroep. In het 
voorlaatste hoofdstuk worden de resultaten van studies aan 
adrenoceptoren besproken bij een groep patiënten, die lijden 
aan een syndroom, dat wordt gekenmerkt door het snel onstaan 
van koude handen en/of voeten en het primaire Raynaud-
fenomeen wordt genoemd. Het kan optreden na koude, maar ook 
na emoties, die vaatkrampen veroorzaken. In het laatste 
hoofdstuk is het effect van stress op de adrenoceptoren bij 
een aantal patiënten onderzocht, bij wie de bijnieren vroeger 
waren verwijderd, en die dus nauwelijks of geen adrenaline 
meer kunnen aanmaken. 
In hoofdstuk l is de binding van het radiofarmacon (-
)X25Iodocyanopindolol (X25ICYP; een antagonist voor de (Jz-
adrenoceptor) aan intacte lymfocyten en aan membraan-
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suspensies van lymfocyten vergeleken. Bij membraansuspensies 
werd een verlies aan p2-adrenoceptoren gezien. Bij intacte 
cellen werd een vals hoog aantal specifieke bindingsplaatsen 
gemeten door interferentie van additionele bindingen, 
waaronder vermoedelijk opname van het radioligand in de cel. 
Dit laatste kon voor een groot deel verhinderd worden door 
bij het meten van de aspecifieke binding gebruik te maken van 
een hydrofiele ß-blokkerende stof, CGP-12177. 
Hoofdstuk 2 omvat kinetische studies van ^"ICYP binding 
aan intacte lymfocyten. Associatie-experimenten lieten zien 
dat bij een concentratie van 4 pM 12SICYP pas na 3 uur een 
evenwichtsituatie werd bereikt. De consequentie van het niet 
bereiken van evenwicht voor de interpretatie van de 
bindingstudies, onder de onjuiste aanname dat wél evenwicht 
is bereikt na 1 uur incuberen, wordt besproken. Voor de 
affiniteit betekent dit een onderschatting van 175%, voor de 
ßz-adrenoceptor-dichtheid een overschatting van 10%. 
Aangezien verlenging van de incubatietijd een aanzienlijke 
achteruitgang van het aantal receptoren veroorzaakte ten 
gevolge van een afname van het aantal cellen, is in de 
verdere studies een incubatietijd van 1 uur gehanteerd. 
In hoofdstuk 3 wordt een literatuuroverzicht gegeven van 
de «^-adrenoceptor op humane bloedplaatjes. Deze gegevens 
worden vergeleken met onze eigen resultaten betreffende 
binding van het radiofarmacon 3Hrauwolscine aan intacte 
humane bloedplaatjes en membraan suspensies van 
bloedplaatjes. De door ons gevonden waarden voor de 
antagonist-affiniteit en het receptoraantal van de "=2-
adrenoceptor op bloedplaatjes komen goed overeen met de in 
de literatuur opgegeven waarden. 
Bij 66 patiënten met essentiële hypertensie en 67 gezonde 
personen met een normale bloeddruk werden de eigenschappen 
van de adrenoceptoren op bloedcellen gemeten. De resultaten 
zijn beschreven in hoofdstuk 4. Tegelijkertijd werden een 
aantal andere factoren gemeten, die op zichzelf van invloed 
zijn op de bloeddruk. Het betrof de bepaling van 
catecholamine (adrenaline en noradrenaline) en renine gehalte 
in het bloed en de zoutuitscheiding in de urine. Er werden 
geen verschillen gezien tussen beide groepen wat betreft de 
aantallen en de antagonist-affiniteiten van zowel de и
г
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adrenoceptoren op bloedplaatjes als de pa-adrenoceptoren op 
lymfocyten. Voorts werd gekeken naar correlaties tussen de 
aantallen van beide adrenoceptor subtypen enerzijds en de 
andere gemeten variabelen anderzijds, om mogelijke relaties 
op te sporen. Uit deze berekeningen kwamen geen sterk 
significante relaties naar voren. 
In hoofdstuk 5 is bij 14 gezonde vrijwilligers het effect 
van mentale stress, middels een 5 minuten durende 
hoofdrekentest op de catecholamineconcentraties in het plasma 
en de aantallen adrenoceptoren van bloedcellen onderzocht. De 
conclusie van dit onderzoek was dat tijdens de test het 
aantal ßz-adrenoceptoren op lymfocyten met 23% toenam, 
terwijl het aantal «z-adrenoceptoren op bloedplaatjes 
onveranderd bleef. 
In hoofdstuk 6 is bij 20 patiënten met essentiële 
hypertensie en een controlegroep van 20 personen met normale 
bloeddruk het effect van een hoofdrekentest op bloeddruk, 
hartslag, onderarmsdoorbloeding, catecholaminespiegels en 
adrenoceptoren op bloedcellen onderzocht. Beide groepen 
bleken op dezelfde wijze te reageren voor wat betreft de 
gemeten variabelen. 
Hetzelfde kan gezegd worden van de in hoofdstuk 7 
beschreven studie, waarin het effect van isometrische 
spierarbeid door middel van een "handgriptest" werd gemeten, 
bij patiënten met hoge en met normale bloeddruk. 
Om na te gaan of het aantal meetbaar toegenomen 32-
adrenoceptoren op lymfocyten na een stress test ook werkelijk 
functioneel is, werd in hoofdstuk 8 onderzocht in hoeverre 
een bij 9 vrijwilligers uitgevoerde fietstest niet alleen 
invloed had op de ß2-adrenoceptoren van lymfocyten, maar ook 
op de productie van CAMP. cAMP is de "second messenger", die 
in de cel ontstaat, wanneer deze geactiveerd wordt via een 
functionerende receptor. Hierbij werd gebruik gemaakt van 
isoprenaline, dat een specifieke agonist is voor ß-
adrenoceptoren. Het aantal receptoren nam tijdens de test toe 
met 56%. Dit ging gepaard met een toename van de door 
isoprenaline stimuleerbare intracellulaire cAMP ophoping van 
68%. Uit deze uitkomsten wordt geconcludeerd, dat de nieuw 
geëxposeerde receptoren inderdaad functioneel zijn. 
In hoofdstuk 9 werd het effect van een dynamische 
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inspanning (fietstest) op bloeddruk, hartslag, het gehalte 
aan catecholamines in het plasma en adrenoceptoren op 
bloedcellen onderzocht bij 10 patiënten met essentiële 
hypertensie en 10 gezonde vrijwilligers. Terwijl na de 
"handgrip" en de hoofdrekentest een toename in ß2-
adrenoceptoren werd gezien, die in de orde van grootte van 
14-27% lag en die in beide groepen gelijk was, werd nu een 
stijging gevonden van ongeveer 60%, zowel bij de 
hypertensiepatienten als bij de gezonde proefpersonen. Er 
werd een positieve correlatie gevonden tussen de procentuele 
stijging van het aantal ß2-adrenoceptoren en de procentuele 
stijging van de adrenalinespiegel tijdens de test. Dit 
laatste geeft aan dat adrenaline mogelijk een rol speelt bij 
de acute "up-regulatie" van ß2-adrenoceptoren op lymfocyten. 
Evenals bij de hoofdrekentest en de "handgriptest", 
veranderden ook gedurende het fietsen de dichtheid van de 
»z-adrenoceptoren en de antagonist affiniteit niet. 
In hoofdstuk 10 zijn 24 patiënten met het primaire 
fenomeen van Raynaud vergeleken met een controle groep van 24 
gezonde proefpersonen wat betreft bloeddruk, hartslag, 
huiddoorbloeding van de hand, plasmacatecholamines en de 
adrenoceptoren op bloedcellen. Bij de patiënten was de 
diastolische bloeddruk hoger, terwijl de huiddoorbloeding 
lager was dan bij de controles. Daarnaast werd bij de 
patiënten zowel een verhoogd noradrenalinegelialte als een 
groter aantal «z-adrenoceptoren op bloedplaatjes gevonden. 
Bij twee subgroepen werd respectievelijk een hoofdrekentest 
en een koude-provocatietest (afkoeling van de hand) 
uitgevoerd. Gelijke reacties op receptor niveau werden 
gezien in zowel de patiëntengroep als de controlegroep. Dit 
gold voor beide tests, ofschoon de ratio ßz/^z 
adrenoceptordichtheid na de hoofdrekentest bij de 
patiëntengroep wel, maar bij de controlegroep geen 
statistisch significante stijging liet zien. Deze bevindingen 
wijzen in de richting van een mogelijke afwijking in de 
regulatie van de aantallen adrenoceptoren bij patiënten met 
het primaire fenomeen van Raynaud. 
Om de mogelijke rol van adrenaline bij de acute toename 
van ßz-adrenoceptoren op lymfocyten nader te bestuderen, werd 
bij 8 vrouwen bij wie wegens de ziekte van Cushing de 
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bijnieren verwijderd waren het effect van een hoofdrekentest 
op de plasmacatecholamines en de ßz-adrenoceptoren op 
lymfocyten bestudeerd. Ter vergelijking werden de 
onderzoekingen eveneens uitgevoerd bij 8 vrouwen met 
essentiële hypertensie en 8 gezonde vrouwen met een normale 
bloeddruk, die qua leeftijd overeenkwamen met de boven-
genoemde groep. De resultaten worden beschreven in hoofdstuk 
11. Bij de normotensieve en hypertensieve vrouwen werd een 
toename in het aantal p2-aärenoceptoren op lymfocyten gezien 
van respectievelijk 27 en 20 % tijdens de test. In tegen-
stelling tot de twee andere groepen, werd bij de vrouwen 
zonder bijnieren geen stijging in aantal ßz-adrenoceptoren 
gezien, terwijl het adrenaline gehalte in het plasma zowel 
voor als na de test onmeetbaar laag was. De bevindingen vor-
men andermaal een aanwijzing dat adrenaline een rol speelt in 
de acute "up-regulatie" van ß2-adrenoceptoren op lymfocyten. 
Algemene conclusies 
Samenvattend kan gesteld worden dat er geen verschillen 
zijn gevonden in aantallen «z- en ßz-adrenoceptoren en 
antagonist-affiniteiten voor deze receptoren op bloedcellen 
tussen patiënten met essentiële hypertensie en mensen met een 
normale bloeddruk. De beide groepen verschilden ook niet wat 
betreft de veranderingen in de eigenschappen van de adreno-
ceptoren, zoals die werden gemeten op bloedcellen na diverse 
provocatietests. 
Dit onderzoek heeft dus geen aanwijzingen opgeleverd voor 
een abnormale regulatie van de adrenoceptoren bij essentiële 
hypertensie. Wel is het zeer waarschijnlijk geworden dat 
adrenaline, in tegenstelling tot noradrenaline, een 
belangrijke rol speelt bij de acute "up-regulatie" van de ßz-
adrenoceptoren bij diverse vormen van stress. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd geboren op 25 april 
1949 te Bolsward. Na het behalen van het einddiploma HBS-B 
aan het Katholiek Veluws College te Apeldoorn in 1967 begon 
hij met de studie Biologie aan de Katholieke Universiteit te 
Nijmegen (kandidaatsexamen 1970, doctoraalexamen 1977, met 
als bijvakken Farmacologie en Dierecologie en als hoofdvak 
Chemische Microbiologie). In 1973 werd een aanvang gemaakt 
met de studie Geneeskunde aan dezelfde Universiteit 
(kandidaatsexamen 1974, doctoraalexamen 1976, artsexamen 
1979). Tot januari 1980 vervulde hij de militaire 
dienstplicht (keuringsarts, Knoopkazerne te Utrecht). Van 
januari 1980 tot januari 1985 was hij in opleiding tot 
internist in de Kliniek voor Inwendige Ziekten van het St 
Radboudziekenhuis te Nijmegen (opleider: Prof. Dr. A. van 't 
Laar). Aansluitend werd het onderzoek voortgezet, waarmee 
tijdens de opleiding tot internist reeds een begin gemaakt 
was en waarvan dit proefschrift het resultaat is. Sedert 
april 1988 is hij op part-time basis werkzaam bij het College 
ter Beoordeling van Geneesmiddelen. 
Hij is getrouwd met Wil Rijnvos, kinderarts te Soest. Zij 
hebben 3 kinderen Simon, Eva en Inge. 
STELLINGEN 
1. Patienten met essentiële hypertensie en gezonde mensen 
met een normale bloeddruk verschillen niet in aantal 
adrenoceptoren en in de antagonist-affiniteit van de 
receptoren, noch in de reactie van deze receptoren op 
diverse vormen van stress. 
-dit proefschrift-
2. Adrenaline speelt, in tegenstelling tot noradrenaline, 
een belangrijke rol bij de acute "upregulation" van ß2-
adrenoceptoren op lymfocyten. 
-dit proefschrift-
3. Bij de meting van aantallen receptoren op intacte 
cellen moet rekening gehouden worden met interferentie 
door opnameprocessen, waardoor een te hoog aantal 
gevonden kan worden. 
-dit proefschrift-
4. Het vermelden van de tijd nodig om evenwicht te bereiken 
bij een bimoleculaire reactie (farmacon-receptor-
interactie in receptor-bindingstudies) heeft slechts zin 
als tevens vermeld wordt bij welke concentraties van de 
reactiepartners de bepaling heeft plaatsgevonden. 
-dit proefschrift-
-McArdle S et al. J Pharmacol Exp Ther 1989,248:12-16. 
5. Direct na een stress-test is het aantal ß2-adreno-
ceptoren op lymfocyten toegenomen. Deze receptoren 
functioneren normaal, daar het ontstaan van cAMP in de 
cellen, als reactie op stimulering met isoprenaline, is 
toegenomen. 
-dit proefschrift-
6. De plasmaspiegel van onverzadigde vrije vetzuren, die in 
staat zijn het enzym Na,K-ATP'ase te remmen en via dit 
mechanisme bloeddrukverhogend zouden kunnen werken, is 
verhoogd bij patiënten met essentiële hypertensie. 
-Swarts HGP et al. J Hypertension 1988, 6(suppl.4): 
S693. 
7. De levensprognose van de patient met insuline-afhan-
kelijke diabetes wordt hoofdzakelijk bepaald door het al 
dan niet optreden van diabetische nefropathie. 
-Borch-Johnsen К et al. Diabetologia 1985, 28:590-596. 
8. Naast erfelijke afwijkingen in het •low-density-
lipoprotein'-receptormolekuul kan 'familiaire hyper-
cholesterolemie' ook worden veroorzaakt door een defect 
in apolipoproteïne B-100. 
-Innerarity Th et al. Proc Natl Acad Sci 1987, 84: 
6919-6923. 
9. De vroege registratie van zidovudine voor de behandeling 
van AIDS staat onderzoek naar werkingsmechanismen en 
effecten op lange termijn in de weg en werkt 
uiteindelijk in het nadeel van de patiënten. 
-J Infect Dis 1989, 159:412-415. 
10. Gezien het antagonisme tussen Coffeine en dipyridamol is 
,201Thallium-myocardscintigrafie na dipyridamolinfusie' 
als diagnostische test voor coronarialijden zinloos 
indien de patient kort tevoren koffie of thee heeft 
gebruikt. 
-Smits Ρ et al. Nucl Med Commun 1989, 10:207-208. 
11. De huidige neiging om hoogleraren slechts dan te 
benoemen en onderzoekprojecten slechts dan te 
subsidieren, wanneer zij passen in een locaal 
•zwaartepunt', werkt verstarrend en bedreigt de 
creativiteit en de kwaliteit van onderzoek, onderwijs en 
academische patiëntenzorg. 
12. Medicamenten worden door het College ter Beoordeling van 
Geneesmiddelen onderzocht op de balans tussen 
werkzaamheid en schadelijkheid. In navolging hiervan 
verdient een dergelijke beoordeling van ambtenaren 
aanbeveling. Dit kan uitgevoerd worden door het op te 
richten College ter Beoordeling van de Bureaucratie. 
13. Het door de overheid gevoerde beleid ten aanzien van het 
onderwijs bewijst eens te meer dat deze sector van een 
prioriteit een posterioriteit is geworden. 
14. Het plan, tandartsen voortaan de opsporing van verhoogde 
bloeddruk in hun praktijken te laten uitvoeren, toont 
aan dat er in de markt nogal wat gaten zijn te vullen. 
-Abraham-Inpijn L en Gortzak RATh. Ned Tijdschr 
Geneeskd 1989, 133:604-606. 
15. Biologische systemen blijven bestaan dankzij kringloop-
mechanismen op cellulair, organisch, individueel of 
ecologisch niveau. Het doorbreken van een kringloop 
betekent op de duur het einde van het systeem. De mens, 
die zich in zijn handelen slechts laat leiden door 
groeipercentages zal eenzelfde lot beschoren zijn. 
Nijmegen, 25 mei 1989 
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